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Preface 
Surgical treatment of malignancies within the abdominal cavity is regularly complicated 
by peritoneal tumour recurrence. Peritoneal tumour recurrence refers to the 
convalescence of tumour foci on the peritoneal membrane lining the abdominal cavity. 
The underlying mechanisms of tumour recurrence are not fully clear. To elucidate this, 
a profound understanding of the anatomy of the peritoneum and its elementary 
response to surgical trauma is essential. 
The flaring up of an inflammatory reaction followed by the initial steps of wound healing 
are the first signs of regeneration after surgical trauma to the peritoneum. During these 
processes, Pandora's box of cytokines and growth factors is opened with a potentially 
ambiguous influence on tumour recurrence. 
This thesis addresses the multi-factorial response of the peritoneum after surgical 
injury, clarifying different pathways of stimulated tumour recurrence. 
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Part I 

Chapter I 
GENERAL INTRODUCTION 
The peritoneum 
The peritoneum is the largest and the most complex arranged serous membrane in the 
body that lines both the intra-abdominal wall and the viscera contained within the 
peritoneal cavity. It is capable of walling off infections and has several functions such 
as the ability to synthesise, secrete or absorb. The peritoneum diminishes friction 
among abdominal viscera, thereby enabling their free movement. 1-4 With a surface 
area of some 10,000 cm2 in adults5, almost equal to that of the skin, this membrane 
may be considered among the largest organs in humans. The peritoneal cavity 
normally contains less than 100 ml of serous fluid that resembles an ultrafiltrate of 
plasma and contains less than 3 g/dl protein.6 Taken together the surface area and the 
functional capacity of the peritoneum, this enables the peritoneal cavity to be used for 
continuous ambulatory dialysis (CAPO) as well as an internal reservoir during drainage 
procedures (i.e. ventriculoperitoneal shunts). 
The peritoneum and the serosal surfaces of organs within the peritoneal cavity are 
composed of mesothelium and sub-mesothelial connective tissue. Highly differentiated 
mesothelial cells, resting on a basement membrane, overly the connective tissue. 
Embedded in this layer are numerous blood vessels and lymphatics. In terms of blood 
supply per mass, the peritoneum is one of the most richly vascularised organs. 3 ;4;7 
Interspersed among the connective tissue are poorly differentiated, epithelioid-like cells 
similar to fibroblasts (figure 1.1 )4;8'10 
Injury of the peritoneum triggers a series of events aimed at mesothelial regeneration. 
Some of the prinCipal elements in the regenerative process are leukocyte influx into the 
abdominal cavity, fibrin deposition and activation of both peritoneal macrophages and 
the normally quiescent mesothelial cells. 3;7;11 
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Schematic representation of the peritoneum. 8M: basement membrane; PMN: leukocyte: 
M~:macrophage; E: epithelioid cells; Call: collagen eo us fibers; V: vasculature. 
Mesothelial cells 
The mesothelium consists of a single layer of flattened cells with epithelioid 
morphology. The mesothelial cells produce a lubricating suriactant that allows easy 
gliding of opposing peritoneal suriaces. In addition, long microvilli project from the 
apical surface of the cells to minimise the shear between facing peritoneal 
surfaces. 8;9;12-16 
Electron microscopic studies show that mesothelial cells are joined peripherally through 
tight junctions while spot desmosomes provide mechanical stability.9;10;14;15 
Nonetheless, the mesothelium is very susceptible to damage. Any form of injury 
initiates acute changes of peritoneal morphology. Peritonitis is associated with a 
14 
transition in mesothelial morphology from flat to cuboidal, an increase in the 
intercellular space and cell shedding.' Drying, wetting or rubbing causes mainly 
denudation of the mesothelial surface. 15- 18 
Minimal peritoneal tissue trauma already causes a reactive inflammatory response, 
which coincides with the appearance of numerous leukocytes between and on 
mesothelial cells. ' 9;20 Mesothelial cells are multipotential and capable of secreting pro-
and potentially anti-inflammatory mediators and are thus capable of contributing 
significantly to a cytokine network operating to initiate, amplify and control peritoneal 
inflammation (table 1.1).4,21,22 
Cytokines Growth factors Miscellaneous Receptors 
IL_1a23;24 TGF_~7,25-27 GM-CSF"" ICAM-I28-" 
IL -1 ~23;24:31:34 bFGF"'oo RANTES" VCAM-I'"'' 
I L -6 7;24;31 ;37-39 PDGF-A" MCP_1",,",,7 I L -1 ~R24,34 
IL_S7;11'''''o PDGF-B'o IL-1RA" TNF-aR37 
TNF_a37 ;41 IGF_I42-44 PG ,,,,'0 EGF_R'o"o, 
IGF-II" PAl-I ''0 IGF-IR 
Table 1.1 
Secretory products and receptors expressed by mesothelial cells. 
Primary peritoneal defence mechanisms 
Complement activation is an early component of the non-specific peritoneal defence 
mechanisms and involves opsanisation of micro-organisms, enhancement of 
inflammatory response, clearance of immune complexes and cell lysis,49 The normal 
peritoneal cavity contains about 300 cellsimm3, including mainly macrophages plus 
some lymphocytes and desquamated mesothelial cells. Peritoneal injuries induce the 
migration of leukocytes into the peritoneum. Inflammation can result in leukocyte 
counts of more than 3000 cells/mm3,50 Studies of kinetics of macrophage recruitment to 
the peritoneum after induction of acute inflammation show most of the resident 
macrophages disappear from the recoverable peritoneal cell population within the first 
hour. This coincides with the influx of leukocyles and is sustained for at least several 
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days.51 Degranulation of peritoneal mast cells releases vasoactive substances with an 
outpouring of fluid rich in complement and opsins that coat bacteria and promote 
phagocytosis.6 Mesothelial cells have the potential to contribute to the activation and 
control of the inflammatory process, i.e. by generating signals for the recruitment of 
leukocytes into the peritoneum.11 ;22 
Peritonitis 
Inflammation of the peritoneum can be caused by a multitude of factors like bacteria, 
starch and bile. Infectious peritonitis occurs by contamination of the peritoneal cavity 
with micro-organisms. Following surgical trauma of the peritoneum, sterile peritonitis 
generally plays a role. Regardless of the type of peritonitis, a common series of events 
follows. 
When challenged by an inflammatory stimulus, resident peritoneal macrophages 
become activated and begin to secrete cytokines and chemoattractants, which initiate 
the inflammatory cascade. Leukocytes respond to the presence of specific 
chemoattractants and begin to appear in large numbers. Mesothelial cells amplify the 
inflammatory response by generating chemoattractants and cytokines and by 
becoming more adhesive. 11 ;22 
During inflammation morphological changes of the mesothelial cells are also evident. 
An increased number of peritoneal cells adhere to the mesothelium and the continuity 
of the mesothelium is interrupted by rounding of mesothelial cells and the infiltration of 
leukocytes.9;19 
The scientific basis of this non-specific inflammatory reaction within the peritoneal 
cavity is also founded by the lack of difference in cytokine and reactive oxygen species 
production during infectious or sterile peritonitis.7;52 
Surgical Peritoneal Trauma 
Surgical trauma to the peritoneum embraces multiplex pathways of injury, including 
drying, wetting, rubbing and inflammation. Loss of mesothelial integrity after surgery 
may induce a sequence of events, which ultimately leads to fibrous adhesions between 
the visceral and parietal surfaces,z;3;7;lB;53;54 However, fibrosis is inhibited when the 
integrity of the mesothelial cell lining is maintained, the inhibition being attributed to the 
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mesothelium's capacity of fibrinolysis, Development of modus operandi to protect 
peritoneal surfaces from surgical injury and to foster fibrinolysis is among the avenues 
of adhesion prevention research. 18;54-S6 
The pathophysiological sequence from peritoneal injury to permanent fibrous 
adhesions is controlled by the local inflammatory reaction",54 The effect of 
inflammatory cells and cytokines has gained attention in the context of peritoneal 
inflammation and repair, Invading leukocytes have been shown to enhance peritoneal 
injury by adhering to and damaging mesothelial cells through the release of reactive 
oxygen species,57'60 Experimental studies demonstrate a modulating role of leukocytes 
in post operative adhesion formation. 61 ;62 Cytokines reduce fibrinolytic activity of the 
mesothelium. It seems the inflammatory reaction after surgery may enhance 
mesothelial damage and prevent normal mesothelial regeneration. 3;7;54;56 
Minimising peritoneal surgical trauma through the use of minimal invasive techniques is 
a turning point in the development of post~surgical adhesions. 54;56 Laparoscopic 
surgical procedures with their minimal access to the abdominal cavity are probably 
associated with fewer postoperative adhesions compared to open surgery.63;64 
Additionally, laparoscopic surgery appears to impact less on the cellular components of 
the immune response. 65-67 
Acute Phase Response 
Tissue injury induces a constellation of host responses, collectively referred to as the 
acute phase response, aimed at minimising damage and starting the healing 
process,"'" Inflammation is a multifunctional process, with both local and systemic 
features, The primary inflammatory response, the acute phase, is the migration of 
neutrophils, macrophages and other leukocytes to the site of inflammation.6;11;2o;69 
Cytokines are the key mediators of this inflammatory reaction, Tissue injury triggers the 
synthesis and release of several cytokines that act locally, but may also act 
systemicaJly after entry to the blood stream. The cytokine response to operative trauma 
appears to be influenced by the degree of surgical trauma'y°-75 Post-surgical cytokine 
concentrations measured systemically and locally (in the peritoneal fluid) demonstrate 
the cytokine response after abdominal surgery originates largely from the peritoneal 
cavity.74;76 Peritoneal lymphocytes, sub-mesothelial monocytes, leukocytes and 
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mesothelial cells act in an orchestrated response under the control of locally expressed 
cytokines, chemokines and adhesion molecules. The peritoneal membrane and the 
mesothelium in particular, as a site for the production of mediators, playa pivotal role in 
the activation and control of inflammation (figure 1.2)4;21;77;78 
The results of the inflammatory response include ultimate resolution of the 
inflammatory process, by triggering events that lead to cell regeneration and wound 
healing. On the other hand, progression of the inflammatory response may lead to 
progressive organ dysfunction. 68:69;79 Normal inflammatory defences become 
detrimental to the host if the balance between mediators of the inflammatory response 
is IOSt.80;81 
Peritoneal wound healing after surgical trauma 
The response of the peritoneal membrane to acute injuries highlights some of the 
inherent defence mechanisms and reparative properties of this tissue. Normally, the 
mesothelium is a quiescent population of cells with a low endogenous turnover rate. 11 
Minimal damage to the mesothelium causes a detachment of many of these cells, 
denuding the surface and herewith exposing the underlying extra cellular matrix 
components. 16-18 Upon denudation, which occurs fairly easily through wetting 17 , 
drying16;17 or rubbing with surgical gauze18 , the percentage of mesothelial cells 
undergoing mitosis has been reported to increase from less than 3% to as much as 
8%.11;82 
Mesothelial surfaces regenerate in a different way than the skin. The two main 
differences are the way epithelialisation occurs and the consequences of fibrin 
deposition. In addition to centripetal migration as seen in skin injury, in mesothelial 
regeneration small islets of cells intersperse throughout the wound surface.3:7-9;53;83;84 
This implies that large defects require the same time to re-epithelialise as small ones, 
generally completed in seven days, and that peritoneal defects do not have to be re-
approximated to ensure optimal healing. At present, there is considerable debate as to 
the origin of cells that colonise the exposed surface of the peritoneum. Hypotheses 
extend from differentiation of multipotential sub-mesothelial cells to exfoliation and 
proliferation of mesothelial cells from adjacent or opposing suriaces.8;9;82-84 
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Schematic representation of the acute phase response after surgical peritoneal trauma. 
Production of chema-attractants and inflammatory factors by mesothelial cells and 
macrophages leads to an upregulation of cell adhesion molecules and leukocyte recruitment 
from the sub-mesothelial vasculature. Production of growth factors by mesothelial cells and 
macrophages stimulates the wound healing process. 
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Cytokines, growth factors and peritoneal wound healing 
Numerous cytokines and growth factors have a role in the stimulation of a particular 
facet of the healing process, such as angiogenesis, matrix protein deposition or cell 
proliferation. 85-87 Wound healing is based upon the synthesis and release of several 
growth factors and cytokines at the site of injury, which act through autocrine and 
paracrine pathways to regulate healing. Individual and synergistic interactions of 
growth factors and cytokines take place, as well as cross talking between cells. 
In peritoneal wound healing the mesothelium plays an active role by producing 
chemoattractants, prostaglandins, cytokines and growth factors (table 1.1 )4;11;23-25 
Peritoneal macrophages and leukocytes, attracted to the injured site contribute to the 
production of factors to enhance wound healing?:7;25 The microenvironment of the 
wound therefore, contains a plethora of growth factors and cytokines and is a 
prerequisite area for cell proliferation and differentiation. Although the exact 
mechanisms involved in mesothelial healing are controversial, it is certain that the 
healing process requires the activation, proliferation and migration of residual 
mesothelial celis. 7;82 
Cell adhesion molecules 
Cell adhesion molecules provide the possibility for specific cell adhesion to tissue 
surfaces. A number of cell surface associated molecules have been characterised and 
are classified in four groups according to their biochemical structure: integrins, 
immunoglobulin-like proteins, cadherins and selectins.88;89 
Adhesion molecules mediate specific cell-cell or cell-extra cellular matrix interactions. 
Besides a role in physiological cellular communications, an essential role in the 
pathophysiology of disease has been demonstrated. During peritoneal inflammation, 
leukocyte influx across mesothelial cells depends on specific adhesion molecules.29 
Lack of expression or dysfunction of these adhesion molecules causes leukocyte 
adhesion deficiency (LAD) characterised by frequent and overwhelming infections due 
to the inability of leukocytes to infiltrate pathogen-bearing tissues. In contrast, 
inflammatory diseases like psoriasis and arthritis are associated with up regulation or 
over-expression of adhesion molecules.89 
In tumour progression and metastasis, adhesion molecules have also been 
demonstrated to play an essential role. 88;89 The initial attachment of tumour cells to the 
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intact or denuded peritoneal surface is a critical step in establishing tumour 
implantation. Cytokines are known to induce or upregulate adhesion molecules, hereby 
increasing the prospect of cell adhesion?8;32;33;90;91 During wound healing enhanced 
concentrations of cytokines and growth factors in the peritoneal cavity may framework 
a prerequisite area for enhanced cell adhesion. 
Surgery and peritoneal tumour recurrence 
Peritoneal dissemination is a common cause for post surgical tumour recurrence and 
represents the terminal stage of disease.92-95 Distribution patterns of first peritoneal 
recurrence show the resection site is preferential, and combined recurrence on 
peritoneal surfaces and resection site is common.95 Peritoneal recurrence rates of up to 
50% have been reported in patients with gastric cancer. The majority of patients with 
recurrent pancreatic cancer can be found to have peritoneal carcinomatosis. Nearly 
half of all patients who undergo reoperative surgery for recurrent coloredal cancer 
have implants on peritoneal surfaces.96 
Early tumour cell seeding or per~operative spill are the cause of local recurrence or 
peritoneal carcinosis. 92;97-99 With current techniques, disseminated cancer cells are 
detectable in the peritoneal cavity in patients with gastric, colorectal and pancreatic 
cancer. 100 94;101 Previous experimental data has demonstrated that the proliferative and 
metastatic potential of these spilled cells are well preserved.";102 Furthermore, the 
occurrence of tumour cells in the peritoneal cavity has been shown to correlate with the 
postoperative survival rate. Positive peritonea! cytology in patients with gastric, 
colorectal and pancreatic cancer is associated with poor prognosis.94;103-105 
The process of haemotogenic or lymphogenic cancer metastasis consists of a series of 
sequential, interrelated steps including invasion, embolism and transport, arrest in 
organs, adherence and growth.106 In case of peritoneal carcinosis due to pre- or per-
operatively seeded tumour celis, the metastatic process only depends on adherence 
and subsequent growth. Prevention of peritoneal carcinosis by impeding these steps 
offers a promising mode of improving disease free survival. 
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Mechanisms of action in peritoneal tumour recurrence 
Several theories speculate on the fundamental mechanisms in recurrence of spilled 
tumour cells. Implantation strategies of tumour cells include the theory of metastatic 
efficiency and the fibrin entrapment hypothesis. According to the theory of metastatic 
efficiency, implantation of tumour cells onto raw tissue surfaces is an efficient process 
as opposed to inefficient implantation on intact surfaces.95 The fibrin entrapment 
hypothesis proposes that peroperatively spilled tumour cells are trapped in fibrin that 
occurs in the resection site and on abraded peritoneal surfaces. These tumour cells will 
be protected from host defences and systemic chemotherapy causing a high incidence 
of intra-abdominal tumour recurrence. 107 
In peritoneal wound healing, inflammatory and mesothelial cells produce an abundance 
of cytokines and growth factors. 3;7;11;21;23-25 Surgical trauma to the peritoneum may 
therefore induce the release of substances that are also beneficial for tumour growth. 
This makes the surgical wound in particular, a fertile field for tumour growth. 106;108;109 
Apart from stimulated cell growth, tumour cells may profit from the enriched wound 
microenvironment by enhancing the prospect of cell adhesion.32;89;91 This would explain 
tumour recurrence at not directly traumatised peritoneal surfaces. Most likely, 
metastatic cells respond to physiologic signals produced when homeostasis is 
disturbed. Tumour cells that either originate from or have an affinity for growth in a 
particular organ can also respond to these signals.106 
It seems surgical trauma to the peritoneum and the ensuing regeneration may affect 
tumour recurrence in various ways. The experiments described in this thesis aim at 
unravelling pathways of enhanced tumour cell adhesion and growth after surgical 
peritoneal trauma. 
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Chapter II 
AIM OF THE THESIS 
Pre- or per-operatively seeded tumour cells influence the prognosis of patients with 
gastro-intestinal malignancies dramatically. Tumour cells traumatically disseminated 
after surgical dissection cannot be treated using conventional routines. Intra-operative 
irrigation will remove some spillage, but sufficient irrigation of the peritoneal cavity is 
not possible. 
New surgical techniques, like extended lymphadenectomy and wider margins of 
excision, minimise the surgery induced microscopic residua! disease that may result 
from surgical trauma. 110;111 In addition, several experimental approaches to control the 
local recurrence of tumour cells have been initiated. Clinical tfials are investigating the 
possibility of intra-peritoneal chemotherapy.110:112:113 Lavaging the abdominal cavity with 
chemotherapeutic agents will deteriorate the micro milieu for residual tumour cells. 
However, adverse side-effects on wound healing and peritoneal adhesion formation 
obscure success."4-11? Photodynamic therapy (PDT) is another promising approach to 
attack manifest peritoneal tumour recurrence. PDT is a surface oriented, locally 
cytotoxic intervention. Defined tumour foci are specifically eradicated, hereby only 
traumatising restricted areas of the peritoneum.118-120 
The above mentioned therapies are mainly aimed at annulling manifest peritonea! 
tumour foci. A profound understanding of the pathophysiology of tumour recurrence 
may lead to more specific tools to confront the initial process of implantation. As 
mentioned in the previous section, recurrence patterns may be related to surgical 
trauma. The fact that the resection site and surgical wounds are predestined sites for 
recurrence 109 , indicates there may be a mechanistic relation between surgical tissue 
trauma and tumour recurrence. Therefore, this thesis aims at identifying pathways of 
enhanced tumour recurrence and to elucidate surgery related factors. 
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In vivo studies 
Recent experimental studies elaborate on the correlation between peritoneal injury and 
fibrous adhesions. Diminishing the extent of peritoneal trauma minimises adhesion 
formation. 18;121 Clinical studies comparing minimal invasive surgery with conventional 
surgery support this notion.63 Possibly, similar mechanisms are at play during tumour 
recurrence. 
Operative skills seem to be a relevant factor in tumour prognosis. Excessive per-
operative blood loss followed by transfusion has been associated with increased 
tumour recurrence. 122 Based on these clinical data, experiments are performed to 
explore the relation between the extent of peritoneal tumour recurrence and operative 
skills, like trauma-intensity and per-operative blood-loss. Different in vivo models are 
used to differentiate whether surgery related factors impact on tumour recurrence as a 
whole or specifically enhance tumour growth. 
Furthermore, the consequence of surgical trauma to the peritoneal equilibrium is 
investigated. The inflammatory response to surgical trauma, its related cytokine 
production and cellular migration are taken into account. The effect of acute 
inflammatory mediators on peritoneal tumour recurrence is evaluated. 
Supported by the results from the in vivo experiments described above, the generalised 
term 'tumour recurrence' is separated into the more elementary mechanisms tumour 
cell adhesion and tumour growth. Both components may contribute evenly to 
successful tumour recurrence (figure 2.1). 
Tumour recurrence 
/ " Tumour cell growth Tumour cell adhesion 
Growth factors -autocrine "' ? 
-paracrine Peritoneum 
-presence 
Figure 2.1 
Elementary mechanisms of peritoneal tumour recurrence. 
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Adhesion molecule -expression 
-function 
-interactIon 
In vitro studies 
In the subsequent experiments the attention is focused on the influence of surgical 
trauma on these individual aspects. The peritoneal response to surgical trauma plays a 
pivotal role in these processes. Mesothelial cells of the peritoneum form the primary 
barrier for tumour cells. Therefore, an in vitro model is developed to study tumour cell 
adhesion to a monolayer of mesothelial cells in order to mimic in vivo tumour 
recurrence. Using this model, possible interactions between tumour cells and the 
peritoneum can be correlated with adhesion molecule expression and function. 
Following adhesion, tumour ceBs must grow to form recurrent disease. Growth factors 
and cytokines, produced after surgical trauma to enhance peritoneal wound healing, 
may also stimulate tumour cell growth. Their role is investigated in peritoneal 
regeneration and, additionally, the direct (autocrine) and paracrine response of tumour 
cells to these factors will be studied. 
The results obtained from these experiments will elucidate the influence of surgical 
peritoneal trauma on local tumour recurrence and on which processes recurrence is 
based. Furthermore, it will provide information which pathways may be used for 
specific therapeutical alternatives. 
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Part II 
Surgical Peritoneal Trauma and Tumour Recurrence 
in vivo 

Chapter III 
REDUCTION OF PERITONEAL TRAUMA BY USING NON-SURGICAL GAUZE 
LEADS TO LESS IMPLANTATION METASTASIS OF SPILLED TUMOUR CELLS 
Adapted from the original publication in Annals of Surgery 1998; 227: 242-248 
Surgical abdominal trauma induces mechanical damage to the peritoneal lining of the 
abdominal cavity. The experiments described in this chapter were designed to evaluate 
whether surgical peritoneal trauma affects tumour recurrence. 
The results of the presented in vivo experiments demonstrate that a significant 
correlation exists between the amount of peritoneal trauma and the degree of tumour 
recurrence at traumatised and not directly traumatised peritoneal surfaces. In addition, 
a significant correlation between the degree of peritoneal trauma and the growth of 
ectopic tumours, situated under the renal capsule, is demonstrated. Within a few hours 
after infliction of peritoneal trauma, factors can be captivated in a lavage fluid and 
enhance peritoneal tumour recurrence in naive recipients. 
From these studies we conclude that surgical trauma promotes tumour recurrence. 
This effect is not restricted to the traumalised sites, but has a generalised character. 
Furlhermore, surgery related factors produced in the early hours after surgical 
peritoneal trauma, are potent stimulators of tUmour recurrence. 
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INTRODUCTION 
Locoregiona! recurrence of gastro-intestinal carcinoma remains an important 
complication after potentially curative surgical resection. Its incidence varies from 0% to 
45%.1-4 Ways to prevent these locoregional recurrences are the subject of various 
clinical and experimental studies.S-9 The most common site for colorectal adeno-
carcinoma to recur is the site of the primary tumour; the second is the peritoneal 
surface. 3;5;10;11 The tumour cell entrapment hypothesis might explain this pattern of 
surgical treatment failure resulting in loco-regional recurrence. When a tumour is 
removed, tumour cells can leak from transected lymphatics into the abdominal cavity.l1 
Experimental studies have shown that the proliferative and metastatic potentials of 
these spilled cells are very well preserved. Consequently, exfoliated carcinoma cells 
may undergo further division and give rise to implantation of metastases. 12;13 However, 
implantation of spilled tumour cells on surfaces with intact basement membranes is an 
inefficient process, whereas implantation on damaged surfaces, resulting from intra-
abdominal manipulation, is very efficient. 11 ;14 The dynamic process of peritoneal 
healing after ischaemic damage of the peritoneal surfaces, sometimes leading to 
adhesion formation, also seems to be important in the process of adhesion and growth 
of spilled tumour cells on the peritoneum. '5 In clinical situations, it appears that 
peritoneal tumour implants may recur within a fibrous adhesion resulting from surgical 
trauma. 11 
In a rat model, we recently showed that surgical trauma evoked by standard surgical 
gauze led to marked adhesion formation, which could significantly be reduced by using 
a nonabrasive textile. 16 The present study was undertaken to evaluate whether the 
intra-abdominal use of this less traumatic non-surgical textile would also lead to less 
intra-peritoneal tumour cell adhesion and tumour growth of spilled carcinoma cells. In 
addition, experiments were performed to evaluate whether the relation between the 
degree of trauma and tumour growth was merely a loca! phenomenon, or whether 
systemic effects might also be involved. 
MATERIALS AND METHODS 
Animals 
Female inbred rats of the WAG strain were obtained from Harlan-CPS, Zeist, The Netherlands. 
The rats were bred under specific pathogen free conditions, kept under standard laboratory 
conditions (temperature 20-24°C, relative humidity 50-60%, 12 hours light! 12 hours dark), fed 
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with laboratory diet (Hope Farms, Woerden, The Netherlands) and water ad libitum. The 
experimental protocol adhered to rules laid down by the Dutch Animal Experimentation Act and 
was approved by the Committee in Animal Research of the Erasmus University Rotterdam, The 
Netherlands. Before performing any new experiments, the validity of the model used in the 
previous adhesion studies, employing Wistar rats,16 was checked and found equally valid in 
WAG/Rij rats. 
Tumour cell line 
CC531 is a moderately differentiated, weakly immunogenic colon adeno~carcinoma induced in 
the WAG/Rij rat by 1,2-dimethylhydrazine.17 A cell line was established from this carcinoma and 
maintained by serial passage after trypsinization in culture medium. CC531 tumour cells were 
cultured in RPMI1640 medium supplemented with 5% foetal calf serum, L-glutamin (2 mM) and 
penicillin (105 U/L). Medium and all supplements were obtained from Life Technologicals BV, 
Breda, The Netherlands. Cells were passaged once a week using trypsin (0.05%) and EDTA 
(0.02%). Viability was measured by trypan blue exclusion and always exceeded 90 percent. 
To grow solid tumour, 1x108 tumour cells were injected into the right flank of a syngeneic 
WAG/Rij rat. After 6 weeks, a tumour mass with a volume of 2.5 cm 3 had grown and could be 
asepticaJly isolated form the outer membrane of the main lesion with a scalper. The harvested 
tumour was cut into 1 mm3 cubes (weighing 5.8~7.2 mg) and immersed in a culture solution 
stored at 4°C. Within 1 to 4 hours after collection of the solid CC531 tumour, the cubes were 
implanted sUb-renally in syngeneic WAG/Rij rats. 
Gauzes 
The gauzes used were surgical Medipres gauze, consisting of 100% cotton, commonly used in 
abdominal surgery {van Heek Medical, Lasser, The Netherlands} and non-surgical Fastsorb 
clean-room wiper, used in the electronics industry on abrasion-sensitive surfaces (Berkshire 
Corp., Great Barrington, MA, USA). Fastsorb is a rayon-polyester blend with strength, softness, 
and a high absorbing capacity. In previous experiments, we demonstrated that non-surgical 
Fastsorb textile was less traumatic for the peritoneum and caused less adhesion formation after 
intra-abdominal manipulation than surgical Medipres gauze.16 
Operative procedures 
Under ether anaesthesia, the abdomen was shaved and cleansed with alcohol 70%. 
Laparatomy was performed using a lower midline incision of 5 cm. Both horns of the uterus 
were exposed, rubbed with either severely traumatising surgical gauze or less traumatising non-
surgical Fastsorb textile, or not manipulated at all by any gauze. Rubbing took place using a 
device enabling the application of a constant pressure of 120 g/cm2 •16 The uterus horn was 
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rubbed 10 times over its total length. Thus, three different peritoneal traumas could be inflicted. 
After performing one of these 3 procedures, the uterus horn was subsequently sutured to the 
lateral peritoneum, both proximally and distally, using single Surgi!ene 6~0 sutures (B Braun, 
Melsungen AG, Germany). The abdomen was closed in 2 layers with Dexon 5~0 and silk 2~0 
sutures (B Braun). 
Experimental design 
Effect of uterus horn manipulation on intra~peritoneal tumour growth 
Ten rats (group I) underwent an operation in which one uterus horn was rubbed with surgical 
gauze and the other was not manipulated. In 10 rats (group II), one uterus horn was rUbbed with 
non-surgical textile and the other was not touched. In 9 rats (group III), one uterus horn was 
rubbed with surgical gauze and the other with non-surgical textile. Directly after manipulation of 
the peritoneum and before closing the abdomen, 0.5 million CC531 tumour cells in 1 ml RPM I 
1640 medium were injected intra-peritoneally. Three weeks after surgery, the rats were killed 
and intra-peritoneal tumour load was scored the parietal peritoneum, omentum, liver, kidneys, 
retroperitoneum and mesentery. The scoring ranged from 0 to 5 per site according to the 
peritoneal cancer index as described by Steller. A score of 0 meant there was no tumour 
growth, a score of 1 indicated an estimated tumour diameter of less than 0.5 cm, a score of 2 a 
tumour diameter between 0.5 and 1 cm, a score of 3 a tumour diameter between 1 and 2 em, a 
score of 4 a tumour diameter between 2 and 3 cm, and a score of 5 an estimated diameter of 
more than 3 Cm. 18 
Effect of uterus horn manipulation on established ectopic tumour growth 
On day 1, 30 rats underwent a laparotomy using a midline incision of 2.5 cm. A solid cube of 
CC531 colon tumour weighing about 6 mg was placed under the capsule of both exposed 
kidneys under microscopic vision. Thereafter, the abdomen was closed in one layer. On day 3, 
all 30 rats were operated on again. Both uterus horns and 5 cm of the small bowel were rubbed, 
in 10 rats (group IV) with surgical gauze and in 10 rats (group V) with non-surgical textile. Group 
VI (n=10) underwent a laparotomy only; the uterus horns nor the small bowel were touched. Ten 
days after tumour implantation, the rats were killed and the growth of the sub-capsular tumours 
was measured by weighing the 60 e-nucleated lumps (for each rat, the 2 individual data were 
averaged; 10 data per group were used for statistical analysis). 
Passive transfer experiments 
To evaluate whether the tumour promoting effect of surgical trauma of the peritoneum could be 
passively transferred to naive non-traumatised rats, the following procedure was employed. 
Three rats were operated on. Two animals underwent a laparotomy, during which both uterus 
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horns and a 5 cm long part of the small intestine were rubbed with either surgical gauze (rat 1) 
or non-surgical textile (rat 2). Rat 3 only underwent a laparotomy. The abdomen was closed in 
one layer. After 5 hours, these rats underwent a second laparotomy, during which the 
abdominal cavity was rinsed 5 times per rat with 5 ml RPMI 1640. Each time, 1 ml of the 
injected irrigant was collected. 
Subsequently, 15 naive rats were treated. In 5 rats (group VII), 1 ml of irrigant collected from rat 
1 (peritoneal manipulation with surgical gauze) and 0.5 million CC531 tumour cells in 1 ml RPMI 
1640 were injected intra-peritoneally. In 5 rats (group VIII), the same procedure was performed 
with the irrigants collected from rat 2 (peritoneal manipulation with non-surgical textile). In the 
last group (group IX), irrigants collected from rat 3 (no peritoneal manipulation) were used. 
After 3 weeks, the rats were killed after which tumour load and growth were scored. 
Statistical analysis 
The median and range of intra-peritoneal tumour load and the means and standard deviations 
of the sub-renal tumour weights were calculated. Statistical analysis was performed using the 
Wilcoxon matched pairs test if two groups were compared and the non-parametric Kruskal-
Wallis test if three groups were compared. If the latter overall test indicated significance, 
comparisons between groups were made using the Mann-Whitney U test. Statistical 
significance was defined as p<0.05. 
Uterus horns Tumour load p·value 
I. No touch o (0·0) 
I. Medipres manipulalion 4.5 (3·5) 0.0001 
II. No touch 0(0·0) 
II. Fastsorb manipulation 2 (0·3) 0.0001 
III. Medipres manipulation 5 (4·5) 
III. Fastsorb manipulation 1 (0·3) 0.0002 
Table 3.1 
Median tumour load (range) at uterus horns severely traumatised by rubbing with surgical 
Medipres gauze, mildly traumatised by rubbing with non-surgical Fastsorb textile and not 
directly traumatised uterus horns (no touch). 
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RESULTS 
Effect of uterus horn manipulation on intra-peritoneal tumour growth 
Table 3.1 summarises the results observed at the site of the uterus horns. In three 
different experiments, a significant correlation was found between tumour load and the 
degree of peritoneal trauma imposed by rubbing. Rubbing with severely traumatising 
surgical gauze produced the highest tumour load, whereas no rubbing resulted in the 
lowest (group I; p=0.005). Rubbing with mildly traumatising non-surgical textile raised a 
low degree of tumour load, but it was still significantly more than if no rubbing had 
taken place (group II; p=0.0018). At the site of the uterus horns, the tumours were often 
located in adhesions. Table 3.2 shows the tumour load at the non-manipulated remote 
peritoneal sites in groups I, II and III. It shows significant differences at two abdominal 
sites (the retroperitoneum (p~0.01) and the omenturn (p:;0.01) between group II (non-
surgical textile) and groups I and III (surgical gauze). A significant difference in total 
tumour load between the same groups (II versus I and II versus III) was found 
(p:;0.005). Differences in tumour load at the other three peritoneal sites were not 
significant. 
Abdominal Sites I Medipres II Fastsorb III Medipres & 
Fastsorb p1 p2 p3 
Par. Peritoneum 0(1-3) 2 (0-3) 1 (0-4) ns ns ns 
Mesentery o (0-2) o (0-1) o (0-1 ) ns ns ns 
Kidney 1 (0-2) 1 (0-2) 1 (0-2) ns ns ns 
Liver 2 (0-3) 1 (0-2) 2 (1-3) ns ns ns 
Retroperitoneum 2 (1-3) 1 (0-2) 2 (1-3) 0.007 ns 0.01 
Omentum 2 (0-3) 1 (0-1) 2 (2-4) 0.01 ns <0.0001 
Total 1.5 (0-3) 1 (0-3) 1.5(0-4) 0.005 ns 0.001 
Table 3.2 
Median tumour load (range) at different not directly traumatised peritoneal sites in rats having 
been intra-abdominally manipulated by severely traumatising surgical gauze (group !), mildly 
traumatising non-surgical textile (group II) or a combination of both materials (group III). 
The p-value 1 represents differences between group I and II; p-value 2 represents differences 
between group I and II!; p-value 3 represents differences between group II and Ill. 
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Effect of uterus horn manipulation on established ectopic tumour growth 
The mean weight of the sub-renal tumours was measured 10 days after tumour 
implantation, 7 days after manipulation with surgical gauze and non-surgical textile. 
Significant differences in mean tumour weight between the three groups were found 
(Figure 3.1). Again, a significant correlation between the degree of peritoneal trauma 
and tumour growth was observed. The mean weight of the ectopic tumour was the 
highest in rats rubbed with surgical gauze (IV) and significantly lower in rats rubbed 
with non-surgical textile (V) (p=O.009). When the peritoneum was not touched (VI), the 
lowest mean tumour weight was found, significantly lower than rubbing with non-
surgical textile (p=O.002) or surgical gauze (p<O.0001). 
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Figure 3.1 
Tumour weight (mean (SO) in mg) of the sub-renal tumours after intra-abdominal rubbing with 
severely traumatising surgical gauze (group IV), with mildly traumatising non-surgical textile 
(group V) or after no rubbing of the peritoneum (group VI). * p<O.01 vs Medipres, ** p<O.001 vs 
Fastsorb. 
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Passive transfer experiments 
The median total peritoneal tumour load in rats injected with irrigants collected from 
abdomina! cavities, manipulated with surgical gauze or non-surgical textile or not, 
differed significantly (table 3.3, p~0.016). These differences were mainly due to 
differences at the site of the omentum and the kidney. As in the previous experiments, 
a decreasing gradient of tumour load was found, from surgical (VII) to non-surgical 
(VIII) to non-traumatised abdominal cavities (IX). 
Abdominal Siles VII Medipres VII Faslsorb IX No louch pi p2 p3 
Uterus A 0 0 0 ns ns ns 
Uterus B 0 0 0 ns ns ns 
Mesentery 0 0 0 ns ns ns 
Par. peritoneum 0 0 0 ns ns ns 
Kidney 2 (0-3) 1 (0-2) 0 ns 0.03 0.03 
Liver 2 (1-3) 1 (0-2) 0(0-2) ns ns ns 
Retroperitoneum 1 (0-3) 1 (0-2) 1 (0-2) ns ns ns 
Omentum 3 (2-5) 1 (0-3) 0(0-2) 0.03 0.008 ns 
Total o (0-5) o (0-3) 0(0-2) 0.02 0.008 0.002 
Table 3.3 
Median tumour load (range) at different peritoneal sites in rats after intra-abdominal injection 
with irrigant obtained form rats that underwent rubbing of the peritoneum with severely 
traumatising surgical gauze (group III), mildly traumatising non-surgical textile (group VIII) or no 
rubbing (group IX). 
The p-value 1 represents differences between group VII and VIII; p-value 2 represents 
differences between group VII and IX; p-value 3 represents differences between group VIII and 
IX. 
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DISCUSSION 
Experimental and clinical studies suggest that surgical trauma promotes tumour cell 
adhesion and tumour growth. 15;19-22 The mechanism by which surgical trauma promotes 
these processes is not completely understood but is probably multi-factorial, because 
tumour cell adhesion as well as local and regional tumour growth can be enhanced. It 
seems that trauma leads to a process during which locally and regionally active tumour 
promoting agents are produced. 15,22 We recently demonstrated that surgical Medipres 
gauze was more traumatising to the peritoneum than non-surgical Fastsorb textile, 
leading to significantly more adhesion formation." Our current data suggest that the 
factors responsible for the formation of post-surgical adhesions also playa role in the 
adhesion and growth of tumour cells to the peritoneum. The most impressive tumour 
growth was observed at sites where abrasion of the mesothelium was most severe. 
The degree of tumour growth at traumatised sites was highly correlated with the degree 
of trauma. Abrasion with surgical gauze produced the highest tumour load, whereas 
untouched peritoneum showed the lowest tumour burden and surfaces traumatised by 
non-surgical textile presented intermediate tumour growth. The finding that traumatised 
surfaces are privileged sites for tumour cells has been demonstrated before,15;23;24 
It is conceivable that the process of enhanced tumour growth in traumatised tissue is 
biphasic. First, trauma of the peritoneum and the ensuing inflammatory response leads 
to upregulation of adhesion molecules, thus promoting the anchoring of tumour cells. 
Second, the subsequent healing of the peritoneum leads to growth promotion of the 
adhered tumour cells through the action of locally produced growth factors. 
USing the same tumour model as in the present study, we recently demonstrated that 
the phenomenon of enhanced tumour growth as it relates to trauma and healing also 
occurs in the experimental settings. It was found that laparoscopic removal of a bowel 
segment led to less adherence of intra-peritoneal tumour cells than when conventional 
surgery was performed, again indicating that the degree of surgical trauma was 
proportional tot the extent of tumour growth. 19 In addition, we observed that the growth 
of a regenerating liver after partial hepatectomy led to a marked propagation of intra-
hepatic tumour growth.2s;26 
Interestingly, our present results indicate that the sequelae of peritoneal trauma with 
regard to tumour growth are not confined to the inflicted site itself, but appear to have a 
generalised character. We showed that trauma led to more tumour at the traumatised 
site and also at non-traumatised peritoneum. Again, the amount of tumour at these 
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loco-regional sites correlated with the severity of the inflicted trauma. This clear 
correlation was also found in the experiment in which we studied the effect of 
peritoneal trauma on tumour growth under the renal capsule. Even in this ectopic 
tumour model, the consequences of the intra-abdominal trauma were demonstrable. 
Because promotion of adherence was irrelevant in this model, this experiment also 
revealed that trauma could evoke enhancement of the growth of an established 
tumour. Gutman et al. 27 made comparable observations, finding that a regenerating 
liver induced enhanced tumour growth not only in the liver but also at distant sites. 
Our final experiment, in which we demonstrated that within a few hours after infliction of 
peritoneal trauma, the effects on tumour growth could be passively transferred to naive 
recipients, supports the notion that trauma per se has a marked effect, most likely on 
tumour eel! adhesion. 
Taken together, the current experiments suggest that both tumour cell adherence and 
growth are modified by surgical trauma. It is clear that the present model provides 
unique possibilities to unravel further the similarities and differences between the 
processes of adhesion formation and tumour cell adhesion and tumour growth. 
Variables such as kinetics of adhesion molecule expression with regard to 
inflammatory cytokines and growth factors and the role of mesothelial hyaluronic acid 
are currently being investigated. These studies may lead to sophisticated tools to 
prevent the unwanted side effects of surgery. The present study clearly indicates that 
these unwanted side effects can partly be omitted by the use of delicate surgery and 
non-abrasive gauze material. 
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Chapter IV 
THE INFLAMMATORY SEQUELAE OF SURGERY PROVOKE ENHANCED TUMOUR 
RECURRENCE; A CRUCIAL ROLE FOR NEUTROPHILS AND CYTOKINES 
Submitted for publication 
In the previous chapter we demonstrated that within a few hours after peritoneal 
trauma, surgery related factors in the abdominal cavity could be captivated in a lavage 
fluid and enhance peritoneal tumour recurrence in naive recipients. 
Using the same experimental model, in this chapter, the collected post trauma lavage 
fluid was separated in a cellular and supernatant component, the latter containing 
soluble factors. Intra-peritoneal injection of naive recipients with both components of 
the collected lavage fluid, without inflicting additional surgical trauma, resulted in 
statistically significant more tumour recurrence. The cellular component produced the 
highest tumour load. 
Analysis of the lavage fluid, gathered immediately after laparotomy (mild trauma) or five 
hours after laparotomy combined with additional peritoneal trauma (severe trauma), 
demonstrated a significant influx of neutrophils after severe trauma. The acute phase 
cytokines IL-IJJ, IL-6 and TNF-a were present irrespective of trauma-intensity. 
Statistically significant more IGF-I was detected in the severely traumatised rats. 
ft seems in vivo tumour recurrence is mainly promoted by the cellular component of the 
post-surgical inflammatory process. Cytokines also enhance in vivo recurrence, but 
play an inferior role. IGF-I may facilitate the growth of lodged tumour cells. 
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INTRODUCTION 
Surgical treatment of gastro-intestinal malignancies is often complicated by loco-
regional recurrence. 1 Regardless this detrimental adversity, surgery remains the best 
treatment option. In a clinical trial, Busch et al put forward an association between 
recurrent disease and the extent of surgical injury.2 In experimental models, post-
surgically produced factors have been shown to augment local and remote tumour 
growth. Experimental and clinical studies have demonstrated that enhanced tumour 
cell adherence and tumour growth are inevitable repercussions of surgical trauma. 1;3-7 
In the previous chapter we demonstrated that within a few hours after infliction of 
peritoneal trauma, surgically related factors in the abdominal cavity could be captivated 
in a lavage fluid and enhance tumour recurrence in naive, non-operated recipients.? 
Surgery is an inflammatory stimulUS that activates the body's immune response. The 
ensuing influx of polymorph nuclear leukocytes (PMN) and mononuclear cells to the 
surgically traumatised site is mediated through chemotactic factors like IL-8 and pro-
inflammatory cytokines such as IL-1 ~ or TNF-c< and is the first line of defence.'-1O 
Insights in the host defence mechanisms of the peritoneum have demonstrated that 
peritoneal lymphocytes, sub-mesothelial monocytes, PMN and mesothelial cells act in 
an orchestrated response under the control of locally expressed cytokines, chemokines 
and adhesion molecules. The peritoneal membrane and the mesothelium in particular, 
as a site for the production of mediators, playa pivotal role in the activation and control 
of inflammation, 11;12 
Inflammatory products produced after abdominal surgery might participate directly or 
indirectly in effective tumour recurrence. In this study, we focus our attention on the 
individual capacity of inflammatory peritoneal cells and soluble factors to ascertain 
which element is responsible for enhanced tumour recurrence. In an experimental 
model post surgically produced tumour enhancing factors are captivated in a lavage 
fluid, and passively transferred to naive recipients. 
The in vivo and in vitro studies presented in this paper investigate a possible 
correlation between the inflammatory cells present in the abdominal cavity after 
surgical trauma and the cell free soluble factors on tumour cell adhesion and growth. 
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Figure 4.1 
Surface of the uterine horn before (1 A) and after (1 B) standardised rubbing with surgical gauze. 
The peritoneum has been traumatised by exfoliation of the covering mesothelial cells and 
disruption of the underlying layers. Magnification 40x. 
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MATERIALS AND METHODS 
Animals 
Female inbred rats of the WAG strain were obtained from Harlan-CPS, Zeist, The Netherlands. 
The rats were bred under specific pathogen free conditions, kept under standard laboratory 
conditions (temperature 20-24°C, relative humidity 50-60%, 12 hours Iightl12 hours dark), fed 
with laboratory diet (Hope Farms, Woerden, The Netherlands) and water ad libitum. The 
experimental protocol adhered to rules laid down by the Dutch Animal Experimentation Act and 
was approved by the Committee in Animal Research of the Erasmus University Rotterdam. 
Tumour cell line 
CC531 is a moderately differentiated, weakly immunogenic colon adenocarcinoma induced in 
the WAG/Rij rat by 1,2-dimethylhydrazine. A cell line was established from this carcinoma and 
maintained by serial passage after trypsinization in culture medium.13 CC531 tumour cells were 
cultured in RPM11640 medium supplemented with 5% foetal calf serum, L-glutamin (2 mM) and 
penicillin (105 U/L). Medium and all supplements were obtained from Life Technologicals BV, 
Breda, The Netherlands. Cells were passaged once a week using trypsin (0.05%) and EDTA 
(0.02%). Viability was measured by trypan blue exclusion and always exceeded 90 percent. 
IN VIVO EXPERIMENTS 
Gathering of lavage fluid for passive transfer 
Under ether anaesthesia, of 14 rats the abdomen was shaved and cleaned with alcohol 70%. 
Laparotomy was performed using a midline incision; exposure and rubbing of the uterus horns 
and a 5-cm long part of the small intestine with surgical Medipres gauze inflicted subsequent 
trauma to the peritoneum. Rubbing was performed with a device enabling the application of a 
constant pressure of 120 g/cm2 .7 In this way, a standardised amount of peritoneal trauma can 
be inflicted. Figure 4.1 shows the extent of peritoneal damage after gauze rubbing. The 
abdomen was closed in one layer with silk 2-0 sutures (Braun, The Netherlands). After 5 hours, 
a second laparotomy was performed during which the abdominal cavity was lavaged with 5 ml 
RPMI 1640 medium. After massaging the abdomen the remaining fluid was aspirated, pooled 
and kept on ice until further processing. 
Experimental design passive transfer 
The collected post trauma lavage fluid was centrifuged, the cell pellet resuspended to original 
volume with RPMI and thus divided into a "supernatant" containing soluble components 
produced after surgical trauma and a "cellular" component containing the different cell types 
present in the abdominal cavity after surgical trauma. 
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Subsequently 24 rats were divided in three groups. Group I served as control group receiving 
RPM I 1640 medium. Group II was acceptor for the supernatant of the post trauma lavage fluid 
and group HI was acceptor for the ceJlular component. Of all three components, 3 ml was 
injected intraperitoneally together with 0.5 million GG531 cells (in 0.5 ml RPMI) without opening 
the abdominal cavity. In this way, the factors contained by the different components represented 
the mediators after surgical abdominal trauma, without inflicting additional trauma. 
Tumour score 
Tumour scoring took place three weeks after tumour injection. The rats were sacrificed and 
intraperitoneal tumour take was scored at the parietal peritoneum, omentum, liver, kidneys, 
retro peritoneum and mesentery. The scoring ranged from 0 to 5 per site according to the 
peritoneal cancer index as described by Steller. A score of 0 meant there was no tumour 
growth, a score of 1 indicated an estimated tumour diameter of less than 0.5 cm, a score of 2 a 
tumour diameter between 0.5 and 1 cm, a score of 3 a tumour diameter between 1 and 2 cm, a 
score of 4 a tumour diameter between 2 and 3 cm, and a score of 5 an estimated diameter of 
more than 3 cm. i4 For each rat the scores were summarised and defined as total tumour load. 
Gathering of lavage fluid for ELISA and cell differentiation 
Additional lavage fluid was collected directly after performing a midline laparotomy {mild trauma, 
n=10} and 5 hours after standardised trauma by gauze rubbing (severe trauma, n=14). The 
collected lavage fluid samples were kept individually on ice and were separated in a 
supernatant and cellular component. The supernatants were filtered over a low binding 0.45 J.lm 
filter and stored at -BOoG for further analysis. The presence of the acute phase cytokines IL-1Jj, 
IL-6 and TNF-a in addition to the growth factor IGF-I were determined by ELISA (Biomedical 
Diagnostics, Brugge, Belgium) and RIA (Biosource Europe, Fleurus, Belgium). 
The cellular component was resuspended in RPMI medium, total cell amount was determined 
and HE stained cytocentrifuge slides were made for ceJl differentiation. Under a light 
microscope at a magnification of 100x, 100 cells were counted and classified into granulocytes 
(eosinophils, neutrophiJs and mast cells) and lymphoid cells (mononuclear phagocytes and 
lymphocytes). Cell classification was done on duplicate slides. 
IN VITRO EXPERIMENTS 
Mesothelial cell culture 
Mesothelial cells (MG) were isolated from the small bowel mesentery of rats as described 
before. is Mesothelial monolayers were established in 96 well plates (Packard, The Netherlands) 
precoated with collagen type I (15 Ilg/cm 2, Boehringer Mannheim, Mannheim, Germany). The 
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plates were incubated at 37°C, in a humidified atmosphere of 5% CO2 in air. Medium consisted 
of RPMI enriched with 10% FCS, glutamin (2 mM), penicillin (105 U/L) and fungizone (1.25 
mg/L), and was replaced daily with fresh medium. Monolayers reached confluence in 2 days as 
determined by microscopic evaluation. 
Tumour cell labelling 
The dye solution, calcein-AM, used to quantify tumour cell adhesion was prepared by dissolving 
50 f-lg calcein (Molecular Probes, Leiden, The Netherlands) in 5 ) .. d anhydrous dimethyl 
sulphoxide and adding this solution to 5 ml of RPMI medium supplemented with 0.5% bovine 
serum albumin (RPMIJO.5%BSA). Trypsinized CC531 cells (1*106 cells/ml) were incubated in 
this solution at 37°C for 45 minutes with occasional mixing. Before adding to the mesothelial 
monolayers, the labelled cells were washed twice with RPMIJO.5%BSA to remove free dye. 
Tumour cell adhesion assay 
To demonstrate an effect of surgery related soluble factors on tumour cell adheSion to the 
mesothelial cells of the peritoneum, a standardised tumour cell adhesion model was used.16 
After confluence, overnight pre-incubation of the mesothelial mono layers took place with 200 ~d 
of the collected supernatant samples or RPM I medium enriched with 10% FCS. Non pre-
incubated mono layers in mesothelial cell culture medium served as standardised control. 
Medium was removed from the monolayers and 200 ~tI RPMI/O.5%BSA containing 30,000 
calcein labelled tumour cells was added. Plates were centrifuged for 1 minute at 80 g on a 
Heraeus centrifuge and incubated for 1 hour at 37°C to allow cell adhesion. After this, the 
medium of each well was removed and washed twice with 200 ).II RPMI/O.5%BSA. 
Fluorescence of adherent cells was measured on a Perkin Elmer plate reader using 485 
excitation and 530 emission filters. On each plate a standard curve was prepared by adding 
different numbers of labelled tumour cells to the wells. The amount of tumour cells adhered was 
determined by calibrating the measured fluorescence of the experimental wells on the standard. 
Statistical analysis 
In case of more than two groups, statistical analysis was performed using the non-parametric 
Kruskall Wallis analysis of variance to determine overall differences. Differences between 
groups were analysed using the non-parametric Mann Whitney U-test. 
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RESULTS 
Effect of post trauma lavage fluid on peritoneal tumour load 
After intra peritoneal injection of the lavage fluid samples collected after surgical 
trauma, diffuse peritonea! tumour load was found in all groups. However, injection with 
the cellular component of the lavage fluid resulted in the highest amount of recurrence. 
When compared to the control group (RPMI) both the supernatant and cellular factors 
caused significantly enhanced tumour recurrence. Injection of tumour cells with RPM I 
alone resulted in a total of 31% tumour load whereas injection with the supernatant or 
cells resulted in 67% and 79% total tumour load (figure 4.2). 
Impressive differences in peritoneal tumour deposits were observed between the 
groups receiving the supernatant and cellular part of the lavage fluid. When taking the 
tumour size into account an obvious shift towards Jarger tumours is evident in the latter 
group. Whereas no tumours larger than 2 crn are found in the control or supernatant 
group, 38% of the cellular group was scored in this range (figure 4.3). Table 4.1 shows 
the distribution of tumour deposits at the different peritoneal sites. Statistically 
Significant differences in tumour load were scored in omentum, liver, mesentery and 
retroperitoneum between the supernatant and cellular fraction. 
FACS analysis of the cellular solution showed 75% PMN, 10% lymphocytes and 5% 
macrophages in the cell differentiation (data not shown). Therefore, additional lavage 
fluid was collected to investigate what effect surgical trauma has on the cellular 
distribution of inflammatory cells in the abdominal cavity. 
Figure 4.2 
Differences in peritoneal tumour load after passive transfer of RPM I only, supernatant fraction or 
cellular fraction of lavage fluid. * p=O.01 and ** p=O.001 versus RPMI; *** p=O.003 versus 
supernatant. The percentage total tumour load was defined after scoring the presence or 
absence of a tumour irrespective of tumour size. 
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I RPMI II Supernatant '" Cells p-value 
p1 p2 p3 
Omentum 0 (0-2) 3 (0-5) 4.5 (4-5) 0.004 0.000 0.005 
Liver 1 (0-1 ) 2.5 (0-3) 4 (2-5) 0.01 0.001 0.01 
Kidney 0 (0-3) 1 (0-2) 2.5 (0-4) ns ns ns 
Parietal peritoneum 0 (0-0) 0 (0-0) 0 (0-0) ns ns ns 
Mesentery 0 (0-2) 0.5 (0-2) 2 (1-3) ns 0.007 0.03 
Retroperitoneum 0 (0-2) 2.5 (0-3) 3.5 (3-5) 0.007 0.000 0.007 
Total 0 (0-3) 1 (0-5) 3 (0-5) 0.01 0.001 0.003 
Table 4.1 
Median tumour load and range at different abdominal sites in rats having been injected with 
RPMI medium (group I), supernatant fraction of lavage fluid (group II) and the cellular fraction of 
lavage fluid (group Ill). The p-value 1 represents differences between group I and II: p-value 2 
represents differences between group I and III; p-value 3 represents differences between group 
II and III. 
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Figure 4.3 
Comparison of tumour size after passive transfer of RPMI only, supernatant fraction or cellular 
fraction of lavage fluid. Open bars represent RPMI, cross hatched bars the soluble fraction, 
filled bars the cellular fraction. 
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Effect of surgical trauma on peritoneal cell compilation 
There was no change in total cell amount between the mildly (laparotomy only) and 
severely (laparotomy and rubbing) traumatised rats (figure 4.4). In the cell 
differentiation however, a reversal was seen regarding the ratio of lymphoid cells and 
granulocytes, with a 22-78% ratio of granulocytes-lymphoid cells in the mildly 
traumatised group versus an 78-22% ratio in the severely traumatised group (figure 
4.5, p<O.OOO1). 
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Figure 4.4 
Differences in total cell amount between mildly and severely traumatised rats. Median and 
range are shown; mild trauma 9.0 (2.8-11.6) and severe trauma 9.8 (5.6-15.0), ns. 
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Figure 4.5 
Differentiation of cellular fraction of lavage fluid taken from mildly and severely traumatised rats. 
Open bars represent lymphoid cells, filled bars granulocytes. There was a significant shift 
towards granulocyte ratio after severe trauma from 22% to 78% (p=0.0001). 
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Effect of surgical trauma on cytokine and growth factor production 
IL-1r was detected in 7 out of 14 lavage fluid samples of the severely traumatised rats 
ranging from 20 to 72 pg/ml and 2 out of 10 of the mildly traumatised rats (37 and 59 
pg/ml). IL-5 was present in 13 samples of the severely traumatised (range 54-848 
pg/ml) and all samples of the mildly traumatised groups (range 72-1194 pg/ml), TNF-a 
in 2 and 5 samples of the mildly and severely traumatised rats (67 and 170 pg/ml and 
range 35-110 pg/ml) respectively. IGF-I was present in all samples, however 
statistically significant more IGF-I was detected in lavage fluid from the severely 
traumatised rats (figure 4.6, p<0.0001). 
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Median and range of IGF-I concentration in supernatant fraction of lavage fluid. Statistically 
significant more IGF-I was found in severely traumatised rats, p<O.0001. 
Mild trauma: median (range) 1.7 (0.9-2.1). Severe trauma: median (range) 6.3 (4.8-7.2). No 
IGF-I was detected in RPM!. 
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Tumour cell adhesion assay 
Figure 4.7 shows the percentage of tumour cell adhesion versus the standardised 
control of the adhesion assay, consisting of mesothelial cell culture medium. Control 
cell adhesion consisted of 23% from the total amount of cells added (data not shown). 
RPMI did not affect tumour cell adhesion, nor did lavage fluid samples from both 
surgically traumatised groups. 
Figure 4.7 
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Percentage tumour cel! adhesion versus control after pre-incubation of mesothelial cells with 
lavage fluid gathered after different intensities of surgical trauma. Mean values are shown +SD 
(n=6 per fluid sample). There was no difference in cell adhesion between groups. 
DISCUSSION 
The success of surgical treatment in patients with gastro intestinal cancer is often 
limited due to local recurrence or peritoneal carcinosis by peroperatively seeded 
tumour cells.' In this study, a cell seeding model was used to mimic the clinical 
situation of free intra peritoneal tumour cells and associates the combination of cell 
adhesion and growth ultimately leading to manifest tumour recurrence. The presented 
results give evidence that the inflammatory sequelae of surgery enhance peritoneal 
tumour recurrence. Using the same experimental rat model, we demonstrated in 
chapter 3 that components produced after surgical abdominal trauma, combined in a 
lavage fluid, could enhance tumour recurrence in naive reclpients.? The current study 
demonstrates that components of the lavage fluid collected after inflicting surgical 
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trauma i.e. inflammatory cells and soluble factors, each lead to enhanced tumour 
recurrence. 
The cellular fraction however, led to the greatest tumour load manifested by large 
tumours. More detailed analysis of the cellular fraction reveals a trauma related influx 
of PMN into the abdominal cavity. Similar shifts in cell differentiation have also been 
demonstrated in other animal models following peritonea! trauma,9;10;17 The shift of 
primarily monocytes to PMN will evidently affect the homeostatic milieu of the 
peritoneum. PMN generate reactive oxygen metabolites and discharge contents of 
granular organelles into either phagocytic vacuoles or the local environment to ingest 
foreign particles or microorganisms. Both oxygen-dependent and oxygen-independent 
processes participate in the killing of bacteria and also in damage to host tissue,10;18;19 
In vitro, increased adhesion of activated PMN to a mesothelial monolayer has been 
shown to induce retraction, gap formation and detachment ending with substantial 
mesothelial cell injury.20 Mesothelial cell injury leads to exposure of the underlying extra 
cellular matrix components. Experimental studies have demonstrated a preferential 
adhesion of tumour cells to these denuded areas,21 Effective inhibition of tissue injury 
by PMN has been achieved by blocking of cell adhesion molecules used to enter the 
inflamed tissue20;22 and scavenging of reactive oxygen species.23;24 
A relation has been demonstrated between the extent of tissue trauma and tumour 
recurrence. In order to diminish tissue trauma and tumour recurrence, minimal invasive 
surgery is promoted. 3;7;21 Diminished tumour recurrence after laparoscopic surgery as 
compared to conventional surgery has been attributed to this phenomenon.3;21 In 
addition, laparoscopic surgery appears to impact on the cellular components of the 
immune response less than laparotomy.5;25 Carbon dioxide pneumoperitoneum has 
been shown to impair peritoneal macrophage cytokine production (11-1, TNF-a) and 
coincides with diminished neutrophil superoxide anion release and chemotaxis.26 
In a peritonitis model, Pruimboom et al also showed a non-significant increase in celis 
in the peritoneal cavity. In the peritoneal cell compilation a pronounced increase of 
PMN was seen on the first day followed by an influx of macrophages from day 1 until 
seven days after induction of peritonitis. PMN produced inflammatory mediators, 
however the capacity of these celis was very low in comparison with peritoneal 
macrophages.';10 In this study, the supernatant fraction of the lavage fluid, containing 
inflammatory factors produced after surgical trauma also enhanced tumour recurrence 
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in vivo. In vitro, no difference was seen in cell adhesion between lavage fluid taken 
from differently traumatised rats versus the control. 
The presence of the acute phase cytokines IL-1~, IL-6 and TNF-a was detected in the 
fluid although no significant differences in concentration were observed between mild 
and severely traumatised rats. IL-1f and TNF-a have been shown to upregulate cell 
adhesion molecules on mesothelial cells, which are used by PMN for adhesion. 20 In 
addition, cytokine activated mesothelial cells produce chemoatlractant cytokines such 
as IL-8, required for PMN recruitment.";27 In this way, the mesothelium and 
inflammatory cells in the abdominal cavity may perpetuate a cytokine loop, resulting in 
extreme activation of the inflammatory process. However, when omitting inflammatory 
cells, as done in vitro, the sole effect of cytokines present in the peritoneal fluid does 
not affect cell adhesion. The in vivo effect may therefore be indirect, based on the 
additional trauma inflicted by inflammatory cells. High concentrations of IL-1~ and TNF-
IT have been demonstrated to upregu!ate adhesion molecule expression and therefore 
enhance the possibility of cell adhesion. 12;27 Taking this into account a direct cytokine 
effect may occur locally, at the site where cytokines are produced. In this study this 
effect may be missed as the absolute concentration of cytokines is diluted by lavaging 
with excess fluid. 
Growth factors playa vital role in post surgical wound healing. Insulin like growth 
factor-I (IGF-I) is released during the first stage of wound healing.28 The in vitro 
experiments described in chapters 7 and 10 demonstrate that IGF-I does not affect 
tumour cell adhesion but is a potent growth stimulant for tumour and mesothelial cells. 
Clinical and experimental studies have demonstrated that surgery is followed by a rapid 
decrease of IGF-I in serum.29;30 This apparent suppression of the IGF-I system is 
thought to be caused by an increased efflux of IGF-I from the blood to the peripheral 
tissues.29 In this study, significantly higher IGF-I concentrations were found in the 
abdominal lavage fluids from severely traumatised rats. The origin of IGF-I could be the 
proposed efflux from the blood or could be the result of local production by mesothelial 
cells. i5 IGF-I stimulation and over-production has been shown in several types of 
carcinoma and may support an autocrine growth loop of the tumour cells. IGF-I is also 
potently capable of priming PMN for an enhanced respiratory burst that may lead to 
additional peritoneal tissue damage. 31 In this way tumour cells can use the hosts 
immune response in wound healing for their own benefit. 
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In conclusion, the studies brought forward in this paper give evidence that the 
inflammatory sequelae after surgery promote tumour recurrence and that this effect is 
mainly based on the cellular component of the inflammatory process. Extrapolation of 
the presented results to the clinical situation is limited as the inflammatory response in 
animals deviates from humans. There is however limited species variation in the first 
line of defence after surgical trauma when taking PMN influx and macrophage 
activation into account.1O Preventing tissue damage by inflammatory cells therefore 
may provide a novel strategy to defeat progression and metastasis of cancer. 
Manipulation of the intricate cytokine network may cause unwanted side effects in the 
wound healing process. Tackling of reactive oxygen products however seems a 
feasible way of preventing cellular tissue damage ultimately resulting in diminished 
tumour recurrence. 
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Part III 
Intra-Abdominal Blood Loss and Peritoneal Tumour 
Recurrence in vivo 

Chapter V 
RED BLOOD CELLS INHIBIT TUMOUR CELL ADHESION TO THE PERITONEUM 
Adapted from the original publication in the British Journal of Surgery 1999; 86: 509-513 
Operative skills seem to be a relevant factor in tumour prognosis. Excessive per-
operative blood loss followed by transfusion has been associated with increased 
tumour recurrence and poor prognosis. Particularly blood loss in the peritoneal cavity 
might be a tumour promoting factor when focal recurrence is concerned. The aim of the 
present studies was to investigate whether the presence of blood in the peritoneal 
cavity affects local tumour recurrence. 
Contrary to our hypothesis, intra-peritoneal (ip) injection of blood or red blood cell 
(RBC) concentrate prevented recurrence of per-operatively spilled tumour cells in vivo. 
This tumour inhibitive effect only took place if blood was injected in the peritoneal 
cavity within 24 hours after surgical trauma (Iaparatomy). RBC concentrate and intra 
RBG substances had a comparable inhibitive effect on tumour recurrence. Additional in 
vitro studies demonstrated that RBC inhibit tumour cell adhesion but do not affect 
tumour growth. 
The presence of blood in the peritoneal cavity after surgical peritoneal trauma leads to 
reduced adhesion of per-operatively spilled tumour cells. The tumour inhibitive effect 
by blood takes place within 24 hours after surgical trauma and is mediated by intra-
RBC substances. 
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INTRODUCTION 
Peroperative blood transfusion, independent of its type -allogeneic or autologous- is 
associated with enhanced tumour recurrence and poor prognosis in patients with 
colorectal cancer. This was concluded in more than one clinical prospective 
randomised trial. 1-3 
In the study by Busch et ai, the association between recurrent disease and blood 
transfusion appeared to exist only for the incidence of local recurrence and not for the 
incidence of distant metastases. Furthermore it was concluded that not so much the 
transfusion itself but the circumstances necessitating transfusion are the real 
determinants for prognosis. 1 Conditions leading to blood transfusion are the location 
and extent of the primary tumour, skill of the surgeon and length of operation. Blood 
loss in the per-operative period however, is the most common reason for transfusion. 
The effect of blood loss on tumour recurrence has been studied extensively in 
experimental animal models. Studies performed in our laboratory demonstrated that 
blood loss with or without subsequent administration of blood transfusion had no 
significant effect on the formation of tumour colonies. However, blood loss promoted 
growth of established tumour metastases, irrespective of whether transfusion was 
given or not.4 This tumour growth promoting effect could be prevented by an immediate 
plasma transfusion, but not by evoking a normal haemoglobin level after blood loss by 
pre-treatment with erythropoietin. In addition, NK activity was shown to be significantly 
depressed as a consequence of blood loss indicating that modulation of the immune 
response could playa role.' When different types of tumour cell lines were employed in 
the same experimental model, transfusion had both an inhibitory and stimulating effect 
on tumour growth and metastases, depending on the cell line. The authors concluded 
that several mechanisms, not only immunological, may be responsible. 6 
Based on the clinical observation that conditions leading to transfusion are the real 
determinants for prognosis, as well as the experimental results indicating that blood 
loss itself is an important factor influencing tumour growth, we hypothesised that local 
blood loss, i.e. in the peritoneal cavity, might be an overlooked factor influencing local 
tumour recurrence. This hypothesis was evaluated in a rat model by investigating the 
effect of blood and blood components on tumour cell adhesion and growth in vivo and 
in vitro. 
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MATERIALS AND METHODS 
Animals 
Inbred rats of the WAG strain were obtained from Harlan-CPS, Zeist, The Netherlands. The rats 
were bred under specific pathogen free conditions, kept under standard laboratory conditions 
(temperature 20-24"C, relative humidity 50-60%, 12 hours light! 12 hours dark), fed with 
laboratory diet (Hope Farms, Woerden, The Netherlands) and water ad libitum. The 
experimental protocol adhered to rules laid down by the Dutch Animal Experimentation Act and 
was approved by the Committee in Animal Research of the Erasmus University Rotterdam. 
Tumour cell tine 
CC531 is a moderately differentiated, weakly immunogenic colon adenocarcinoma induced in 
the WAG/Rij rat by 1,2-dimethylhydrazine. A cel! line was established from this carcinoma and 
maintained by serial passage after trypsinization in culture medium.7 GG531 tumour cells were 
cultured in RPMI 1640 medium supplemented with 5% foetal calf serum, L-glutamin (200 
mmoI/L), penicillin (5000 U/ml) and streptomycin (5000 U/ml). All supplements were obtained 
from Gibco, Paisley, UK. Before use, cells were trypsinized (5 minutes at 3Y°C), centrifuged (5 
minutes at YOO g), resuspended in RPM I 1640 and counted. Viability was measured by trypan 
blue exclusion and always exceeded 90 percent. 
Blood products 
Syngeneic WAG rats were exsanguinated through heart punction. The blood was collected in a 
previously heparinized vial (heparin Leo, Leo Pharmaceutical products, Weesp, The 
Netherlands). RBC concentrate was obtained by centrifugation of blood at 3000 rpm during ten 
minutes (Mistral 2000i). The buffy coat and plasma were removed and the pelleted RBG 
resuspended in RPM I medium to original volume. Using this suspension, the RBG were lysed 
by freezing in liquid nitrogen. The resulting homogenate was divided in 1.5 ml aliquots and 
centrifuged at 10,000 rpm for 15 minutes to pellet cell fractions. The supernatants were used to 
determine the effect of RBG content on tumour load. 
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IN VIVO EXPERIMENTS 
Operative procedure and tumour scoring 
Under ether anaesthesia the abdomen of rats was shaved and cleaned with alcohol 70%. 
Laparotomy was performed using a midline incision followed by peritoneal inoculation of one 
million CC531 tumour cells. The abdomen was closed in one layer with silk 2~O sutures (Braun, 
The Netherlands). 
Three weeks postoperatively the rats were sacrificed and intra-peritoneal tumour load was 
scored at the following sites: sub~cutaneously (at the site of the incision), omentum, liver, 
kidneys, retroperitoneum and mesentery. The scoring ranged from 0 to 5 per site according to 
the peritoneal cancer index as described by Stener.B A score of 0 meant there was no tumour 
growth, a score of 1 indicated an estimated tumour diameter of less than 0.5 cm, a score of 2 a 
tumour diameter between 0.5 and 1 cm, a score of 3 a tumour diameter between 1 and 2 cm, a 
score of 4 a tumour diameter between 2 and 3 cm, and a score of 5 an estimated diameter of 
more than 3 cm. For each rat the scores were summarised and defined as total tumour load. 
Experimental design 
In the first experiment (I) the effect of syngeneic whole blood was evaluated on intra-peritoneal 
tumour load. After laparotomy, the experimental group (n=10) received 1.5 ml whole blood 
together with 1 million GG531 tumour cells (this amount was used for all experiments). The 
control group (n=10) received 1.5 ml PBS. 
To distinguish between impairment of tumour cell adhesion or tumour growth, an additional 
experiment (II) was performed in Which tumour cells were allowed to adhere before performing 
a re-Iaparotomy after 24 hours and adding 1.5 ml whole blood. The control group received 1 ml 
PBS. 80th groups consisted of 8 rats. 
In the third experiment (III) the effect of 1.5 ml RBG concentrate on tumour load was evaluated. 
The control group received 1.5 ml PBS; both groups consisted of 10 rats. 
In the last experiment (IV) a distinction was made between RBG and RBG content using the 
supernatants of 1.5 ml lysed RBG concentrate. Both groups consisted of 9 rats. 
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IN VITRO EXPERIMENTS 
Mesothelial cell culture 
Mesothelial cells (MC) were isolated from the small bowel mesentery of rats and identified 
immunohistochemically as described before.9 
Mesothelial monolayers were established in 24 well plates (Costar, The Netherlands), pre-
coated with collagen type I (Boehringer Mannheim, Mannheim, Germany). To do so, confluent 
Me were washed with phosphate buffered saline (PBS) and harvested with trypsin/EDTA (O.05 
% I 0.02 %) and 90-95,000 Me in 1 ml of culture medium were added to each well. The plates 
were incubated at 3?DC, in a humidified atmosphere of 5% CO2 in air; medium was replaced 
daily with fresh medium. Monolayers reached conffuence in 4 days as determined by 
microscopic evaluation. 
Experimental design 
RBG ranging in concentration from 10-250 x 106 were added to the wells with confluent 
monolayers mesothelium or to wells precoated with collagen type l. In the first experiment RBG 
and 40 000 CC531 tumour cells per well were added simultaneously to the plates. 
In the second experiment the effect of RBG on tumour growth was evaluated. 40 000 CC531 
cells were left to adhere to the multiwell plate overnight, before adding the RBG in different 
concentrations. To determine a potential direct toxic effect, RBG were added to a monolayer 
mesothelium. 
After 48 hours, plates were collected by washing away supertluous non-adherent cells and kept 
at -20°C for DNA analysis to measure total amount of cells. 
DNA analysis 
The total DNA content of the wells was measured using the bisbenzimide fluorescent dye 
(Boehring Diagnostics, La Jolla, USA) as previously described by Hofland et al.1O The DNA 
measured represents the total amount of cells/well. 
Statistical analysis 
Statistical analysis was performed using the non-parametric Kruskall Wallis analysis of variance 
to determine overall differences followed by the non-parametric Mann Whitney U test to 
compare differences between groups. 
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RESULTS 
In vivo experiments 
Effect of whole blood on peritoneal tumour recurrence 
Statistically significant differences in tumour load at all scored peritoneal sites were 
found between the control group and experimental group. The results indicate that 
adding 1.5 ml blood to the peritoneal cavity simultaneously with tumour cells, prevents 
recurrence of the seeded tumour cells. Range with median tumour load together with p-
values are shown in table 5.1. 
When blood was injected after the CC531 tumour cells had adhered however, no 
statistically significant differences in tumour load could be detected (results not shown). 
This indicates that the protective effect of blood is based on warding off tumour cell 
adhesion rather than affecting tumour growth. 
1,5 ml PBS 1.5 ml blood p-value 
Subcutis 2-5 (3) 0-3 (1) 0.001 
Mesentery 1-3 (2) 0-1 (0) <0.0001 
Kidney 1-5 (3) 0-1 (1) 0.0001 
Liver 1-3 (2) 0-1 (0) 0.0001 
Omentum 2-5 (3) 0-1 (0) <0.0001 
Retroperitoneum 0-2 (1.5) 0(0) 0.0002 
Table 5.1 
Effect of blood in the peritoneal cavity on peritoneal tumour recurrence. Range with median 
tumour load (values between brackets) together with p-value are shown. 
Effect of RBG on peritoneal tumour recurrence 
The results obtained after adding 1.5 ml of pure RBC concentrate together with tumour 
cells were similar to those when whole blood was used. At all peritoneal sites 
statistically significant less tumour load was scored when RBC concentrate was added 
simultaneously with 1 million CC531 tumour cells (table 5.2). 
When comparing the effect of RBC with RBC content, no differences in tumour load 
could be scored. These results indicate the evaded tumour cell adhesion to the 
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peritoneum can be attributed to the content of RBC rather than the RBC as a whole. 
Table 5.3 shows the range with median score. 
1.5 ml PBS 1.5 ml RBC p-value 
Subcutis 4-5 (5) 0-3 (1) <0.001 
Mesentery 1-4 (2.5) 0-4 (0) =0.002 
Kidney 2-5 (3) 0-5 (1) =0.004 
Liver 2-4 (2.5) 0-2 (0) <0.001 
Omentum 4-5 (5) 0-5 (0) <0.001 
Retroperitoneum 0-3 (1) 0-4 (0) =0.05 
Table 5.2 
Effect of RBC in the peritoneal cavity on peritonea! tumour recurrence. Range with median 
tumour load (values between brackets) together with p-value are shown. 
1.5 ml RBC 1.5 ml RBC content p-value 
Subcutis 1-4 (2) 1-5 (1) 0.81 
Mesentery 0-4(1) 0-1 (1) 0.95 
Kidney 0-2 (1 ) 0-1 (1) 0.33 
Liver 0-3 (1) 0-3 (1) 0.70 
Omentum 1-4 (1) 1-5 (3) 0.37 
Retroperitoneum 0-3 (0) 0-1 (1) 0.55 
Table 5.3 
Effect of RBC versus RBC content in the peritoneal cavity on peritoneal tumour recurrence. 
Range with median tumour load (values between brackets) together with p-value are shown. 
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In vitro experiments 
RBC in high amounts did not have a direct toxic effect on the mesothelial monolayer. A 
statistically significant inhibition of tumour cel! adhesion was observed, irrespective of 
adherent underground, after adding 50 million RBC or more (p<0.05). No increment of 
the inhibitive effect was seen after adding >100 million RBC. Values are shown with 
standard deviation in figure 5.1. When CC531 cells were left to adhere before adding 
the RBC no difference in adherent cells could be measured (data not shown). These in 
vitro results indicate, as the In vivo results, that the observed inhibition of tumour load 
by RBC is based on impeding tumour cell adhesion rather than affecting tumour 
growth. 
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Figure 5.1 
Tumour cell adhesion represented by total DNA measured. II monolayer mesothelium, • 
CC531, T monolayer mesothelium and CC531. Values ± SO (n=4). 
DISCUSSION 
Tumour recurrence is the result of a combination of tumour cell adhesion, cell survival 
and subsequent tumour growth. Per-operatively spilled tumour cells that fail to adhere, 
may not survive to form a loca! recurrence. Our observation that the presence of RBC 
in the peritoneal cavity CQuid ward off tumour recurrence was reason enough to explore 
this phenomenon. There were primarily three hypotheses proposed for the mechanism 
of this effect, the first being a growth obstructing effect. Can RBC directly inhibit tumour 
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growth and consequently diminish tumour recurrence? The in vitro studies 
demonstrated that once the tumour cells had adhered, there was no decline in total 
DNA after 48 hours caused by RBC, i.e. no decline in tumour cell number. After 
adhesion of CC531 cells in vivo a growth inhibiting effect could not be detected either. 
Both experiments prove that RBC do not inhibit tumour growth, and that the inhibition 
of tumour load by RBC takes place at the point of tumour cell adhesion. 
The second hypothesis proposed that tumour cell adhesion could be impeded by 
mechanical inhibition. Although in the in vivo studies this hypothesis was less likely to 
be relevant, in the in vitro studies a statistically significant inhibition of tumour cell 
adhesion was seen after adding 50xl06 RBC or more. This is at least 1250x more RBC 
than tumour cells which may lead to impeded tumour cell adhesion through mechanical 
inhibition by large amounts of RBC. 
The third hypothesis was accredited to an unknown function of the RBC that could be 
executed by either the RBC-membrane or RBC-content. The results from experiment 
IV demonstrated that the latter resulted in a similar tumour inhibitory effect as the intact 
RBC, indicating that mechanical inhibition by an excess of RBC is of no relevance. In 
addition, these results demonstrate the evaded tumour cell adhesion to the peritoneum 
can be attributed to the content of RBC rather than the intact RBC. 
Other than oxygen-transporters, RBC are well known for carrying several anti-oxidant 
protectors. These anti-oxidant scavengers catalyse or accelerate the dismantlement of 
oxygen free radicals which are well known to playa fundamental role in cellular injury 
in a wide variety of pathophysiologic processes. Following abdominal surgery, the most 
likely source of these free radicals is a rapid influx of neutrophils and macrophages, 
recruited to the abdominal cavity due to surgical trauma or inflammation. 11 ;12 The 
purpose of these reactive cell products is to destroy invading organisms and damaged 
tissue. 
Excessive or inappropriate production of free radicals is associated with morbidity and 
mortality after peritoneal trauma and inflammatory diseases. 13;14 The role of oxidant 
damage to tissues has already been demonstrated in rheumatoid arthritis, reperfusion 
injury, ischemia and many other diseases. Diminution of peritoneal trauma by anti-
oxidant scavengers affecting free radical mediated injury, might add to the prevention 
of implantation of spilled tumour cells. 
The results of the present paper point in the direction of a possible relation between 
scavengers carried by RBC and prevention of free radical mediated injury. In chapter 3 
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we demonstrated a significant correlation between the extent of peritoneal trauma and 
the degree of tumour recurrence. 15 The evidence to date supports an effector role of 
the RBC in actively preventing tumour cell adhesion to the peritoneum resulting in less 
tumour recurrence. Additional studies need to be performed to illustrate which of the 
three anti-oxidant scavengers, that RBC transport in their cytoplasm (glutathion 
peroxidase, catalase and superoxide dismutase), bring about this effect. 
The potential for clinical application of anti-oxidant scavengers to modify free radical 
injury, and hence inhibit tumour recurrence of per-operatively spilled tumour cells, 
sounds a promising indication for new therapeutic approaches for loco-regional 
recurrence. 
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Chapter VI 
SCAVENGING OF REACTIVE OXYGEN SPECIES LEADS TO DIMINISHED 
PERITONEAL TUMOUR RECURRENCE 
Submitted for publication 
In the previous chapter we demonstrated that red blood cells (RBG) inhibit the 
recurrence of per-operatively spilled tumour cells. The aim of this study was to identify 
on which RBG component(s) the inhibitory effect is based. Employing a cell-seeding 
model in rats, the effect of RBG related anti-oxidant scavengers (haemoglobin, 
catalase and superoxide dismutase (SOD)) on peritoneal tumour recurrence was 
investigated. 
Intra-peritoneal injection of haemoglobin caused 45% more tumour load. At least 40% 
inhibition of tumour recurrence was achieved with the use of catalase or SOD. 
Gombining SOD and catalase did not lead to additional inhibition of tumour recurrence. 
Inhibition of the overwhelming oxidative potential after surgical peritoneal trauma with 
the use of scavengers may lead to interesting new approaches for diminishing 
peritoneal tumour recurrence. 
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INTRODUCTION 
Local or regional tumour recurrence of gastro-intestinal carcinoma remains an 
important complication after potentially curative surgical resection.' Prevention of this 
affliction remains the goal of many clinical and experimental studies. 1-3 The results of 
these stUdies show a correlation between surgical peritoneal trauma and loeo-regional 
tumour recurrence.2:3 Minimising surgical trauma, through the use of laparoscopic 
surgery or other minimal invasive techniques, was shown to reduce peritoneal trauma 
and tumour recurrence. 2;3 
Excessive production of reactive oxygen species (ROS) and related tissue injury plays 
a fundamental role in a wide variety of disease processes,4:5 Besides by chronic 
inflammatory diseases, ROS are also produced after surgical trauma.4 :6 The main 
producers of ROS are inflammatory cells entering damaged tissue after surgical 
trauma. The purpose of these cell products is to destroy invading organisms and 
damaged tissue. Despite this beneficial effect, the overwhelming oxidative potential can 
result in additional tissue destruction,4;6 
After peritoneal surgery an acute inflammatory reaction occurs, even in the absence of 
any apparent bacterial contamination.' In chapters 3 and 4 we demonstrated that the 
inflammatory sequelae after abdominal surgery promote tumour recurrence and that 
this effect is mainly based on the cellular component of the inflammatory process.';8 
Using the same experimental model we showed in chapter 5 that red blood cells 
(RBC), introduced in the peritoneal cavity after surgical trauma, effectively inhibited 
loco-regional tumour recurrence,9 These studies were performed in a cell-seeding 
model and demonstrated that the inhibitory function of RBC was primarily based on 
preventing adhesion of per-operatively spilled tumour cells. Moreover, we 
demonstrated that RBC homogenates were equally effective excluding the possibility of 
a mere steric hindrance of tumour cell adhesion. 
The aim of this study was to identify which component(s) of the RBC homogenate 
could underlie the inhibitory effect of RBC on tumour take. For this purpose, the effect 
of catalase (peroxide decomposition), haemoglobin (nitric oxide scavenger) and 
superoxide dismutase (SOD, superoxide decomposition) were compared to the 
inhibitory effect of RBC on peritoneal tumour recurrence. 
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MATERIALS AND METHODS 
Animals 
Inbred rats of the WAG strain were obtained from Harlan-CPS, leist, The Netherlands. The rats 
were bred under specific pathogen free conditions, kept under standard laboratory conditions 
(temperature 20-24°C, relative humidity 50-60%, 12 hours light! 12 hours dark), fed with 
laboratory diet (Hope Farms, Woerden, The Netherlands) and water ad libitum. The 
experimental protocol adhered to rules laid down by the Dutch Animal Experimentation Act and 
was approved by the Committee for Animal Research of the Erasmus University Rotterdam. 
Tumour cell line 
CC531 is a moderately differentiated, weakly immunogenic colon adenocarcinoma induced in 
the WAG/Rij rat by 1,2-dimethylhydrazine. A cell line was established from this carcinoma and 
maintained by serial passage after trypsinization in culture medium. 10 CC531 tumour cells were 
cultured in RPMI 1640 medium supplemented with 5% foetal calf serum, L-glutamin (200 mM) 
and penicillin (105 U/L). All supplements were obtained from Ufe Technologicals BV, Breda, The 
Netherlands. Before use, cells were trypsinized (10 minutes at 37°C), centrifuged (5 minutes at 
700 g), resuspended in RPMI 1640, counted and brought to a concentration of 0.5 million 
cells/ml. Viability was measured by trypan blue exclusion and always exceeded 90 percent. 
RBC, Catalase, SOD and haemoglobin 
To obtain RBC concentrate, the same procedure was followed as previously described. 9 In 
short, WAG/Rij rats were exsanguinated by heartpunction. The blood was collected in a 
heparinized vial (heparin Leo, Leo Pharmaceutical products, Weesp, The Nelherlands), RBC 
concentrate was obtained by centrifugation of blood at 1000 9 for ten minutes (Mistral 2000i), 
removing the buffy coat and plasma. The pelleted RBC were resuspended in RPMI medium to 
the original volume. 
Catalase (3000 U/mg) and haemoglobin were purchased from SIGMA-Aldrich Chemie BV, 
Zwijndrecht, The Netherlands. Superoxide dismutase (SOD) (5000 U/mg) was purchased from 
Roche Diagnostics BV, Almere, The Netherlands. Before use, solutions containing the different 
scavengers in the desired concentration were prepared in phosphate buffered saline (PBS) and 
kept on ice. 
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IN VIVO EXPERIMENTS 
Catalase and SOD determination in RBC 
Catalase. Pelieted RBC were resuspended in 50 mM phosphate buffer (pH 7.0) to the original 
volume, and diluted 10 times in distilled water to lyse the RBC at 3rC for 45 min. Next, the 
hemolysate was further diluted in phosphate buffer, added in a volume of 0.02 ml to 3 ml 10.5 
mM H20 2 , and the time (sec) recorded to obtain a decrease in optical density at 240 nm from 
0.450 to DADO. This value was used to calculate the amount of International Units of catalase 
per ml sample according to the formula: 17 x 13.1/(time x 0.02).11 We found per m! of pelleted 
RBC 13563 (± 1252) IU of catalase (n=8), thus 1.5 ml RBC concentrate contained 9155 IU. 
sao. The RBC hemolysate was serially diluted in 50 mM phosphate buffer (pH 7.8) containing 
0.1 mM EDTA, 0.01 mM ferricytochrome c, 0.05 mM xanthine, 0.025 U xanthine oxidase/m!. 
The SOD was assayed on the basis of its ability to inhibit the reduction of ferricytochrome c at 
550 nm by superoxide anions generated by the xanthine-xanthine oxidase system.12 At pH 10.0 
the SOD appeared about 9 times more active, and could be completely inhibited by 1 mM KCN. 
Pelleted RBC contained 1096 U SOD per ml, which meant that the RBC concentrate contained 
750 U SOD per 1.5 ml. 
Operative procedure and tumour scoring 
Under ether anaesthesia the abdomen of rats was shaved and cleaned with ethanol 70%. 
Laparotomy was performed using a midline incision followed by intra peritoneal (ip) inoculation 
of 0.5 million CC531 tumour cells. The abdomen was closed in one layer with silk 2-0 sutures 
{Braun, The Netherlands}. 
Three weeks postoperatively the rats were sacrificed and intra-peritoneal tumour load was 
scored as described previousll at the following sites: parietal peritoneum (at the site of the 
incision), omentum, liver, kidneys, retro peritoneum and mesentery. The scoring ranged from 0 
to 5 per site. A score of 0 meant there was no tumour growth, a score of 1 indicated an 
estimated tumour diameter of less than 0.5 cm, a score of 2 a tumour diameter between 0.5 and 
1 cm, a score of 3 a tumour diameter between 1 and 2 em, a score of 4 a tumour diameter 
between 2 and 3 cm, and a score of 5 an estimated diameter of more than 3 cm. For each rat 
the scores were summarised and defined as total tumour load. 
Effect of catalase, SOD and haemoglobin on peritoneal tumour recurrence 
In this experiment the inhibitory effect of RBC on peritonea! tumour recurrence was compared to 
the effect of two major components carried by RBC, i.e. catalase and haemoglobin. After 
laparotomy, 0.5 million CC531 cells were injected into the peritoneal cavity together with 1.5 ml 
PBS (control group, n=10), with 1.5 ml RBC concentrate (n=10), with 3000 U catalase (in 1.5 ml 
PBS, n=10) or 0.5 mg haemoglobin (in 1.5 ml PBS, n=10). 
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Next, the effect of a higher concentration of catalase was investigated. After laparotomy, CC531 
cells were injected into the peritoneal cavity together with 1 ml PBS (control group, n=10), with 
3000 U catalase (in 1 ml PBS, n0 9) or with 6000 U catalase (in 1 ml PBS, n0 9). 
Finally, the effect of SOD alone and in combination with catalase was studied. The experimental 
groups received 0.5 million tumour cells together with 6000 U catalase (n=8), with 2000 U SOD 
(n 0 8) or with 6000 U catalase and 2000 U SOD (n 0 8). To make up for total volume, 1 ml PBS 
was added. The control group (n=5) received 2 ml PBS and 0.5 million of tumour cells. 
Statistical analysis 
Statistical analysis was performed using the non-parametric Kruskall Wallis analysis of variance 
to determine overall differences followed by the non-parametric Mann Whitney U test to 
compare differences between groups. 
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Figure 6.1 
A: Effect of RBC and Hb on peritoneal tumour load. The mean of the total tumour score is 
shown with SEM. * pc:;O.001 vs control. B: Distribution of treatment dependent tumour size. 
Open bars: control group; filled bars: RBC; crosshatched bars: haemoglobin. 
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RESULTS 
Effect of two major components of RBG versus intact RBG on peritoneal tumour 
recurrence 
After intra-peritoneal injection of tumour cells with RBG, the inhibition of tumour 
recurrence was comparable (mean tumour load ± SEM is 4.9 ± 2.0 in RBG vs 19.3 ± 
0.9 in control group, p=0.001; table 6.1, fig 6.1) to that as found previously.' 
Administration of haemoglobin led to more tumour recurrence (28.3 ± 0.6, p<0.0001 vs 
control), with statistically significant higher tumour diameters at 4 of 6 scored peritoneal 
sites. In the haemoglobin group, one rat suffered from overload peritoneal tumour load 
and was sacrificed before 3 weeks (this rat was excluded for statistical purposes). 
Significant differences in peritoneal tumour size were observed. In the haemoglobin 
group 85% of the tumours were larger than 3 cm, compared to 28% in the control and 
3% in the RBG group (fig 6.1 B). 
When compared to the control, 3000 U of catalase inhibited tumour recurrence (10.5 ± 
2.0 catalase, p=0.002). Although this was a statistically significant inhibition, the effect 
of catalase on peritoneal tumour load was less than the inhibitory effect of RBG 
(p=0.008). In the catalase group the majority of the tumours (40%) were between <0.5 
and 2 cm in diameter while in the RBG group 50% was tumour free. Only 5% of the 
tumours in the catalase group were larger than 3 em in diameter. 
To study if increasing the amount of catalase would improve the inhibitory effect on 
tumour recurrence, 6000 U were administered ip. Total tumour load in the control group 
of this experiment was similar to the control in the previous section (mean tumour load 
± SEM is 21.6 ± 1.5; fig 6.2A). However, in this experiment the tumours were relatively 
large, i.e. 42% of the tumours were larger than 3 cm (fig 6.2B), whereas in the previous 
experiment the control tumours were more heterogeneous in size (fig 6.1 B). After intra 
peritoneal injection of 3000 U catalase, mean tumour load amounted to 12.3 ± 1.3 
(p=0.004 vs control). Tumour load did not decrease significantly using 6000 U catalase 
(12.6 ± 2.4, p=0.003 vs control). 
Using more catalase also did not lead to a further decrease in tumour size. With 3000 
U catalase 41 % tumours were smaller than 0.5 cm, with 6000 U catalase 43% (not 
significant). 
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A: Effect of different concentrations of catalase on peritoneal tumour load. The mean of the total 
tumour score is shown with SEM. * p:s;O.01 vs control. B: Distribution of treatment dependent 
tumour size. Open bars: control group; filled bars: 3000 U catalase; crosshatched bars: 6000 U 
catalase. 
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A: Differences in peritoneal tumour load in rats receiving SOD (2000 U) and a combination of 
catalase (6000 U) and SOD (caUSOO) compared to a control. The mean of the total tumour 
score is shown with SEM. 'Ie psO.05 and ** p<O.01 vs control. B: Distribution of treatment 
dependent tumour size. Open bars: control group; filled bars: SOD; crosshatched bars: 
caUSOD. 
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Effect of catalase and SOD on peritoneal tumour recurrence 
To investigate if SOD could affect tumour recurrence as well, 2000 U of SOD were 
administered ip at the time of tumour seeding. SOD led to a significant reduction in 
tumour recurrence in comparison with the control, respectively 12.6 ± 3.2 and 25 ± 2.9 
(p<0.05). The inhibitory effect of 6000 U catalase was similar as described in the 
previous section (table 6.2). The combined administration of SOD (2000 U) and 
catalase (6000 U) showed a minor but not significant stronger inhibition of tumour 
recurrence (mean tumour score 10.6 ± 2.3 in the cat/SOD group; fig 6.3A, table 6.2). 
The sizes of tumour deposits in the antioxidant enzyme groups varied greatly, whereas 
in the control group mostly large tumours were scored (57% larger than 3 cm). In the 
control group 6.7% scored between 0 and < 0.5 cm tumour size, in the SOD group 
42% and in the combined group 57% (fig 6.3B). 
DISCUSSION 
The major finding of the present study is that the antioxidant enzymes SOD and 
catalase have been identified as the components that are (partially) responsible for the 
tumour inhibiting function of RBC. 
In a previous experimental study we demonstrated that the inflammatory sequelae after 
surgery promote tumour recurrence and that this effect is mainly based on the cellular 
component of the inflammatory process. 3 " Analysis of the cell population demonstrated 
the presence of more than 75% PMN. In ischaemia reperfusion injury, where related 
inflammatory mechanisms are at play, most tissue trauma is inflicted by ROS.13~15 
Scavenging of, or blocking its production demonstrated that ROS significantly impede 
wound healing and graft survival after transplantation. 14;16;17 Since PMN are a major 
source of ROS, similar PMN related injury might playa role in surgical peritoneal 
trauma and tumour recurrence and likewise antioxidants may reduce tumour 
recurrence. 
Based on previous results of a tumour impeding effect of RBC, we questioned which 
RBC component could underlie this effect. RBC convey three major scavenging 
enzymes to diminish the toxic effects which can be caused by uncontrolled levels of 
superoxide radical anions (0,.) or hydrogen peroxide (H,O,). These are superoxide 
dismutase (SOD), catalase and glutathion peroxidase. 18 While haemoglobin is the 
principal oxygen carrier, it can scavenge nitric oxide radical as wel1. 19 
First we investigated the effect of haemoglobin and found tumour recurrence was in 
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fact increased compared to the control. Catalase inhibited tumour recurrence more 
than 40% in all experiments, showing the consistency of this effect in vivo. However, 
the peritoneal tumour load remaining after catalase injection was significantly higher 
than after RBC injection. Although we detected 9000 U catalase in RBC concentrate, 
we did not see a decrease in tumour recurrence when using a higher amount of 
catalase in the in vivo experiments. This indicates an additional tumour impeding effect 
brought about by RBC that is not attained with catalase. 
The affinity of catalase for its substrate hydrogen peroxide is low, in other words, 
catalase works efficiently only when the concentration of hydrogen peroxide is high. 
The finding that catalase is a potent inhibitor of tumour recurrence indicates that 
hydrogen peroxide is an important factor in enhancing peritoneal tumour recurrence. 
However, apparently the concentration of this ROS is low and therefore glutathion 
peroxidase, another component of RBC that reduces low concentrations of hydrogen 
peroxide in the presence of reduced glutathion with high efficiency", may be a better 
choice. 
SOD, another antioxidant enzyme contained by RBC, dismutates superoxide to 
peroxide and oxygen (02·.+02".+2H' -> H20 2+02). Experiments investigating 
ischaemia reperfusion injury use SOD to inactivate the tissue traumatising effect of 
superoxide. 13- 15 The results of these experiments show that neutralising superoxide 
reduces tissue injury15, enhances post operative wound healing14, increases bursting 
pressure of sutured small intestine14 and increases graft survival after transplantation." 
In our experiment 50% inhibition of tumour recurrence was observed by using this 
enzyme in excess (500 U present in RBC concentrate and 2000 U used in 
experiments). Apparently the superoxide anion also promotes tumour recurrence. 
However, SOD alone and in combination with catalase was not more efficient than 
catalase alone. 
The above mentioned results illustrate that intra peritoneal injection of haemoglobin 
stimulates tumour recurrence and that inhibition of hydrogen peroxide and superoxide 
related tissue trauma diminishes tumour recurrence. Taken together, these results 
provide evidence for the role of another ROS, namely the hydroxyl radical (OHo) as the 
real effector molecule in promoting tumour recurrence. Hydroxyl radicals are extremely 
reactive, unstable and powerful free radicals compared to the relatively unreactive 
peroxide and superoxide';5;15 Catalysed by iron, peroxide is converted to the hydroxyl 
radical in the Fenton reaction (Fe2++H 20 2 --+ Fe3++OH-+OHe). On its turn ferric iron is 
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reduced to ferrous iron by superoxide in the Haber-Weiss reaction (OZ+H,O, --> 
O,+OH-+OH·). This may explain why the combination of SOD and catalase did not lead 
to a better outcome than each antioxidant enzyme alone, and why haemoglobin, given 
as a source of iron, increased tumour recurrence. The production of the hydroxyl 
radical will ultimately lead to enhanced peritoneal tissue damage and hence, enhanced 
tumour recurrence. Eliminating superoxide or hydrogen peroxide with SOD and 
catalase respectively prevents the production of the hydroxyl radical. Although 
glutathion peroxidase (together with reduced glutathion), based on its high efficiency to 
neutralise low hydrogen peroxide concentrations, may improve the inhibitory effect on 
tumour recurrence, a promising alternative approach may be the use of iron chelators. 
In conclusion, we have shown that inhibition of ROS mediated peritoneal damage with 
the use of scavengers leads to diminished tumour recurrence. A great deal of insight 
exists about ROS mediated ischaemia reperfusion damage and the prevention of this 
mechanism by scavengers. Recent studies proclaim improved results against tissue 
damage using chemically and biologically stable mimics of SOD and catalase. 20 
Inhibition of the overwhelming oxidative potential after surgical peritoneal trauma (or 
any other form of surgical trauma) with the use of scavengers may also lead to 
interesting new approaches for diminishing tumour recurrence. 
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MEDIAN TUMOUR LOAD (RANGE) AT DIFFERENT PERITONEAL SITES 
Abdominal PBS RBC Haemoglobin catalase 
Sites (n=10) (n=10) (n=9) (n=10) 
Omentum 5 (4-5) 0(0-5) 5 (5) 1.5(0-4) 
Liver 2.5 (2-4) o (0-2) 5 (5) 1.5 (0-3) 
Kidney 3 (2-5) 1 (0-5) 5 (4-5) 3 (1-5) 
Par. peritoneum 5 (4-5) 1 (0-3) 5 (5) 1.5 (1-5) 
Mesentery 2.5 (1-4) o (0-4) 3 (2-5) 1.5 (0-4) 
Retro peritoneum 1 (0-3) 0(0-4) 5 (3-5) 1 (0-2) 
Total 19.5 (15-24) 2.5 (1-21) 28 (25-30) 12(3-21) 
A 
Abdominal 
Sites p1 p2 p3 p4 
Omentum <0.0001 ns <0.0001 0.04 
Liver <0.0001 <0.0001 0.008 0.03 
Kidney 0.004 0.002 ns ns 
Par. peritoneum <0.0001 ns 0.001 0.05 
Mesentery 0.002 0.05 ns ns 
Retro peritoneum 0.05 <0.0001 ns 0.03 
Total 0.001 <0.0001 0.002 0.008 
B 
Table 6.1 
A: Median tumour load and range at different abdominal sites in rats having undergone a 
laparotomy followed by ip injection of tumour cells with PBS, RBC, haemoglobin (0.5 g) or 
catalase (3000 U). B: The p~value 1 represents differences between rats receiving PBS (control) 
and RBG, p-value 2 represents differences between PBS and haemoglobin; p-va[ue 3 between 
PBS and catalase and p-value 4 between RBG and catalase. 
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MEDIAN TUMOUR LOAD (RANGE) AT DIFFERENT PERITONEAL SITES 
Abdominal control catalase SOD Cat/SOD 
Sites (n=5) (n=8) (n=8) (n=8) p1 p2 p3 
Omentum 5 (3-5) 2.5 (0-5) 2 (0-5) 1 (1-3) ns ns 0.003 
Liver 4 (1-5) 1.5 (0-4) 1 (0-3) 1 (0-2) ns 0.03 0.01 
Kidney 4 (2-5) 0.5 (0-4) 2 (0-4) 1 (0-4) 0.007 0.02 0.01 
Par. perit 5 (1-5) 0.5 (0-5) 2.5 (0-5) 4 (0-5) ns 0.03 0.02 
Mesentery 5 (1-5) 1.5 (0-4) 2 (0-5) 1 (0-5) 0.03 ns 0.03 
Retro perit 5 (2-5) 1 (0-5) 1.5 (0-5) 1 (0-5) 0.02 ns 0.04 
Total 28 (14-30) 13 (1-25) 11.5 (1-26) 9 (2-24) 0.03 0.02 0.007 
Table 6.2 
Median tumour load and range at different abdominal sites in rats having undergone a 
laparotomy followed by ip injection of tumour cells with PBS, catalase (6000 U), SOD (2000 U) 
or a combination of catalase and SOD {cat/SO~). The p-value 1 represents differences between 
rats receiving PBS (control) and catalase; p-value 2 represents differences between PBS and 
SOD, p-value 3 between PBS and cat/SOD. 
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Part IV 
Mesothelial and Tumour Cell Adhesive Interactions 
in vitro 

Chapter VII 
EFFECT OF INFLAMMATORY CYTOKINES AND GROWTH FACTORS ON 
TUMOUR CELL ADHESION TO THE PERITONEUM 
Accepted for publication in the Journal of Pathology 
In this experimental study the effect of inflammatory cytokines and growth factors on 
tumour cell adhesion to the peritoneum was investigated. A reproducible in vitro assay 
to study the adhesion of CC531 colon carcinoma cells to an autologous monolayer of 
rat mesothelial cells was developed. 
Tumour cell adhesion to mesothelium pre-incubated with IL -1 jJ and EGF resulted in at 
least 60% more tumour cell adhesion at maximal stimulation. TGF-jJ pre-incubation 
resulted in minor though significant stimulation of cell adhesion (maximal 16%). The 
effect of IL-1jJ was time and dose dependent. No mesothelial cell proliferation took 
place afler pre-treatment with IL -1 jJ, indicating enhanced adhesion was not based on an 
increase in the number of mesothelial cells. Pre-treatment with EGF stimulated 
mesothelial cell growth as measured by DNA analysis. This effect on cell growth and 
adhesion was dose dependent. 
Additional blocking experiments with anti-IL -1 jJ resulted in statistically significant 
inhibition of IL-1jJ stimulated tumour cell adhesion, demonstrating the specificity of this 
effect. IFN-y, TNF-a, IL-6 and IGF-I pre-incubation had no effect on tumour cell 
adhesion. 
The presented results prove IL-1 jJ and EGF are significant promoting factors in tumour 
cell adhesion to mesothelium in vitro and may therefore account for tumour recurrence 
to the peritoneum in vivo. 
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INTRODUCTION 
Despite intentionally curative resection for gastro-intestinal carcinoma, peritoneal 
dissemination is a common cause for post-surgical recurrence. 1 Several theories 
suggest that exfoliation of tumour cells at the time of operation, microscopic deposits in 
lymphatics and presence of malignant cells at the anastomosis play an important role 
in the aetiology of intra-abdominal tumour recurrence. 2 Patterns of first recurrence 
show the resection site is preferential, and combined recurrence on peritoneal surfaces 
and resection site is common. 1-3 
The tumour cell entrapment theory proposes that the fibrinous exudate, formed as 
initial response to surgical trauma, facilitates the implantation of cancer cells onto raw 
tissue. Tumour growth is subsequently encouraged by growth factors produced by 
inflammatory cells participating in the repair process. 2 Using an ectopic tumour growth 
model, we recently demonstrated enhanced growth of extra peritoneal tumour 
metastases after inflicting surgical trauma to the peritoneum (see also chapter 3)4;5 In 
an experimental model, Hofer et al demonstrated enhanced tumour growth in vivo after 
"direct" surgical wounding and "artificial" wounding with wound fluid or growth factors.' 
These studies indicate that factors produced after surgical trauma enhance local and 
distant tumour growth. 
Apart from stimulated cell growth, residual tumour cells may profit from the enriched 
wound micro-environment by enhancing the prospect of cell adhesion. This would 
explain tumour recurrence at not directly traumatised peritoneal surfaces. Although 
tumour cell adhesion is the first step for successful recurrence, few studies have been 
performed to elucidate the mechanisms behind this process. In vitro upregulation or de 
novo synthesis of cell adhesion molecules in a wide range of cell types after pre-
treatment with inflammatory cytokines has been reported.7~10 These studies however, 
do not foresee the effect on tumour cell adhesion. 
In the present study, we developed an in vitro cell adhesion model in order to quantify 
cell adhesion and evaluate the effect of inflammatory cytokines and growth factors on 
the number of adhered tumour cells. A reproducible assay was designed to study the 
adhesion of CC531 colon carcinoma cells to an autologous monolayer of rat 
mesothelial cells. This study was undertaken to demonstrate that cytokines and growth 
factors present in wound fluid after surgical trauma not only enhance tumour growth, 
but also affect tumour cell adhesion. Expression of cell adhesion molecules was 
assessed to verify elementary interactions between the investigated cell types. 
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MATERIALS AND METHODS 
Animals 
Inbred WAG/Rij rats, obtained from Harlan-CPS, Zeist, The Netherlands were used. The rats 
were bred under specific pathogen-free conditions, kept under standard laboratory conditions 
(temperature 20-24°C, relative humidity 50-60%, 12 hours IighU 12 hours dark), fed with 
laboratory diet (Hope Farms, Woerden, The Netherlands) and water ad libitum. The 
experimental protocol adhered to rules laid down by the Dutch Animal Experimentation Act and 
was approved by the Committee in Animal Research of the Erasmus University Rotterdam. 
Isolation and identification of mesothelial cells 
Mesothelial cells (Me) were isolated from the small bowel mesentery of a male rat, according to 
techniques modified from Akedo et aJ 11 as described previously.12 In brief, under ether 
anaesthesia the abdomen of a rat was shaved, cleaned with alcohol 70% and subsequently 
opened. Window like transparent triangular sheets of mesentery were isolated and collected in 
Hank's Balanced Salt Solution (HBSS) containing 5% human serum albumin (CLB, Amsterdam, 
The Netherlands) penicillin (105 U/L), glutamin (2 mM) and fungizone (1.25 mg/L). After washing 
the sheets twice in this medium, they were incubated in a mixture of collagenase (1 gIL) and 
dispase (2.4 x 103 U/L) (Roche Diagnostics, Almere, The Netherlands). Following incubation 
during 15 minutes at 37°C and continuous gentle shaking, the detached mesothelial cells were 
pelleted by centrifugation at 300 g for 5 minutes. Cell viability was determined by trypan blue 
and always exceeded 95%. The pelleted mesothelial cells were resuspended in culture 
medium. Culture medium consisted of RPMI 1640 supplemented with 10% foetal calf serum, 
glutamin (2 mM), penicillin (105 U/L) and fungizone (1.25 mg/L). Medium and all supplements 
were obtained from Life Technologicals BV (Breda, The Netherlands). The mesentery derived 
cells grew forming a monolayer in a 37°C, fully humidified, 5% CO2 incubator in polystyrene 
culture flasks (75 cm2 ; Corning BV, Schiphol-Rijk, The Netherlands) precoated with collagen 
type I (15jlg/cm 2 collagen S (type I), cell biology Roche Diagnostics). 
Tumour cell line 
CC531 is a moderately differentiated, weakly immunogenic colon adeno-carcinoma induced in a 
WAG/Rij rat by 1,2-dimethylhydrazine. A cell line was established and maintained by serial 
passage after trypsinization in culture medium.13 CC531 tumour cells were cultured in RPMI 
1640 medium supplemented with 5% foetal calf serum, glutamin (2 mM) and penicillin (105 U/L), 
and passaged once weekly using trypsin (0.05%) and EDTA (0.02%). 
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Cytokine and growth factor pre-incubation 
Recombinant rat inter!eukin-1 p (IL-1 ~), interleukin-6 (lL-6) and tumour necrosis factor-a (TNF-a) 
were obtained from R&D Systems, Uithoorn, The Netherlands. Epidermal growth factor (EGF), 
insulin like growth factor-I (IGF-I) and transforming growth factor-~ (TGF-P) were obtained from 
Sachem, Bern, Switserland. Interferon-y (IFN-y) was obtained from Sanvertech, 
Heerhugowaard, The Netherlands. Pre-incubation of the mesothelial monolayer was performed 
using increasing concentrations of these mediators. 
To demonstrate time-dependency, IL-1 p pre-incubation of the mesothelial monolayer was 
performed at different time intervals (O to 24 hours pre-incubation). 
Anti-rat IL-1P was obtained from R&D Systems. To inactivate IL~1p, pre~incubation was 
performed with a hundred-fold excess of anti~IL~1P during 1 hour at 37°C according to 
instructions of the manufacturer. After this, the formed IL-1p/anti~IL~1P complex was added to 
the mesothelial monolayer for pre~incubation. 
Calcein-AM solution and incubation 
The dye solution, calcein-AM, used to quantify tumour cell adhesion was prepared by dissolving 
50 )J.g calcein (Molecular Probes, Leiden, The Netherlands) in 5 )J.I anhydrous dimethyl 
sulphoxide (Sigma-Aldrich, ZWijndrecht, The Netherlands) and adding this solution to 5 ml of 
RPMI medium supplemented with 0.5% bovine serum albumin (RPMI/0.5%BSA, BSA obtained 
from Sigma-Aldrich). Trypsinized CC531 cells (1x106 cells/ml) were incubated in 
RPMI/0.5%BSA at 37°C for 45 minutes with occasional mixing. 
Adhesion assay 
To quantify tumour cell adhesion to mesothelium, a standardised cell adhesion assay was 
developed according to methods from Catterall et af.14 Mesothelial mono layers were established 
in 96 well plates (Canberra Packard, Groningen, The Netherlands), precoated with collagen 
type I (15 ~lg/cm2, coating according to instructions of the manufacturer). To do this, confluent 
cells were washed with phosphate buffered saline (PBS) and harvested with trypsin (0.05%) 
and EDTA (0.02%) and 1.5 x 104 mesothelial cells were added in 200 ~tI of medium to each well. 
The plates were incubated at 37°C, in a humidified atmosphere of 5% CO2 in air; medium was 
replaced daily with fresh medium. Monolayers reached confluence in 2 days as determined by 
light microscopy. In order to determine the effect of the inflammatory cytokines and growth 
factors on tumour cell adhesion, mesothelial monolayers were pre-incubated with increasing 
doses. Non pre~incubated mesothelial monolayers served as controls. 
Tumour cells were labelled with calcein as described above. Before adding to the mesothelial 
mono!ayers, the labelled cells were washed twice with RPMI/O.5%BSA to remove free dye. 
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Medium from the experimental wells was removed and 200 )..II RPMIIO.5%BSA containing 
30.000 calcein labelled tumour cells was added. Plates were centrifuged for 1 minute at 80 g on 
a Heraeus centrifuge and incubated at 37°C for 60 minutes. After this, the medium of each well 
was removed and washed twice with 200 ~LI RPMIIO.5%BSA medium. The remaining 
fluorescence per well was measured on a Perkin Elmer plate reader using 485 excitation and 
530 emission filters. On each plate a standard was prepared by adding different numbers of 
labelled tumour cells to the wells. The amount of tumour cells adhered was determined by 
calibrating the measured fluorescence of the experimental wells on the standard. 
DNA-assay 
To establish whether overnight incubation of the mesothelial monolayer with the different 
cytokines was of influence on cell growth, a DNA measurement was performed. In this assay, 
the DNA content of the mesothelial cells was measured using the bisbenzimide fluorescent dye 
(Roche Diagnostics) as previously described by Hofland et al. 15 
Expression of cell adhesion molecules 
CC531 and mesothelial cells were prepared for staining by cytospin preparation, fixed in 
acetone for one minute and stored at _20°C until use. The cytospins were pre-incubated for 15 
minutes with 10% normal goat serum, diluted in PBS, and incubated overnight at 4°C with 
mouse anti rat monoclonal antibodies to ICAM-1 (kindly provided by E. de Heer, University 
Hospital Leiden, Leiden, The Netherlands), E-cadherin (provided by L. Litvlnov, Un·lversity 
Hospital Leiden, Leiden, The Netherlands), CD44 (kind gift from J. Ate, Academic Medical 
Centre, Amsterdam, The Netherlands) and VCAM-1 (A. Duijvestijn, University of Maastricht, 
Maastricht, The Netherlands). Negative controls were incubated with PBS only. The cytospins 
were subsequently incubated with biotinylated goat-anti-mouse secondary antibodies (Dako, 
Glostrup, Denmark), rinsed and finally incubated with a Streptavidin-biotinylated horseradish 
peroxidase complex (Dako, Glostrup, Denmark). Cytospins were developed in 3.3' 
diaminobenzidine tetrachloride. To detect CD49a, CD49b and CD29 integrin chains, hamster 
anti-rat primary antibodies were used followed by a FIrC conjugated secondary antibody 
(Pharmingen, Leiden, The Netherlands). The expression of cell adhesion molecules was 
quantified by two separate observers using a semi-quantitative scoring system ranging from no 
expression (-), weakly positive (±) to positive expression (+). 
Statistical analysis 
All data were analysed using analysis of variance (ANOVA) to determine overall differences 
between group means. If the ANOVA was significant on a 5% level, the post-hoc Newman-
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Keuls test was carried out to make a comparison between groups. Ps::O.05 was considered to be 
statistically significant. Experiments were carried out at least twice with comparable results. 
RESULTS 
Validation of assay 
Loading of the tumour cells with calcein did not affect their viability (>95% using trypan 
blue). To determine the stability of calcein uptake, the release of fluorescence in the 
supernatant of labelled cells after an incubation time of up to 120 minutes was 
measured. The fluorescence of the washed cells stayed constant for at least 90 
minutes indicating retention of the dye within the cells (data not shown). 
A dilution series was made by using labelled CC531 cells on a mesothelial monolayer. 
There was a direct relationship between the cell number added and measured 
fluorescence resulting in a linear correlation which was used as a standard to calibrate 
the measured fluorescence. In this way the amount of adhered tumour cells in the 
experimental wells could be determined. 
Tumour cell adhesion to a mesothelial monolayer 
Tumour cell adhesion to a non pre-incubated mesothelial monolayer was relatively 
slow and temperature dependent. Maximum adhesion was seen after 60 minutes. At 
this time point a steady state situation was achieved and eel! adhesion did not increase 
hereafter. The tumour cells remained rounded up during these adhesion assays. After 
more than 60 minutes, the first signs of spreading out could be detected under the light 
microscope. Therefore, for all subsequent experiments, 60 minutes was taken as a cut-
off point. Non-stimulated cell adhesion was always between 20-30% of the total 
amount of tumour cells added. 
104 
190 
180 
170 
160 
0 150 ~ 
1: 
0 
C) 140 
VI 
" VI cell adhesion ~ 130 
'" > DNA ~ 
• 120 
110 
100 
5~i 
-4 -3 -2 -1 0 2 
[IL-1Pllog (ng/ml) 
Figure 7.1 
Tumour cell adhesion to, and growth of a mesothelial monolayer after pre-incubation with 
varying concentrations IL-1J3. Data are expressed as the mean (n=6) +SEM. EC50 for tumour 
cell adhesion is 2 ng/ml IL-1J3. Pre-incubation did not significantly modify total DNA of the 
monolayer. 
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Figure 7.2 
Tumour cell adhesion to a mesothelial monolayer after pre-incubation with 10 ngiml IL-1~ at 
varying time intervals. Data are expressed as the mean (n=6) +SEM. * p<O.01 and ** p<0.001 
Effect of cytokine pre-incubation 
Pre-incubation of the mesothelial monolayer with IL-1 ~ resulted in enhanced tumour 
cell adhesion. This effect was dose dependent. Significant stimulation was already 
achieved with 0.1 ng/ml IL-1~ (11% more cell adhesion versus non pre-incubated 
mesothelium, p~0.05). Maximum stimulation was achieved with 50 ng/ml IL-1 ~ 
(p~0.001). The augmented adhesion at this concentration was at least 60% more than 
adhesion to non pre-incubated mesothelium. The ECso of the IL-1 ~ effect is 2 ng/ml 
(figure 7.1 and table 7.1). 
At least 4 hours of pre-incubation were needed to induce enhanced cell adhesion (10 
ng/ml IL-1~, p~0.01). Maximal cell adhesion was achieved after pre-incubation for 12 
hours with this concentration IL-1~ (42% stimUlation). The observed data suggest that 
IL-1 ~ stimulation is time dependent and therefore involves secondary protein synthesis 
(figure 7.2). 
After blocking with anti-IL-1~, stimulation with 1 ng/mllL-1ll (0,1 f,g/ml anti-IL-10) was 
completely inhibited and stimulation with 10 ng/ml IL-1~ (1 flg/ml anti-IL-1~) partially 
inhibited (50%). Pre-incubation of mesothelium with anti-IL-10 alone did not affect 
tumour cell adhesion. These results underline the specificity of IL-1 ~ stimUlation and 
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demonstrates the involvement of a specific receptor related pathway at which 
enhanced tumour cell adhesion to the mesothelium is induced (figure 7.3). 
Interestingly, TNF-a (1-100 ng/ml) and IFN-y (1-100 ng/ml), known to upregulate 
several cell adhesion molecules (eg ICAM-I and VCAM-I), did not affect adhesion of 
CC531 cells to the mesothelial monolayer. Pre-incubation with IL-6 (1-100 ng/ml) did 
not result in altered tumour cell adhesion either (table 7.1). 
Of the studied growth factors, EGF proved a potent stimulator of tumour cell adhesion. 
With light microscopy, morphologic changes were seen in cell appearance of the 
monolayer. There was a dose dependent stimulation of cell adhesion to overnight pre-
inCUbated mesothelium. Maximal stimulation was achieved at 10 _9 M. The ECso is 2.6 x 
10-11 M EGF (figure 7.4 and table 7.2). 
Pre-treatment with TGF-~ (0.1-10 ng/ml) lead to a minor (maximal 16%) though 
significant stimulation in cell adhesion (p<0.05). IGF-I (10-"_10-7 M) did not affect 
tumour cell adhesion (table 7.2). 
[IL-1 P 1 (ng/ml) 
Figure 7.3 
Tumour cell adhesion after pre-incubation of a mesothelial monolayer with 1 and 10 ng/mIIL-1 p, 
with additional blocking using anti IL-1 p (0.1 and 1 pg/ml respectively). Open bars represent fL-
113 pre-treated monolayers and closed bars represent blocking of IL-1j3 stimulation with anti IL-
1~. Values are the mean of n=4+SEM. 'p<O.01 (IL-1~ vs control) and" p<O.01 (IL-1P vs anti 
IL-1 ~) 
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DNA-assay 
Pre-incubation with IL-1~ (2:12 hours) did not modify total DNA content of the 
mesothelial monolayer and therefore did not affect cell growth. This suggests that the 
increased adhesion induced by IL-1~ is not caused by an increase in the number of 
mesothelial cells (figure 7.1). 
EGF induced a significant growth of the mesothelial cells, consistent with the increased 
cell adhesion to mesothelium. At 10 -10 M EGF stimulation, cell grow1h was stimulated 
by 10%, coinciding with 31% more cell adhesion. At 10 -9 M EGF and higher 
concentrations this stimulation was 17%, coinciding with 39% stimulation. The ECso for 
stimulation of mesothelial cell growth is 9.5 x 10 -11 M EGF (figure 7.4). 
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Tumour cell adhesion to, and growth of a mesothelial monolayer after pre-incubation with 
increasing concentrations EGF. Data are expressed as the mean (n=6) +SEM. The ECso for 
tumour cell adhesion is 2.6 x 10-11 M EGF. Pre-incubation significantly enhanced total DNA of 
the monolayer indicating stimulated mesothelial cell growth (EC50 9.5 x 10-11 M). 
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Concentration (ng/ml) IL-1~ TNF-a IL-G TGF-~ 1FN-r 
0.1 111±14- 111± 11-
131 ± 15" 110±13 106 ± 7 116 ± 6- 94 ± 14 
10 152±14" 112±13 100±10 111 ± 9- 97 ± 14 
50 163 ± 14" 102 ± 12 102 ± 7 98 ± 12 
100 97 ± 9 102 ± 6 108±14 
Table 7.1 
Tumour cell adhesion after pre-incubation of a- mesothelial monolayer with cytokines or growth 
factors. Means (n=6, % vs control) +SD are shown. * p<O.05, ** p<O.01 
Concentration (M) EGF IGF-I 
10 11 108 ± 14 
10 H'l 131 ± 18-
10 ' 138 ± 19" 
10 =>l 139 ± 12" 101 ± 8 
10 .{ 132 ± 18-- 100 ± 6 
Table 7.2 
Tumour cell adhesion after pre-incubation of a mesothelial monolayer with growth factors. 
Means (n=6, % vs control) + SD are shown. * p<O.05, ** p<O.01 
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Figure 7.5 
Expression of cell adhesion molecules by mesothelial and CC531 cells. Figures A and B: 
negative control; C and D: ICAM-I; E and F: E-cadherin; G and H: CD44. 
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Expression of cell adhesion molecules 
A variety of cell adhesion molecules are expressed on both cell types offering sites for 
specific cell-cell and cell-matrix adhesion. Results are shown in figure 7.5 and table 7.3. 
Cell adhesion molecule Mesothelial cells CC531 cells 
ICAM-I + ± 
VCAM-I + 
E-cadherin + + 
CD44 + + 
CD49a + ± 
CD49b + + 
CD29 + + 
Table 7.3 
Cell adhesion molecules expressed by mesothelial and CC531 cells. 
DISCUSSION 
For manifest tumour recurrence to develop, adhesion and growth of perwoperatively 
spilled tumour cells is necessary. Cytokines and other inflammatory mediators, 
produced in great amount after surgical trauma, are known to influence tumour 
recurrence in viVO. 5;6;16 The source of these inflammatory mediators is ample. Following 
surgical trauma, the reactive inflammatory process will cause migration of 
macrophages and leukocytes to the injured site in order to promote the wound healing 
process.17 In case of peritoneal trauma, the mesothelial cells lining the peritoneum take 
active part in the inflammatory process by producing a variety of neutrophil and 
monocyte chemokines such as IL-8 and IL_1~.18'19 In order to re-establish the 
traumatised monolayer lining, additional stimulating factors are produced with an 
autocrine function. 18 Therefore locally, at traumatised sites, a rich microenvironment 
with high concentrations of inflammatory cytokines and growth factors are expected. 
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Enhanced reciprocal mesothelial-tumour cell interactions can be established in this way 
in a selected area. 
The results of this study indicate that tumour cells adhere to a monolayer mesothelium. 
However, pre-treatment of mesothelium with inflammatory cytokines and growth factors 
can lead to more than 60% enhanced tumour cell adhesion. A significant increase in 
the adherence of tumour cells was seen after stimulation with IL-10. The demonstrated 
time dependency of this effect, points in the direction of secondary RNA and protein 
synthesis required for enhanced cell adhesion. IL-10 is known to regulate the cell 
adhesion molecules VCAM-1 and ICAM-1 on human mesothelial cells in a time and 
dose dependent manner.';9 In the presented studies pre-treatment with IL-10 did not 
lead to enhanced mesothelial cell growth. The stimulus after IL-10 pre-treatment 
therefore, seems to be based on enhanced adhesion per cell. An upregulation of cell 
adhesion molecules expressed on the mesothelial cell surface is therefore likely to play 
a role in IL-10 enhanced tumour cell adhesion. These effects on cell adhesion are 
similar to those reported by others in a different model system. 20-22 In those studies, IL-
1 promoted the adherence of human colorectal carcinoma cell lines and melanoma cell 
lines to endothelial cells in a time and dose dependent manner. Differential stimuli were 
seen with the melanoma cell lines occurring from highly significant enhancement to no 
significant change in tumour cell adhesion. 21 ;22 
In the presented study, EGF stimulated cell adhesion coincided with an increase in the 
number of mesothelial cells. EGF has been shown to be a potent growth factor for 
mesothelium in addition to augmenting cell adhesion and migration.23;24 Typical 
reversible morphologic changes to a fibroblastic phenotype, as seen in our study, 
accompanied by increased expression of CD29 integrins have been demonstrated.24 
The exact mechanism by which the increase of tumour cell adhesion to traumatised 
mesothelium comes about is yet to be unravelled. In several studies it has been 
demonstrated that TNF-a, TGF-0, IL-10 and IFN-y have the potential to upregulate the 
expression of cell adhesion molecules, hereby increasing the prospect of cell 
adhesion.8-1O;21:2S:Z6 However, upregulation of adhesion molecules does not always 
correspond with enhanced cell adhesion. 21 ;25 As shown in this study, enhanced tumour 
cell adhesion also coincides with mesothelial cell growth. Therefore, two mechanisms 
seem to playa role in this process. Firstly, specific enhanced adhesion per cell through 
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upregulation of adhesion molecules and secondly, enhanced adhesion by increase of 
cell number to adhere to. 
Studies on cell adhesion have generally been performed to investigate the adhesive 
pattern of leukocytes during inflammation on activated and non-activated endothelial 
cells. Most studies harmoniously conclude that inflammatory cytokines lead to an 
upregulation of ICAM-I, VCAM-I, E-selectin and P-selectin expression, hereby inducing 
leukocyte rolling and extravasation'" Studies on mesothelial cells show a similar 
upregulation of cell adhesion molecules (lCAM-1 and VCAM-I) after pre-treatment with 
cytokines,';9;19 This is attributed to the fact that the mesothelium plays an active role in 
trafficking and attachment of leukocytes to the peritoneal membrane,';9;19 Tumour cells 
may utilise this altered expression of cell adhesion molecules during inflammation by 
facilitated lodging to mesothelial cells. 
The expression of adhesion molecules determined on the cells used in this study 
provides ample possibility for cell-cell and cell-matrix interaction under non-stimulated 
conditions. From the known interactions of adhesion molecules, the results suggest 
that CD44, E-cadherin and CD29 integrins may be important in tumour and mesothelial 
cel! interactions. In vivo kinetics of cell adhesion molecule expression following surgical 
trauma are currently being investigated. Preliminary results show an upregulation of 
VCAM-I mRNA on mesothelial cells of the small bowel mesentery. However, it is likely 
that for manifest tumour recurrence more than one subset of cell adhesion molecules 
play a role. Ovarian carcinoma cells have been shown to use several adhesion 
pathways for cell binding to mesothelium in vitro, engaging a combined role for CD29 
integrin chain and CD44.27;28 Nakashio et at demonstrated CD44H and integrin CD29 
mediated adhesion of gastric cancer cells to mesothelium in vivo and in vitro.26 To fully 
understand the underlying mechanisms of enhanced cell adhesion after pre-treatment 
with cytokines and growth factors, it is therefore important to determine the variety of 
adhesion molecules involved and their relation to complementary sites. 
In conclusion, our data suggest that tumour cells benefit from the inflammatory 
response by utilising cytokine induced adhesion stimulation. IL-1P appears to be an 
important mediator of this process. Therefore, in addition to stimulating tumour growth, 
inflammatory metabolites contribute actively to manifest tumour recurrence in two 
ways. 
The apparent relation between the inflammatory process after surgical trauma and 
tumour recurrence necessitates further unravelling of the specific mechanisms 
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involved. This may lead to potential new therapeutic possibilities aimed at abating 
tumour cell adhesion and growth. 
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Chapter VIII 
THE ROLE OF INTEGRINS IN PERITONEAL TUMOUR RECURRENCE OF COLON 
CARCINOMA 
Submitted for publication 
In prior in vivo experiments described in chapter 3 we demonstrated a preferential 
adhesion of colon carcinoma cells to areas of the peritoneum where mesothelial cells 
had been exfoliated. In this study we consider the interaction of tumour cells with 
surgically traumatised peritoneum in depth. 
In vitro studies demonstrated a preferential adhesion of tumour cells to collagen type I 
(50% versus <30% adhesion to other submesothelial matrix (ECM) components and 
mesothelial cells). Tumour cells contained mRNA encoding for ICAM-I, a" a2 and /J, 
integrins and expressed these adhesion molecules on the cell surface. Mesothelial 
cells expressed mRNA encoding for the ICAM-I receptor (aJ],). Unlike a integrin 
chains, /J, mediated tumour cell adhesion to all ECM proteins. Adhesion to collagen I 
was fully mediated by a2/J, integrin. Blocking integrin or ICAM-I mediated adhesion had 
no effect on tumour-mesothelial cell interaction. 
We conclude that for tumour cefl-ECM interaction, J31 is used as a common integrin 
subunit. An intact mesothelia! monolayer forms a natural barrier against tumour cell 
adhesion. Interruption of this protective surface, as happens in surgical trauma, 
enhances tumour cell adhesion to submesothelial surfaces. In the event of tumour cell 
adhesion to intact peritoneum, this occurs through an integrin and ICAM-I independent 
mechanism. 
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INTRODUCTION 
Tumour recurrence remains a frequent complication after intentionally curative 
resection of colorectal malignancies. Apart from distant metastases, isolated loco-
regional recurrence rates vary between 3 and 35%.1-4 Patterns of first recurrence show 
the resection site is the most common anatomic location and is often combined with 
recurrence on peritoneal surfaces,1:2:4;5 Per-operative shedding of tumour cells due to 
handling the tumour and leakage from dissected lymphatic channels are the most likely 
causes of tumour recurrence. Adhesion of these spilled tumour cells and subsequent 
growth results in manifest peritoneal tumour recurrence. 5 
In an experimental rat model we demonstrated earlier that surgical trauma of the 
peritoneum correlates with tumour recurrence in ViVO.5 At the site of inflicted trauma, 
the mesothelial cells lining the peritoneum were exfoliated, hereby exposing the 
underlying extra cellular matrix (ECM). Recurrence of CC531 colon carcinoma cells 
was primarily seen at the traumatised sites, in addition to other non-traumatised 
peritoneal surfaces. 6;7 Tumour cell adhesion to either exposed underlying matrix 
components or mesothelial cells of the intact peritoneum may be the key component in 
the process of tumour recurrence. 
To realise adhesion, tumour cells make use of specific receptors expressed on the cell 
surface. Integrins are cell surface receptors mediating cell adhesion to ECM 
components and also, to a lesser extent, other cells. ICAM-I, the counterpart of aL~2 
integrin, is uniformly expressed by mesothelial cells and used by leukocytes to enter 
the abdominal cavity. The aim of this study was to explore the role of integrins in the 
adhesive pattern of CC531 colon carcinoma cells to different ECM components and 
mesothelium. Furthermore, the role of ICAM-I in tumour cell adhesion was assessed to 
explore a malign use of normally expressed adhesion molecules. With these 
experiments an attempt was made to clarify the use of integrins in the modalities of 
interaction between CC531 cells and the peritoneum following surgical trauma. 
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MATERIALS AND METHODS 
Animals 
Inbred WAG/Rij rats, obtained from Harlan-CPB, Zeist, The Netherlands were used. The rats 
were bred under specific pathogen-free conditions, kept under standard laboratory conditions 
(temperature 20-24°C, relative humidity 50-60%, 12 hours light! 12 hours dark), fed with 
laboratory diet (Hope Farms, Woerden, The Netherlands) and water ad libitum. The 
experimental protocol adhered to rules laid down by the Dutch Animal Experimentation Act and 
was approved by the Committee in Animal Research of the Erasmus University Rotterdam. 
Cell culture 
CC531 is a moderately differentiated, weakly immunogenic colon adena-carcinoma induced in 
the WAG/Rij rat by 1,2-dimethylhydrazine. A cell line was established from this carcinoma and 
maintained by serial passage after trypsinization in culture medium.s For continuous culture 
RPMI 1640 medium supplemented with 5% foetal calf serum, L·glutamin (2 mM) and penicillin 
(10' U/L) was used. 
Mesothelial cells were isolated from the small bowel mesentery of WAG/Rij rats and brought 
into culture as described before. 9 Briefly, resected mesenterial sheaths were incubated in 
collagenase (1g/L) and dispase (2.4 10' U/L) (Boehringer, Mannheim, Germany). The detached 
mesothelial cells were pelleted and resuspended in RPMI 1640 medium supplemented with 
10% foetal calf serum, L-glutamin (2 mM), penicillin (10' U/L) and fungizone (1.25 mg/L). 
Mesothelial monolayers were established in 96 well plates, precoated with collagen type I (17.5 
pg/cm2). For all experiments, primary cell cultures were used. 
Medium, supplements and foetal calf were purchased at Life Technologies, Breda, The 
Netherlands. 
Calcein-AM solution and incubation 
The dye solution, calcein·AM, used to quantify tumour cell adhesion was prepared by dissolving 
50 ~lg calcein·AM (Molecular Probes, Leiden, The Netherlands) in 5 ~tI anhydrous dimethyl 
sulphoxide. This solution was added to 5 ml of the RPM! medium supplemented with 0.5% BSA. 
Trypsinized CC531 cells (1x106 cells/ml) were incubated in this solution at 3rC for 45 minutes 
with occasional mixing. Calcein incubation did not influence the viability of CC531 cells as 
determined by trypan blue exclusion. 
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Cell attachment assay 
To quantify tumour cell adhesion, a standardised cell adhesion assay was developed according 
to methods from Catterall et al. 10 Flat-bottomed 96 well culture plates were coated according to 
prescription of the manufacturer with collagen I (17.5 Ilg/ml), laminin (33 f-lg/ml), fibronectin (20 
~g/ml) (Boehringer Mannheim, Mannheim, Germany), collagen IV (20 ~g/ml) (Sigma-Aldrich, 
ZWijndrecht, The Netherlands) or with a mesothelial monolayer grown to confluence. To 
evaluate the contribution of integrins in the adhesion of tumour cells to extra cellular matrix 
components, calcein-Iabelled CC531 cells were pre-incubated with the function blocking 
antibodies anti-al , anti-a;/! and anti-Pl (concentration 0.005 J.lgiml to 1 f-lgiml) for 30 minutes at 
room temperature. After incubation, the coated plates were washed with medium and tumour 
cells were added at a density of 30,000/2001-1.1. The effect of anti~ul' U2, Pl and ICAM-1 
antibodies on tumour cell adhesion to a monolayer mesothelium was assessed by either pre-
incubating the tumour cells or the mesothelial cells with antibodies before adding tumour cells 
(density of 30,000/2001-1.1) to the mesothelium. Cell adhesion was measured after 60 minutes. 
Total cell adhesion was assessed after washing away unbound cells and by measuring total 
fluorescence on a Perkin Elmer plate reader using 485 excitation and 530 emission filters. On 
each plate a standard curve was prepared by adding different numbers of calcein-Iabelled 
tumour cells to the wells. The amount of tumour cells adhered was determined by calibrating 
the measured fluorescence of the experimental wells on the standard. 
Adhesion assays were performed with RPMI medium supplemented with 0.5% bovine serum 
albumin (BSA, Sigma-Aldrich, Zwijndrecht, The Netherlands). All function-blocking antibodies 
were purchased at Pharmingen (Leiden, The Netherlands) and also used for flow cytometry 
analysis. 
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Cellular integrin expression profile using RT-PCR and Flow cytometry 
Cellular integrin expression profiles were analysed by RT-PCR and flow cytometry. For the RT-
peR study, oligonucleotides were devised to specifically amplify rat sequences. The primers 
were based on rat eDNA sequences present in the database or were chosen in regions of high 
similarity between mouse and human eDNA sequences (see table 8.1). The specificity of the 
oligonucleotides was checked by RT -peR procedure using RNA from various rat tissues such 
as spleen, liver, lung, kidney and lymph nodes. Total RNA was isolated with RNAzolTM B 
(Campro Scientific B.V., Veenendaal, The Netherlands) according to recommendations by the 
manufacturer. The procedure is essentially an improved version of the RNA isolation method 
described by Chomczynski and Sacchi.l1 One ~lg of total RNA was used as a template in a 
reverse transcriptase reaction containing 400 U M-MLV-Reverse Transcriptase, 40 U RNasin, 
0.5 mM dNTP's (Promega, Madison, WI) and 20 ng random primers (Gibco-BRL, Gaitherburg, 
MD) using the M-MLV reaction buffer supplied by Promega. Part of the RT reaction mixture was 
subjected to PCR amplification using the primers sets described above. RT-negative and water 
controls were included in each experiment and never gave rise to a detectable amplified DNA 
fragment. The amplified DNA fragments were cloned into the pCR2.1™ cloning vector 
(Invitrogen, Carlsbad, CA) and sequenced to verify the nature of the amplified product. The 
presence of mRNAs encoding various integrins and ICAM-I was determined in total RNA 
preparations of CC531 colon carcinoma cells and mesothelial cells using an identical RT-PCR 
protocol. 
Expression of a1, U2 and P1 on tumour cells and mesothelial cells was measured using FACS 
analysis and analysed using CellQuest software. (Becton Dickinson, San Jose, CA, USA). The 
indirect immunofluorescence method was used to stain the cells. Cells (5x105 in 50j.t1) were 
incubated with 50tJ.1 PBS/O,2%BSA containing the specific primary antibody or isotype control 
antibody (dilution 1: 1 ° to 1:10,000) at room temperature during 10 minutes and subsequently 
rinsed twice with 2ml PBSIO,2%BSA solution. Then the cells were incubated with 50j.t1 
PBSIO,2%BSA containing FITC-conjugated secondary antibody (dilution 1:50) for another 10 
minutes. The cells were washed twice again with 2ml PBS/0,2%BSA solution. IgG and IgM 
isotype controls served as negative controls. All monoclonal antibodies (purified hamster anti-
rat a1, a2 and Pi; purified mouse anti-rat ICAM-1), FITC labelled immunoglobulins (FITC anti-
hamster IgG and -lgM, FITC anti-mouse IgG) and isotype controls (hamster IgG and IgM) were 
purchased at Pharmingen (Lelden, The Netherlands). 
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Statistical analysis 
Data were analysed using analysis of variance (ANOVA) to determine overall differences 
between group means. If the ANOVA was significant on a 5% level, the post-hoc Newman-
Keuls test was carried out to make a comparison between groups. PsO.05 was considered to be 
statistically significant. 
All experiments were carried out at least twice with comparable results. 
Sequence Size of PCR product 
ICAM-1 5' -GTTCTTGTGTTCCCTGGAAGGCC (forward) 757 bp 
5'-GCACTGTCAGGTGCACGTCC (reverse) 
ex, 5' -CTACAAGATGGAGGA TGGG (forward) 790 bp 
5'-GCCTCAGTGAATCAAGGG (reverse) 
ex, 5'-CATGGATGGCTTT AA TGATGTG (forward) 561 bp 
5' -GTTGACAACATCAGAGGGC (reverse) 
ex4 5'-CTGACGTGA TT ACAGGAAGC (forward) 747 bp 
5'-CCATACACAAA TGAAGTTGGG (reverse) 
exL 5'-GCTGTGTACATCTTCAATGGG (forward) 667 bp 
5'-CCACAGTTCTTCTCAAAAGGG (reverse) 
~, 5' -CCCAA TGATGGCCAGTGTCACC (forward) 967 bp 
5'-GCACCACA TTCACAGATGCCCC (reverse) 
~, 5'-GGCCCTCAACGAGATCACCG (forward) 1015bp 
5'-CCAGCTCCTGGCTGCTCCG (reverse) 
Table 8.1 
Cell adhesion molecule primers used for RT-PCR. 
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RESULTS 
Adhesion of CC531 cells to ECM proteins and mesothelial cells 
Because adhesion is thought to represent the initial step in tumour recurrence, the 
adhesive properties of CC531 cells to matrix proteins and a mesothelial monolayer 
were investigated. Adhesion of CC531 cells reached a plateau at 60 minutes as 
demonstrated in preliminary analysis of binding kinetics (data not shown). CC531 
tumour cells exhibited a preferential adhesion to type I collagen (53% of total cell 
number added versus <30% to other adhesive surfaces; po;O.01). Data from 
representative experiments is shown in figure 8.1. 
collagen I collagen IV fibronectin laminin mesothelium 
Figure 8.1 
Tumour cell adhesion after 60 minutes to different ECM components and a monolayer 
mesothelium. Values are n=4 +8D, the results of a representative experiment are shown. 
*p~O.01 versus collagen IV, fibronectin, laminin and monolayer mesothelium. 
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Analysis of integrin expression 
RT-PCR was performed to investigate the ability of the tumour cells to express cell 
adhesion molecules. The integrity of total RNA isolated from CC531 and mesothelium 
was checked on an agarose gel. Amplified fragments of the expected size were found. 
The results show that CC531 cells express a mRNA pattern of adhesion molecules that 
allow interaction with ECM components. Mesothelial cells express ICAM-I and a 
distinct set of integrins, differing from the expression by tumour cells. The results are 
shown in figure 8.2. 
A preferential adhesion to collagen I shown in the adhesion study, suggested that 
CC531 cells express the integrins mediating this interaction (ex,~, and CX'~,) on the cell 
surface. FACS analysis demonstrated both cell types expressed ex, and ~, integrin 
chains. The (x, integrin chain was detected on mesothelial cells, expression on CC531 
cells however, was extremely low. As a positive cellular control rat lymphocytes were 
used and showed significant expression of the three integrins (data not shown). A 
representative result is shown in figure 8.3. With immuno histochemistry, ICAM-1 and 
VCAM-1 expression were demonstrated on mesothelial cells (chapter 7). 
Cell type 
Mesothelium 
CC531 
Figure 8.2 
+ 
+ 
rJ., 
+ 
+ 
rJ., 
+ + + 
+ 
+ 
ICAM-1 
+ 
+ 
Indicated is the presence (+) or absence (-) of a correctly sized amplified DNA fragment. 
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Mesothelium 
CC531 
Figure 8.3 
Detection of surface membrane expression of u 1> U 2 and Pl (all at 1 :100 dilution) on CC531 
colon carcinoma and mesothelial cells by flow cytometry. 
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Effect of function blocking antibodies on tumour cell adhesion 
Adhesion to type I collagen was completely inhibited by adding 0.05 flg/ml Cl, antibody. 
A clear dose-dependency of this statistically significant inhibitory effect is shown in 
figure 4. A similar pattern of inhibition was seen with type IV collagen and laminin. Cell 
adhesion to fibronectin was not affected significantly (figure 8.4). When adding Cl, 
antibody (concentrations ranging from 0.1 - 1 fLg/ml) a slight inhibition of tumour cell 
adhesion was seen to type IV collagen and laminin (20-40% inhibition of the total 
number of cells added, inhibition at 0,5 fL9/ml, data not shown). The inhibitory effect of 
~, antibody (concentrations ranging from 0.01 - 1 fL9/ml) was most evident on laminin, 
followed by collagen I and IV and fibronectin (figure 8.5). Combining a and ~ chain 
antibodies (a,~, and a,~" concentrations of either integrin chain ranging from 0.1 - 1 
fLg/ml) did not cause a synergistic inhibition on tumour cell adhesion. 
Pre-incubation of the tumour cells or the mesothelium with integrin antibodies did not 
affect tumour cell adhesion to a monolayer mesothelium indicating that U1, U 2 nor P1 
playa role in this interaction. ICAM-1, expressed by CC531 and mesothelium, was also 
inhibited using a function blocking antibody (concentrations ranging from 0.01 - 10 
fLg/ml). Surprisingly, there was no effect on tumour cell adhesion indicating that ICAM-1 
does not play an effective role in this interaction. The same ICAM-1 antibody was used 
in binding studies with FACS scan demonstrating the presence of ICAM-I on 
mesothelial cells and the validity of the antibody. 
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[«2 antibody] (/lg/ml) [«2 antibody] (/lg/ml) 
A B 
[«2 antibody] (/lg/ml) [«2 antibody] ()..tg/ml) 
c D 
Figure 8.4 
Dose dependent inhibition of tumour cell adhesion to collagen I (A), collagen IV (B), fibronectin 
(C) and laminin (D) after pre-incubation with varying concentrations of U2 antibody ranging from 
1 to 0.005 j.lg/ml. Values are n=6 +SD. *p.:-s:O.01 and **p.:-s:0.001 versus control. 
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[131 antibody] ()!glml) [131 antibodY1 ()!glml) 
A B 
o 0.01 0.05 0.1 0.5 
[131 antibody] ()!glml) [131 antibody1 ()!gfml) 
c D 
Figure 8.5 
Dose dependent inhibition of tumour cell adhesion to collagen I (A), collagen IV (B), fibronectin 
(C) and laminin (D) after pre-incubation with varying concentrations of ~1 antibody ranging from 
1 to 0.01 Ilgiml. Values are n=6 +SD. "psO.01 and ""psO.001 versus control. 
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DISCUSSION 
The primary purpose of this study was to analyse the functional role of integrins in the 
adhesion of CC531 colon carcinoma cells to mesothelium and ECM components. In an 
experimental model in rats we demonstrated earlier (chapter 3) that surgical trauma of 
the peritoneum resulted in more adhesion and growth of CC531 cells in vivo. 6 This was 
most evident at the traumatised sites. Paraffin embedded sections of this area revealed 
that the mesothelial lining of the peritoneum had been damaged, hereby uncovering 
the underlying sub mesothelial matrix proteins (see figure 1, chapter 4).6J These results 
indicate that tumour cells adhere more efficiently to sub mesothelial matrix components. 
This study evaluated the interaction of adhesion of CC531 cells to mesothelium and 
ECM components in vitro. Our data demonstrate that CC531 cells adhere preferentially 
to type I collagen. Collagen I is the primary structural component of most matrices 
together with fibronectin. Type IV collagen and laminin comprise the basal lamina on 
which most cel! linings rest. 12 Adhesive patterns of human colon carcinoma cells also 
show differential adhesion to fibronectin, collagen and laminin.13:14 The favoured 
adhesion to collagen in our study suggests that tumour cells express integrins known 
to mediate this interaction (al~1 and a2~1).15-17 
In the presented study the role of u
" 
0.2 and ~, subunits in mediating the adhesion of 
CC531 cells to different ECM components and mesothelium was studied using a 
variety of methods. With RT-PCR the expression of mRNA for u" U" U4, Ul, ~, and ~2 
integrin chains and ICAM-1 was demonstrated. Flow cytometry demonstrated U2 and ~, 
subunits were prominently expressed on CC531 and mesothelial cells. Human colon 
carcinoma cells display a similar pattern of integrin expression. In similar studies using 
human colorectal cancer cell lines, 0.2 and ~1 integrins were abundantly expressed, 
while ICAM-I and other U and ~ integrin chains were differently expressed."",14 
The activity of integrins expressed at the cell surface however, is versatile. Numerous 
studies have reported the pathways of inside-out and outside-in signalling of integrins 
as means of activation. The a2~1 integrin has been shown to be induced from being 
totally inert to an active coHagen receptor. 1S;18 To correlate between integrin expression 
and function we therefore additionally investigated the functional capacity of expressed 
integrin chains in cell adhesion kinetics. 
In these adhesion experiments, function blocking antibodies directed against integrin U2 
and ~, subunits significantly inhibited adhesion to laminin, type I and type IV collagen, 
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providing direct evidence for the functional role of a2~1 in tumour cell adhesion to these 
matrix proteins. The ~, subunit antibody also inhibited adhesion to fibronectin showing 
the wide use of a common ~, subunit. In contrast, although very moderately expressed 
on the cell surface, the a, subunit significantly inhibited tumour cell adhesion to type IV 
collagen and laminin. Similar results were reported of ovarian epithelial carcinoma cells 
binding collagen and laminin, although antibodies directed against the ~, subunit 
inhibited adhesion more effectively than antibodies against a2. 19 Adhesion studies of 
the human colon carcinoma SW480 demonstrated inhibited cell adhesion to laminin 
and fibronectin by anti-p" anti-a, had no effect (collagen not investigated).14 Binding of 
HT29 to collagen and laminin was also effectively inhibited by anti-~,. Moreover, anti-~, 
inhibited the invasive capacity of HT29 through a reconstituted basement membrane 
(Matrigel).'''14 The association of the intracellular domain of ~1 with cytoskeletal 
components" probably plays a vital role in the function of this integrin. 
In our study, none of the integrin antibodies affected tumour cell adhesion to a 
mesothelial monolayer. Blocking of the ICAM-1 receptor, which is commonly expressed 
on mesothelial cells, did not affect adhesion either. Although the counterpart aL~' is not 
expressed by CC531 (as demonstrated by RT-PCR), a reversed interaction is possible 
with '"L~' on mesothelium and ICAM-I on the tumour cells. These results indicate that 
neither ICAM-1 nor its counterpart aL~2' nor a1~1 or a2~1 integrins, contribute to the 
tumour cell - mesothelial cell interaction. Studies on the adhesive properties of human 
colon cancer cell lines also demonstrate that ~1 integrin does not mediate the adhesion 
of human colon carcinoma cell lines to mesothelium.13:14 
Through integrin mediated signal transduction, cell-matrix interactions may contribute 
to regulation of adhesion, growth, migration and differentiation of cells.'"16''' The role of 
a2~1 has been demonstrated in several types of cancer including colon-, ovarian- and 
lungcancer, osteosarcoma and melanoma. In melanoma it plays a role in cell adhesion, 
progression and matrix reorganisation. 15 Additionally, adhesion to an ECM composed 
primarily of collagen through a2~11 integrin has been shown to increase production of 
metalloproteinases enabling dissemination of cancer cells. 19:2o Disruption of cell 
adhesion by antibodies against integrin receptors could therefore prove useful as a 
means of inhibiting these pathways of tumour recurrence. The inhibition of cell 
adhesion obtained in the present study with antibodies against '", and p, subunits 
might indicate a possible approach for new therapy. However, non-selective peptides 
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(ie RGD-directed integrins) may be a more feasible tool for in vivo blocking of integrin 
mediated adhesion. Because most cells express surplus ~1 subunits21 and the 
demonstrated role of this integrin chain in tumour cell adhesion 13-15;18;19;2\ aiming 
therapy at this integrin seems plausible. 
In summary, we have shown that tumour cells show preferential adhesion to sub-
mesothelial collagen. An intact mesothelial monolayer serves as a natural barrier 
against tumour cell adhesion. In the event of tumour cell adhesion to intact peritoneum, 
this occurs through an integrin and ICAM-I independent mechanism. As in similar 
studies using human colon carcinoma cell lines, we demonstrated that for tumour cell -
ECM interaction, ~1 is used as a common integrin subunit. Variability in cell adhesion to 
ECM is primarily mediated through a. integrin chains. Preventing tumour cell adhesion 
through blocking the ~, integrin receptor, may prove a powerful tool in the prevention of 
post surgical tumour recurrence. 
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Mesothelial and Tumour Cell Growth 
in vitro 
Part V 

Chapter IX 
PARACRINE INTERACTIONS BETWEEN MESOTHELIAL AND COLON 
CARCINOMA CELLS IN A RAT MODEL 
Adapted from the original publication in the International Journal of Cancer 1997: 73: 885-890 
This study used a co-culture system with Transwell tissue-culture inserts to investigate 
the role of primary cultures of rat peritoneal mesothelial cells on the proliferation of rat 
colon carcinoma cells (CC531). Mesothelial cells grown to form a monolayer, 
significantly inhibited the growth of CC531 cells, while, conversely, CC531 cells 
stimulated growth of the mesothelial cells. Receptor-binding studies demonstrated the 
presence of high-affinity IGF-I receptors on the mesothelial and CC531 cells. Both cell 
types also produced IGF-I, as measured by radioimmunoassay. IGF-I stimulated DNA 
synthesis in mesothelial cells, but had no effect on the growth of CC531 cells. In co-
culture, it was found that IGF-I potentiated the inhibitory effect of mesothelial cells on 
CC531 cells. The effect of IGF-I on mesothelial cell proliferation was additive to the 
stimulatory effect of CC531 cells. The study provides evidence for the existence of a 
paracrine loop between mesothelial and colon carcinoma cells, giving more insight into 
the basic cellular mechanisms that may modulate the growth of intra-peritoneal colon 
carcinoma. Inhibition of CC531 proliferation by an intact monolayer of rat mesothelial 
cells might explain the earlier finding that tumour cells grow poorly in a surgically 
undisturbed abdomen. 
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INTRODUCTION 
Loco-regional recurrence after surgically treated large bowe! cancer is seen in a 
majority of patients. Tumour cells that gain access to the abdominal cavity may adhere 
to the mesothelium. The resection site is at greatest risk, but all traumatised peritoneal 
and intestinal surfaces are capable of trapping tumour cells.' Studies have been 
performed on tumour cell adhesion ad outgrowth, but the mechanisms by which this 
occurs are not completely understood.' It has been shown that lymphocytes and 
platelets release growth factors that may cause proliferation of tumour cells.' The 
alleged importance of the surrounding tissue on the growth of epithelial tumour cells led 
us to investigate the growth of colon carcinoma cells in the absence and in the 
presence of a monolayer of mesothelial cells in a rat model. We co-cultured both cell 
populations using Transwell tissue culture inserts with microporous membranes. Insulin 
like growth factors are known to have major autocrine and paracrine effects on many 
cellular functions. A role of IGFs in the transformation and proliferation of cancer cells 
has become increasingly evident in the past few years. Several studies indicate that 
IGFs may influence the aetiology of colon cancer by acting as potent autocrine growth 
factors. 3 Human mesothelial cells and colon carcinoma cells have been found to 
express the IGF-I receptor, and both produce IGF_1 4 ;5 We therefore studied the effects 
of IGF-I in this co-culture system, to gain more insight into the basic cellular 
mechanisms that modulate intra-peritoneal tumour growth. 
MATERIALS AND METHODS 
Animals 
To isolate mesothelial cens, inbred WAG/Rij rats, obtained from Harlan-CPS, Zeist, The 
Netherlands were used. The rats were bred under specific pathogen-free conditions, kept under 
standard laboratory conditions (temperature 20-24°C, relative humidity 50-60%, 12 hours IighU 
12 hours dark), fed with laboratory diet (Hope Farms, Woerden, The Netherlands) and water ad 
libitum. The experimental protocol adhered to rules laid down by the Dutch Animal 
Experimentation Act and was approved by the Committee in Animal Research of the Erasmus 
University Rotterdam. 
Isolation of mesothelial cells 
The rats were decapitated and the peritoneal cavities were opened. Window like transparent 
triangular sheets of mesentery were seen, bordered by 2 adjacent jejunal arteries, located 
within streaks of adipose tissue. The centre of each sheet was picked up with small forceps and 
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the transparent part of mesentery was cut along the border of the sheet with scissors.2 
Immediately after removal, the sheets were placed in pre-warmed isolation medium (Hank's 
balanced slat solution, HBSS) and washed twice. The isolation medium was HBSS 
supplemented with 5% hUman serum albumin (CLB, Amsterdam, The Netherlands) penicillin 
(10' U/L), glutamin (2 mM) and fungizone (1.25 mg/L). After washing the sheets twice in this 
medium, they were incubated in a mixture of collagenase (1 gIL) and dispase (2.4 x 103 U/L) 
(Roche Diagnostics, Almere, The Netherlands). Following incubation during 15 minutes at 37°C 
and continuous gentle shaking, the detached mesothelial cells were pelleted by centrifugation at 
300 g for 5 minutes. Cell viability was determined by trypan blue and always exceeded 95%. 
The pelleted mesothelial cells were resuspended in culture medium. The pelleted mesothelial 
cells were re-suspended in culture medium and were counted and cultured as described below. 
Culture medium consisted of RPM I 1640 supplemented with 5% foetal calf serum (FCS), 
glutamin (2 mM), penicillin (105 U/L) and fungizone (1.25 mg/L). Medium and supplements were 
obtained from Ufe Technologicals BV (Breda, The Netherlands). 
Tumour cell line 
CC531 is a moderately differentiated, weakly immunogenic colon adeno-carcinoma induced in a 
WAG/Rij rat by 1,2-dimethylhydrazine. A cell line was established and maintained by serial 
passage after trypsinization in culture medium. 6 CC531 tumour cells were cultured in RPMI 
1640 medium supplemented with 5% FCS, glutamin (2 mM) and penicillin (105 U/L), and 
passaged once weekly using trypsin (0.05%) and EDTA (0.02%). 
Co-culture 
CC531 tumour cells were trypsillized, counted and seeded in multiwell plates in a concentration 
of 40,000 cells per well. Mesothelial cells were seeded at 100,000 cells per Transwell in 
Transwell microporous membranes (0.4 ~lm; Costar, Badhoevedorp, The Netherlands). The 
Transwells were transferred into wells containing 1 ml of culture medium. After one day, the co-
culture experiment started by transferring the Transwells into wells containing 1 ml of culture 
medium with of without CC531 tumour ceJls. Thereafter, the CC531 tumour cells (with or without 
mesothelial cells) were incubated with or without 10 nM IGF-I (Bissendorf, Biochemical, 
Hannover, Germany) for 5 days. At the end of the incubation the DNA content of the cells was 
measured using bisbenzimide fluorescent dye (Boehring Diagnostics, La Jolla, CAl as 
described before. 7 
Measurement of IGF-I production by CC531 tumour cells and mesothelial cells 
The radioimmunoassay kit for IGF-I (code 3015840, Biosource Europe, Fleurus, Belgium) was 
used to measure IGF-I production by CC531 and mesothelial cells. CC531 (40,000) and 
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mesothelia! cells (200,000) were cultured for 3 days with 1 ml of culture medium. After 3 days 
the media were collected and stored at _20°C until further analysis. The control medium was 
culture medium, which was also incubated for 3 days at 37°C. 
IGF-I receptor binding studies 
Reaction conditions were the same as those describe by Zhong et al.8 The radioligand used in 
the binding studies was 3-C 25Ijiodotyrosyl-IGF-1 (Bachem, Heidelberg, Germany). Briefly, 
membrane preparations (corresponding to 1S-30 ~lg protein) of CCS31 tumour cells and 
mesothelial cells cultured in RPM! with 5% FCS were incubated in a total volume of 100 ).11 at 
room temperature for 90 minutes with 30,000 to 50,000 cpm radioligand and increasing 
concentrations of unlabelled IGF-I in HEPES buffer (10 mM HEPES, 5 mM MgCl, and 0.2 gil 
bacitracin, pH 7.6) containing 0.2% BSA (Sigma, St Louis, MO). After incubation, 1 ml ice-cold 
HEPES buffer was added to the assay mixture, and membrane-bound radioactivity was 
separated from unbound by centrifugation during 2 minutes at SOO g in an Eppendorf micro 
centrifuge. 9 The remaining pellet was washed twice with ice-cold HEPES buffer, and the final 
pellet was counted in a gamma counter. Specific binding was taken to be the total binding 
minus binding in the presence of 10 pM unlabelled lGF-1. 
Immunocytochemical determination of keratin, vimentin and von Willebrand 
factor 
Mesothelial cells can be characterised by positive keratin and vim en tin staining and negative 
von Willebrand factor (vWf) staining. In order to exclude the presence of fibroblasts and 
endothelial cells, staining for vimentin and vWf was done. Mesothelial cells were cultured on 
type I collagen 15 mg/cm2 (collagen S (type I), cell biology Boehringer) coated 75 em' flasks. 
After the cells had formed a confluent monolayer of polygonal cells with a typical cobblestone 
appearance, the cells were trypsinized, transferred to glass coverslips and dried in air. 
Staining for keratin was done using a OAKO PAP kit system (anti-serum Z622; DAKO, Glostrup, 
Denmark). Staining for vimentin was done using a OAKO PAP kit system (anti-serum L 1843; 
DAKO). The F8/86 antibody (DAKO) was used to detect the possible presence of vWf. 
Statistical analysis of data 
CCS31 and mesothelial cells were cultured for 24, 48 or 72 hr, after which DNA content was 
measured and the doubling time was calculated. IGF-I receptor binding data were analysed by 
the method of Scatchard.10 
All values are expressed as mean +SO, n=3 wells per treatment group. All data were analysed 
using analysis of variance (ANOVA) to determine overall differences between treatment groups. 
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Subsequently a comparison between treatment groups was made using the Newman-Keuls 
test. P<O.05 was considered to be statistically significant. All experiments were carried out at 
least twice with comparable results. 
RESULTS 
Staining of mesothelial cells 
Figure 9.1 shows that all rat mesothelial cells stained positive for keralin and vimentin, 
while no vWF staining was observed. This confirms the mesothelial origin of the cells . 
• 
. . 
Keratin Vimentin vWf 
Figure 9.1 
Immunocytochemical staining of rat mesothelial cells for keratin, vimentin and vWf. 
Growth curves of CC531 and mesothelial cells 
Figure 9.2 shows that CC531 cells have a mean doubling time of 45 hours. After 48 
hours in serum-free conditions, the growth decreased by 29%. suggesting loss of cell 
viabi lity. Rat mesothelial cells have a mean doubling time of 43 hours (figure 9.2). In 
contrast to the CC531 cells, these cells grew in serum-free conditions, with a mean 
doubling time of 58 hours. 
In order to study the interaction between rat mesothelial and CC531 cells in conditions 
of proliferating CC531 cells; experiments were done in serum-containing medium. 
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Figure 9.2 
Growth rate of 40,000 CC531 tumour cells and 20,000 mesothelial cells. The cells were cultured 
during 72 hours .• serum free; 0 5% FCS. 
IGF·I production by CC531 tumour cells and mesothelial cells 
Table 9.1 shows the IGF·I concentration in the conditioned media of the CC531 and rat 
mesothelial cells. Both cell types produced IGF·I. However, IGF·I production by rat 
mesothelial cells expressed per fig DNA was significantly higher than that by CC531 
cells. 
CC531 cells 
Mesothelial cells 
Table 9.1 
IGF·I production 
(pmoles/flg DNA) 
427 ± 32 
3062 ±464 
KD 
1.2 
2.7 
IGF·I receptors 
Number (fmoles/mg) 
135 
2451 
IGF-I production and IGF-I receptor expression in CC531 colon carcinoma and rat mesothelial 
cells. Values of IGF-I production represent the mean of 4 individual wells ± SO. IGF-I value in 
medium alone: 0.1 nmol/L. 
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IGF-I receptor binding studies 
Using the radioligand 12'I-labelled IGF-I, specific binding was demonstrated on 
membrane preparations of CC531 tumour and rat mesothelial cells. Binding of 12'1_ 
labelled IGF-I on membranes of cultured CC531 and rat mesothelial cells was specific 
and could be displaced in a dose dependent manner with increasing concentrations of 
unlabelled IGF-I (figure 9.3). Scatchard analysis (not shown) of these data revealed a 
single class of high-affinity binding sites with an apparent dissociation constant (Ko) of 
1.2 nM and 2.72 nM, and a maximum binding capacity (Bm,,) estimated to be 135 
fmoles/mg and 2451 fmoles/mg membrane protein for CC531 and rat mesothelial cells 
respectively. Rat mesothelial cells showed significantly higher specific 12'I-labelled IGF-
I binding than CC531 cells. See table 9.1. 
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Figure 9.3 
A: Dose-dependent displacement by unlabeled IGF-1 of 1251_labeled IGF-I binding on a 
membrane preparation of cultured CC531 tumour cells. The incubation time was 90 min. B: 
Dose dependent displacement by unlabeled IGF-I of 125Habeled IGF-I binding on a membrane 
preparation of cultured mesothelial cells. The incubation time was 90 min. 
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Mesothelial-CC531 tumour cell interactions and the role of IGF-I 
In a co-culture system using Transwell tissue-culture inserts, we established the effects 
of rat mesothelial cells on the growth of CC531 tumour cells and vice versa. Figure 
9.4A shows that rat mesothelial cells significantly inhibited the proliferation of CC531 
tumour cells by 25% after 5 days of culture (p<O.01 vs control CC531 cells). IGF-I 
alone had no effect on the proliferation of CC531 tumour cells. However, IGF-I 
treatment potentiated the inhibitory effect of rat mesothelial cells on CC531 tumour 
cells (-35%, p<O.01 vs -25% with rat mesothelial cells). On the other hand, CC531 
cells significantly stimulated rat mesothelial cell proliferation by 54% (p<O.01 vs rat 
mesothelial cells alone, figure 9.4B). IGF-I (10-8M) significantly stimulated rat 
mesothelial cell proliferation by 27% vs control cells. The effect of IGF-I was additive to 
the stimulatory effect of CC531 cells on rat mesothelial cell proliferation (+75%, p<O.01 
vs with CC531 cells). 
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Figure 9.4 
Mesothelial and CC531 cells were cultured separately as well as co-cultured during 5 days. The 
data are the mean ± (SO) of triplicate wells expressed as percentage of growth vs control. 
Figure 4A shows the effect of mesothelial cells (Me) on the growth of CC531 tumour cells with 
or without IGF-I (10 nM). ·p<0.01 vs CC531 cells without MC, .. p<0.01 vs CC531 cells with MC 
alone. Figure 4B shows the effect of CC531 tumour cells on the growth of mesothelial cells with 
or without IGF-I (10 nM). *p<O.01 vs Me without IGF-I, ** p<O.01 vs Me without CC531 celis, *** 
p<O.01 vs CC531 cells alone. 
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DISCUSSION 
Several investigators have demonstrated that traumatised mesothelial surfaces are 
privileged sites for tumour cell recurrence. 1;11 It is conceivable that the process of 
enhanced tumour growth on traumatised tissue is biphasic. First, trauma of the 
peritoneum and the ensuing inflammatory response leads to up-regulation of 
mesothelial adhesion molecules, thus promoting the anchoring of tumour cells. 
Second, the subsequent healing of the peritoneum will lead to growth promotion of the 
adhered tumour cells through the action of locally produced growth factors. Using the In 
vivo counterparts of the cell types employed in the current study, namely seeding of 
CC531 cells in the peritoneal cavity we have demonstrated that tumour growth was 
greatly enhanced after surgical trauma. It was found that laparoscopic removal of a 
bowel segment, representing a minor surgical intervention, led to less adherence of 
intra-peritoneal tumour cells than when conventional surgery was performed, indicating 
that the degree of surgical trauma was proportional to the extent of tumour growth." In 
addition, we observed that growth of a regenerating liver following partial hepatectomy 
led to a marked propagation of intra-hepatic CC531 tumour growth." It is clear that 
these in vivo models, when coupled to a relevant in vitro system, provide unique 
possibilities to unravel surgery-induced variables such as the kinetics of adhesion 
molecule expression and the role of cytokines and growth factors. Although mesothelial 
cells can secrete many factors, including IGF_ls, which can influence the proliferation of 
carcinoma celis, the exact role of these factors on tumour cell growth is still unknown. 
We therefore developed an in vitro model in which the role of a monolayer mesothe!ia! 
cells on growth regu!ation of colon carcinoma cells was investigated in a co-culture 
system. 
This study provides preliminary evidence that paracrine growth factors produced by 
mesothelial cells appear to inhibit proliferation of the colon carcinoma cells. On the 
other hand, paracrine factors produced by the colon carcinoma cells stimulate the 
proliferation of mesothelial cells. 
Colon carcinoma cells have been shown to secrete many growth factors like IGF_1I4 , IL-
4 and TNF-a 14, which can have stimulatory effects on mesothelial cell proliferation. 
Less is known about the stimulating properties of IGF-1. Locally produced IGF-I has 
been shown to be an important regulatory factor of breast cancer cell growth. 1S In the 
presented paper, we demonstrate the presence of high affinity IGF-I receptors on 
CC531 cells and production of IGF-I by these cells. However, IGF-I has no effect on 
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the proliferation rate of CC531 cells. It has been shown that, although almost all colon 
cancers express a significant concentration of high affinity IGF-I receptors, growth 
effect of IGF-I on colon cancer cell lines were not always observed.16 It appears likely 
that endogenously secreted IGF-II desensitises the cells to exogenously added IGFs.3 
High affinity IGF-I receptors are also present on mesothelial cells, which produce IGF-I 
and are stimulated by it. Lee et al. have demonstrated this for human mesothelial 
cells.' Rat mesothelial cells possess a higher number of IGF-I receptors and produce 
more IGF-I than CC531 cells, as demonstrated in this paper. Since CC531 cells and rat 
mesothelial cells possess IGF-I receptors and produce IGF-I, this may be an important 
factor in the paracrine loop between these cells. 
IGF-I treatment potentiated the inhibitory effect of rat mesothelial cells on CC531 cells. 
This could be explained by an increase of IGF-binding protein (IGF-BP) by mesothelial 
cells, since IGF-BPs are known to regulate the action of IGF-1. The stimulation of the 
mesothelial cells by IGF-I, thereby enhancing the production of inhibitory factors, may 
explain a stronger inhibition of the proliferation of CC531 cells. The effect of IGF-I was 
additive to the stimulatory effect of the CC531 cells on mesothelial cell proliferation. 
Increased secretion of IGF-I by CC531 cells may (partly) explain the stimulation in 
growth of the mesothelial cells. Since rat mesothelial cells themselves secrete IGF-I 
and have a high number of IGF-I receptors, an autocrine loop of rat mesothelial cell 
growth by IGF-I is likely. This is also evident from our observation that rat mesothelial 
cells grow well in serum free conditions. However additional experiments using 
neutralising anti-sera to IGF-I or IGF-I receptors are needed to demonstrate a 
paracrine and/or autocrine loop between mesothelial and colon carcinoma cells with 
relation to IGF-I and its receptor. 
In conclusion, our study provides evidence for the existence of a paracrine loop 
between mesothelial cells and colon carcinoma cells, providing more insight into the 
basic cellular mechanisms that may modulate the growth op intra peritoneal colon 
carcinoma. Inhibition of CC531 cell proliferation by mesothelial cells in an intact 
monolayer might explain the finding that tumour cells grow poorly in a surgically 
uncompromised abdomen.12 
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Chapter X 
PARACRINE MODULATORS OF PERITONEAL TUMOUR RECURRENCE IN A RAT 
MODEL 
Submitted for publication 
Peritoneal dissemination is a common cause of post-surgical tumour recurrence. 
Surgically traumatised sutiaces are predestined sites for successful implantation of 
tumour cells. In this process paracrine interactions between regenerating mesotheUum 
and tumour cells may play an important role. In this study we investigated the effect of 
actively proliferating mesothelial cells, as seen during peritoneal wound healing, on the 
growth of colon carcinoma cells, using a co-culture system with Transwell tissue-
culture inserts. The effect of acute phase cytokines like IL-IjJ, IL-6, IFN-yand TNF-a, in 
addition to the peptide growth factors IGF-I, EGF, TGF-a, TGF-jJ and bFGF, known to 
playa role in wound healing, are investigated on their direct as well as paracrine 
growth modulating potential. 
We demonstrate that among the different factors tested, IGF-I was the only one 
exerting statistically significant growth stimulatory effects on the tumour cells in the 
autocrine setting. On the other hand, mesothelial celf proliferation was significantly 
stimulated by IGF-I, TGF-a, EGF and bFGF. During co-culture, tumour cells stimulate 
the growth of mesothelial cells. In contrast to our previous findings with a monolayer 
mesothelial cells, actively proliferating mesothelial celfs stimulate the growth of tumour 
cells. Combining IGF-I and tumour cells resulted in mesothelial cell growth which 
consisted of more than the sum of separate stimulating properties, demonstrating the 
existence of a synergistic paracrine loop. Furthermore, we provide evidence that direct 
proliferative responses and upregu/ation of paracrine growth stimulatory factors may be 
mediated via different pathways. 
This study illustrates that different paracrine loops are present between tumour cells 
and activated mesothelial cells. Stimulation of tumour growth by proliferating 
mesothelial cells might explain the preferential tumour growth to surgically traumatised 
peritoneal membrane. 
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INTRODUCTION 
The success of surgical treatment for gastro-intestinal cancer is often limited due to 
local or regional tumour recurrence by cells that have been seeded at the time of 
operation. The resection site is the most common location for disease spread. Several 
theories have been put forward to explain preferential recurrence to surgically 
traumatised tissue. Experimental studies suggest the prosperous wound environment 
stimulates residual tumour cell growth.' The tumour cell entrapment hypothesis 
proposes that per-operatively spilled tumour cells or emboli nestle in the fibrinous 
matrix of the wound where they are stimulated to grow by growth factors released to 
initiate the healing process at traumatised surfaces. 2 Furthermore, implantation of 
cancer cells on intact basement membrane surfaces is an inefficient process compared 
to implantation onto raw tissue surfaces that result from surgical dissection.2 The 
common factor in these theories is encouraged tumour growth in the wound 
microenvironment. 
The apparent correlation between wound healing and tumour recurrence is of 
relevance to all surgeons with an interest in cancer management. Experimental studies 
unrave!!ing the specific interactions between wound healing and tumour recurrence 
have demonstrated that mediators in wound fluid significantly enhance tumour growth.' 
In various in vivo studies we previously demonstrated a correlation between the extent 
of surgical peritoneal injury and local tumour recurrence. 3;4 Moreover, using a sub-renal 
capsule assay, in which growth of tumour lumps can be determined objectively and 
where promotion of tumour cell adherence is irrelevant, a similar correlation between 
peritoneal injury and tumour growth was found (see also chapter 3).3;4 Within hours 
after injury, wound-healing mediators can be captivated in a lavage fluid and enhance 
tumour recurrence in naive recipients (see also chapters 3 and 4).1;4;5 These results 
suggest that during the acute phase of wound healing, tumour-enhancing factors are 
produced. 
In the in vitro experiments described in the previous chapter, we demonstrated that 
mesothelial cells grown to form a monolayer, exert inhibitory effects on tumour cell 
growth. IGF-I potentiated this inhibitory effect by mesothelial cells, indicating a 
paracrine loop between mesothelial and colon carcinoma cells. 6 These results may 
explain the inferior growth of tumour cells during sustained integrity of the mesothelial 
monolayer in surgically undisturbed peritoneal cavities. 
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The aim of this study was to investigate the effect of growing, activated mesothelial 
cells, as seen during peritoneal wound healing, on the growth of colon carcinoma cells. 
Acute phase cytokines like IL-1~, IL-6, IFN-y and TNF-a, in addition to peptide growth 
factors IGF-I, EGF, TGF-a, TGF-~, and bFGF, known to playa role in wound healing, 
are investigated on their cell growth modulating potential. Furthermore, the effect of 
these factors is investigated in a paracrine setting using a Transwell co-culture system, 
in which the interaction between mesothelial and tumour cells can be investigated. The 
results of these experiments allow us to determine which factors playa direct and/or 
indirect role in growth of colon carcinoma. 
MATERIALS AND METHODS 
Animals 
To isolate mesothelial cells, inbred WAG/Rij rats, obtained from Harlan-CPS, Zeist, The 
Netherlands were used. The rats were bred under specific pathogen-free conditions, kept under 
standard laboratory conditions (temperature 20-24°C, relative humidity 50-60%, 12 hours IighU 
12 hours dark), fed with laboratory diet (Hope Farms, Woerden, The Netherlands) and water ad 
libitum. The experimental protocol adhered to rules laid down by the Dutch Animal 
Experimentation Act and was approved by the Committee in Animal Research of the Erasmus 
University Rotterdam. 
Isolation of mesothelial celis 
Mesothelial cells (Me) were isolated from the small bowel mesentery, according to techniques 
modified from Akedo et al7 as described previously.6 In brief, under ether anaesthesia the 
abdomen of a rat was shaved, cleaned with alcohol 70% and subsequently opened. Window 
like transparent triangular sheets of mesentery were isolated and collected in Hank's Balanced 
Salt Solution (HBSS) containing 5% human serum albumin (CLB, Amsterdam, The Netherlands) 
penicillin (105 U/L), glutamin (2 mM) and fungizone (1.25 mg/L). After washing the sheets twice 
in this medium, they were incubated in a mixture of collagenase (1 gIL) and dispase (2.4 x 103 
U/L) (Roche Diagnostics, Almere, The Netherlands). Following incubation during 15 minutes at 
37°C and continuous gentle shaking, the detached mesothelial cells were pelleted by 
centrifugation at 300 g for 5 minutes. Cell viability was determined by trypan blue and always 
exceeded 95%. The pelleted mesothelial cells were resuspended in culture medium. Culture 
medium consisted of RPMI 1640 supplemented with 10% foetal calf serum (FCS), glutamin (2 
mM), penicillin (105 U/L) and fungizone (1.25 mg/L). Medium and supplements were obtained 
from Life Technologicals BV (Breda, The Netherlands). 
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The mesentery derived cells grew forming a monolayer in a 37°C, fully humidified, 5% CO2 
incubator in polystyrene culture flasks (75 cm2; Corning BV, Schiphol-Rijk, The Netherlands) 
precoated with collagen type I (15 pg/cm2 collagen S (type I), cell biology Roche Diagnostics). 
For all experiments, mesothelial cells in their second passage were used. Isolated mesenteries 
from at least three different rats were used. 
Colon carcinoma 
CC531 is a moderately differentiated, weakly immunogenic colon adeno-carcinoma induced in a 
WAG/Rij rat by 1,2-dimethylhydrazine. A cell line was established and maintained by serial 
passage after trypsinization in culture medium.8 CC531 tumour cells were cultured in RPMI 
1640 medium supplemented with 5% FCS, glutamin (2 mM) and penicillin (105 U/L), and 
passaged once weekly using trypsin (0.05%) and EDTA (0.02%). 
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Growth curves 
The culture medium used in all experiments was RPMI supplemented with FCS, glutamin (2 
mM) and penicillin (105 U/L). Growth curves were made using different concentrations FCS and 
cell densities to establish the ideal culture conditions for studying growth stimulation and 
inhibition. Tumour and mesothelial cell doubling time was calculated as the number of doublings 
in the exponential growth phase ('b-a' in which a = log2 (DNA t=24 hours) and b = log2 (DNA t = 
72 hours). 
To investigate the effects of growth factors and cytokines on cell growth, dose response curves 
were made. Pre-incubation was performed with different factors and initiated immediately after 
seeding of tumour or mesothelia! cells in 24 well plates. Growth response to interleukin-1 ~ (lL-
1 ~), interleukin-6 (IL-6), tumour necrosis factor-a (TNF-a) (purchased from R&D Systems, 
Uithoorn, The Netherlands), insulin-like growth factor-I (IGF-I), epidermal growth factor (EGF), 
basic fibroblast growth factor (bFGF), transforming growth factor-a (TGF-a), transforming 
growth factor-p (TGF-~) (all from Sachem, Bern, Switserland) and interferon-y (Sanvertech, 
Heerhugowaard, The Netherlands) was studied. 
Co-culture 
Tumour cells were trYPsinized, counted and seeded in 24 well plates in a concentration of 
20,000 cells per well. The plates were then centrifuged at 80 g to force floating cells to the well 
bottom. Mesothelial cells were seeded at 10,000 cells per Transwell (Transwell microporous 
membranes 0.4 ~lm, Costar, Sadhoevedorp, The Netherlands). After moistening of the 
membrane, the Transwells were transferred into wells containing the CC531 ceJls and 1 ml of 
culture medium. 
The effect of growth factors and cytokines on the paracrine milieu was investigated by adding 
optimal concentrations, as determined in the obtained growth curves, to the culture medium 
immediately after seeding the tumour cells. After three days, plates and Transwells were 
collected for determination of the DNA content. 
DNA-assay 
To establish an effect on cell growth, analysis of the DNA content was performed. The DNA 
content of the tumour and mesothelial ceHs was determined using the bisbenzimide fluorescent 
dye (Roche Diagnostics) as previously described.9 In short, at the end of the incubation period 
the plates and Transwells were washed twice with saline and stored at -20°C until further 
analysis. The cells were extracted with ammonia solution (1 mmol/L) - Triton x 100 (0.2% v/v) 
by sonification during 5 seconds at amplitude 15 (Soniprep 150; MSE). Thereafter assay buffer 
(100 mmollL NaGI, 10 mmollL EDTA, 10 mmollL Tris; pH 7.0) was added. The remaining 
solution was centrifuged at 2000 g during 5 min and 1 00 ~d aliquots of the supernatant was 
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mixed with 2 ml Hoechst dye H33258 (100 )..I.g/L), Fluorescence was measured after 10 min with 
the excitation and emission wavelengths set at 350 and 455 nm respectively, The fluorescence 
of experimental samples were referenced to a standard curve of calf thymus DNA (type II, no D-
3636; Sigma, Zwijndrecht, The Netherlands), 
Statistical analysis of data 
All data were analysed using analysis of variance (AN OVA) to determine overall differences 
between group means, If the ANOVA was significant on a 5% level, the post-hoc Newman-
Keuls test was carried out to make a comparison between groups. Pc::;0.05 was considered to be 
statistically significant. Experiments were carried out at least twice with comparable results. All 
data are expressed as mean ±SEM. 
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Growth response of CC531 tumour and mesothelial cells to cytokines and growth factors. The 
data are the mean ± (SEM) of quadruplicate wells expressed as percentage of growth vs the 
control during 72 hours incubation. Figure A shows CC531 tumour cells. +EGF (no effect); • 
+IGF-I (2::: i0-10M, p<O.01;ECso 1.1xlO-10M). and mesothelial cells 0 +EGF (;:;: 1O-10M, p<O.01; 
EC50 6.7x10-11 M): 0 +IGF-I (:::: 10--8M, p<O.05; EC50 3.8x10-9M). Figure 8 shows CC531 tumour 
celis • +IL-1~ (~10 nglml, p<O.05); • +bFGF (no effect) and mesolhelial celis 0 +IL-1~ (~1 
nglml, p<O.05); 0 +bFGF (~1 nglml, p<O.01; ECso 1.1 nglml). Figure C shows CC531 tumour 
celis. + TGF-~ (~5nglml, p<O.01); • + TGF-a (no effect). Mesolhelial celis 0 + TGF-~ (no effect); 
0+ TGF-a (>1 nglml, p<O.05; ECso 1.2 nglml). 
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Results 
Growth curves 
Based on the results (data not shown) using different seeding densities, for all growth 
curves tumour cells were seeded at a density of 20,000 cells per well and mesothelial 
cells were seeded at a density of 10,000 cells per well. The amount of DNA 
significantly increased from t~24 to t~72 hours of culture (in all instances p<0.01) 
indicating that the cells are actively growing during this period. In order to compare the 
'growth rates' of the CC531 tumour and mesothelial cells, the number of doublings 
which took place between 24 and 72 h culture period was calculated. There were major 
differences in number of tumour cell doublings between 1 and 5% FCS and when IGF-I 
was added to 1 % serum. After 72 hours, the wells containing tumour cells in 5% FCS 
were full-grown with a mean doubling time (MDT) of 3.0. In 1 % FCS, the tumour cells 
grew with a MDT of 1.8, leaving ample growing opportunity in the wells. In 0.5 % FCS, 
tumour cells grew slowly with a MDT of 1.2 (not shown). Mesothelial cell growth 
appeared more autonomous and was less affected by the concentration of FCS, with a 
MDT of 2.7 in 5% FCS, 2.5 in 1 % FCS and 2.1 in 0.5% FCS (figure 1 0.1A and B). 
In chapter 9 we demonstrated the presence of IGF-I receptors on CC531 cells. 
Therefore, this growth factor was used to determine which time point is preferential for 
assessing maximal effect on cell growth. In 5% FCS, no statistically significant IGF-I 
(10-8M) effect was established at all (figure 10.1A) as demonstrated in the previous 
chapter.' In 1 % FCS however, statistically significant enhanced cell growth (60% 
stimulation) was evident after 72 hours (MDT 2.9, p<0.01), while not at earlier time 
points. Based on these experiments we concluded the optimal concentration for studies 
on the proliferation of tumour and mesothelial cells was 1 % FCS enriched growth 
medium with a cut off point after 72 hours. 
In this setting IGF-I was the only growth factor to stimulate CC531 cell proliferation. 
However, mesothelial cells were growth stimulated by IGF-I, TGF-a, EGF and bFGF. 
IL-1~ and TGF-~ slightly inhibited mesothelial and tumour cell growth when used at 
higher concentrations (Figure 10.2). IFN-y, IL-6 and TNF-a had no effect on either cell 
type (data not shown). 
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A 
B 
Figure 10.3 
Response of CC531 tumour and mesothelial cells to growth factors and inflammatory mediators 
(bFGF 10 nglml; IFN-y 10 nglml; EGF 10-"M; TGF-a 1 nglml; TGF-~ 1 nglml). The data are the 
mean ± (SEM) of quadruplicate wells expressed as percentage of growth vs the non-stimulated 
control after 72 hours incubation. In figure A the growth of CC531 tumour cells is shown in the 
autocrine (open bars) and the paracrine milieu (filled bars). * p<O.01 vs control cells without co-
culture. Figure B shows the growth of mesothelial cells in the autocrine (open bars) and the 
paracrine milieu (filled bars). * p<O.05 vs control cells without co-culture, **p<O.01 vs control 
cells with co-culture. 
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Co-culture 
In a Transwell® co-culture system the paracrine interactions between CC531 tumour 
cells and actively proliferating mesothelial cells were investigated. Both cell types 
stimulated each other in growth. Tumour cells stimulated the proliferation of mesothelial 
cells by 40 to 60% (p<O.Ol vs control mesothelial cells). Mesothelial cells stimulated 
tumour cells to grow with 40 to 60% as well (p<O.Ol vs control tumour cells). The 
different growth factors and inflammatory mediators that were tested and shown in 
figure 10.3 did not influence the autocrine or paracrine growth milieu of CC531 tumour 
cells. Mesothelial cells were highly responsive to growth factors, resulting in stimulated 
cell growth in an autocrine and paracrine setting. The effect of bFGF and TGF-a in the 
paracrine milieu was additive to the effect of CC531 tumour cells, the effect of EGF 
was not additive (figure 10.3). 
In chapter 9 we demonstrated a role of IGF-I in the paracrine loop between a 
monolayer of mesothelial cells and proliferating tumour cells. An inhibitory effect of 
mesothelial cells on tumour cells was shown, which was potentiated by IGF-I.' In the 
present study we wanted to elucidate the role of IGF-I in the paracrine loop between 
active, proliferating mesothelial cells and tumour cells. Contrary to mesothelial cells 
forming a monolayer, proliferating mesothelial cells stimulated tumour growth. Adding 
IGF-I to the autocrine milieu of mesothelial and tumour cells lead to proliferation of both 
cell types. In the paracrine setting, a synergistic effect was seen regarding mesothelial 
cell growth after adding tumour cells with IGF-I. The effect of IGF-I in the paracrine 
milieu of tumour cells was partly additive to the stimulation of mesothelial cells (figure 
10.4). 
Apart from the slightly inhibited tumour cell growth by IL-l~ (dose response curve 
shown in figure 10.2) none of the acute phase cytokines significantly affected the 
growth of mesothelial or tumour cells (figure 10.5). However, in the paracrine setting a 
significant proliferation of mesothelial cell growth was seen after adding tumour cells 
and IL-l~ (p<O.Ol vs paracrine control) indicating this factor plays a role in the 
paracrine loop between growing tumour and mesothelial cells (figure 10.5). 
160 
'0 
~ 
-
" 0 u 
g> 
.s:: j 
e 1 Cl 
J? 
e , 0 J u.. :;; C 19 19 
A 0 (.) + 
0 
:;; 
... 
'0 
~ 
-
" 0 (J 
g> 
.<: j 
0 
~ 
Cl 
:!i! 0 
e J ~ J 
'" c 
" 
"' 
" 
0 0 
B u 0 + 
~ 
'" 
"' 0 
0 
Figure 10.4 
Mesothelial and CC531 ceUs were cultured separately as well as co-cultured during 72 hours. 
The data are the mean ± (SEM) of quadruplicate weils expressed as percentage of growth vs 
control. 
Figure A shows the effect of mesothelial cells (Me) on the growth of CC531 tumour cells with or 
without IGF-I (10-"M). ·p<O.01 vs CC531 cells without IGF-I, •• p<O.01 vs CC531 cells without 
MG, *** p<O.01 vs CC531 cells with or without IGF-I. Figure B shows the effect of CC531 
tumour cells on the growth of mesothelial cells with or without IGF-I (10-8M). *p<O.05 vs Me 
without IGF-I, ** p<O.05 vs Me without CC531 cells, *** p<O.01 vs Me with or without IGF-[ and 
CC531 cells. 
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Response of CC531 tumour and mesothelial cells to the acute phase cytokines IL-1 ~ (10 ng/ml), 
TNF-a (10 nglml) and IL-6 (10 nglml). The data are the mean ± (SEM) of quadruplicate wells 
expressed as percentage of growth vs the non-stimulated control after 72 hours incubation. In 
figure A the growth of CC531 tumour cells is shown in the autocrine (open bars) and the 
paracrine milieu (filled bars). * p<O.01 vs control cells without co-culture. Figure B shows the 
growth of mesothelial cells in the autocrine (open bars) and the paracrine milieu (filled bars). 
p<O.05 vs control cells without co-culture, ** p<O.01 vs control cells with co-culture. 
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DISCUSSION 
Tumour recurrence at wound sites is a well known phenomenon and has been 
demonstrated in clinical and experimental settings by several investigators. 1;2;4 Exact 
mechanisms of Ihe role of wound healing in tumour growth are not clear. Wound 
healing is based upon the synthesis and release of several growth factors and 
cytokines at the site of injury which act through autocrine and paracrine pathways to 
regulale healing. These wound site derived growth factors are thought to take part in 
enhancing local tumour growth,1;2;10 
Peritoneal tissue repair exhibits a more diverse process. Regardless of the type of 
injury, a common pathway of inflammation and restoration follows. The peritoneal 
mesothelium plays an active role in this process by producing chemoattractants, 
prostaglandins and growlh factorsn -14 Most studies investigating tumour growth during 
wound healing, study the autocrine events of wound related growth factors and 
cytokines. Pivotal interactions through cross-talking of cells are neglected in this way. 
Lack of insight in these facets of peritoneal tissue repair and tumour recurrence 
impedes the development of effective tumour modulating agents. 
In this study we evaluated both direct as well as paracrine-mediated effects of different 
growth factors and acute phase cytokines using a co-culture system of colon 
carcinoma cells and proliferating mesothelial cells. We demonstrate that the growth 
stimulating effects of the tumour cells in the autocrine setting are preferentially 
mediated through IGF-1. Mesothelial cells appeared more susceptible to the growth 
stimulating effects of different wound healing factors. In our study, significant 
enhancement of mesothelial cell proliferation is seen after stimulation with IGF-I, TGF-
u., EGF and bFGF. These findings are supported by other studies, which use human or 
rat mesothelial cells, investigating peritoneal repair after wounding. 6;15-17 The presence 
of receptors for different growth factors has been demonstrated on mesothelial 
cells.6 ;18;19 The EGF receptor, which binds EGF as well as TGF-a, is expressed by 
mesothelial cells and plays an active role in peritoneal tissue repair16- 18 as has been 
shown for bFGF16 and IGF-I as wel1.6 Mesothelial cells also express the TGF-~ and IL-
1 ~ receptor. 14;19 The presence of an IGF-I receptor and absence of EGF receptor on 
CC531 tumour cells6;2O explains the response to IGF-I and the lacking response to EGF 
and TGF-a by these cells. 
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In the previous chapter we demonstrated an inhibitory effect of a quiescent, non-
proliferating mesothelial monolayer, on CC531 tumour cell growth. This inhibitory effect 
was potentiated by IGF-I.' The aim of the present study was to elucidate the role of 
IGF-I in the paracrine loop between active, proliferating mesothelial cells and tumour 
cells. The presented results show that, contrary to quiescent cells, proliferating 
mesothelial cells stimulate tumour growth. Addition of IGF-I to either cell type 
stimulates cell growth and implies a role for IGF-I in an autocrine loop. Mesothelial and 
CC531 tumour cells produce IGF-I although the production by mesothelial cells is six-
fold higher (chapter 9).' At paracrine level the stimulation of tumour cells by mesothelial 
cells and IGF-I is higher than by mesothelial cells or IGF-I alone, however it is not fully 
additive. This indicates that IGF-I production by mesothelial cells may be the 
stimulative factor enhancing tumour growth. In return the combination of IGF-I and 
tumour cells causes more stimulation of mesothelial cell growth than either factor 
alone. Moreover, the stimulating effect is more than the sum of the isolated effect of 
tumour cells and IGF-1. This allows the speculation of a synergistic paracrine loop 
involving IGF-1. Based on these results we may speculate that IGF-I stimulation of 
CC531 tumour cells leads to secondary production of a growth factor, which has 
proliferative activity for mesothelial cells. 
The in vivo experiments described in chapter 4 demonstrated a potential pivotal role of 
IGF-I in post-surgical tumour recurrence. Others and we demonstrated that after 
abdominal surgery, serum IGF-I levels decrease?1;22 Minima! invasive surgery, and 
therefore minimal peritoneal trauma, coincides with diminished tumour recurrence and 
affects IGF-I levels less than conventional abdominal surgery." Furthermore, we 
detected elevated concentrations IGF-I in peritoneal lavage fluid after peritoneal 
surgical trauma (chapter 4). Combining these in vivo data and the presented in vitro 
results inevitably demonstrates a pivotal role of IGF-I in tumour recurrence in our 
model. Although the presented data reflect interactions in a rat model, the distance to a 
human model may only be a short step. 
Of the cytokines, IL-1 ~ slightly inhibited tumour cell growth but augmented mesothelial 
cell proliferation during co-culture with tumour cells. Mesothelial cell grow1h is highly 
sensitive to bFGF, TGF-a, and EGF. Increased levels of these growth factors in the 
supernatant might explain mesothelial cell proliferation after co-culture with tumour 
cells and IL-1~. This suggests that the direct proliferative responses and upregulation 
of paracrine growth stimulatory factors are mediated via different pathways. Further 
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studies are required however, to elucidate the nature of these paracrine growth 
stimulating factors. 
In conclusion, the results of this study show that actively proliferating mesothelial cells 
stimulate the growth of CC531 tumour cells. In contrast to the inhibition of tumour 
growth by quiescent mesothelial cells, this may explain the preferential tumour growth 
to surgically traumatised peritoneum. It seems different paracrine loops are present 
during activated mesothelial responses than during peritoneal equilibrium when 
mesothelial cells form a monolayer. IL-1 ~ and IGF-I, released during peritoneal wound 
healing stimulate, directly or indirectly, growth of mesothelial and tumour cells. Further 
unravelling of the effect of cytokines and growth factors in the paracrine loop between 
tumour and mesothelial cells may provide new insights in manipulating tumour 
recurrence. 
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General Discussion and 
Summary 
Part VI 

Chapter XI 
GENERAL DISCUSSION and MODES FOR CLINICAL APPLICATION 
Peritoneal dissemination is a common cause for post-surgical tumour recurrence and 
represents the terminal stage of disease. 1-4 Patterns of first recurrence show the 
resection site is preferential, and distant metastases combined with loco-regional intra-
abdominal recurrence is common. 4 
For successful metastasis, tumour cells undergo a series of sequential, interrelated 
steps including invasion through basement membranes, embolism and transport 
through lymphatics or vasculature, arrest in organs, adherence and growth.5 In case of 
peritoneal recurrence due to intra-abdominal seeding or spill of tumour cells, the 
process of tumour metastasis is essentially facilitated, only leaving tumour cell 
adhesion and growth to be completed. 
Most attempts at limiting peritoneal tumour recurrence are aimed at annulling manifest 
tumour foci. Examples are nec-adjuvant chemotherapyfi, photodynamic therapy7, 
lavage of the abdominal cavity with chemotherapeutic agents8 and post-operative loco-
regional (chemo)radiotherapy.' A different approach to diminishing post-surgical 
peritoneal tumour recurrence is to interfere with the primary implantation process of 
seeded tumour cells. This necessitates a profound understanding of the underlying 
pathophysiologic mechanisms leading to tumour implantation. 
The studies described in this thesis were aimed at unravelling links between surgical 
peritoneal trauma and peritoneal tumour recurrence. Different facets of the peritoneal 
response to surgical trauma were highlighted with the intention to elucidate which 
pathways may be used for specific therapeutical alternatives. 
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Consideration of experimental models 
To investigate patterns of tumour recurrence in vivo, different rat models were used. In 
a cell seeding model the clinical situation of free intra-peritoneal tumour cells was 
mimicked. This model associates the combination of cell adhesion and growth, 
ultimately leading to manifest tumour recurrence. In the sub-renal capsule assay, the 
effect of surgical trauma on the growth of extra-peritoneal tumours was reproduced. 
This model represents the systemic effects on tumour growth that may occur after 
surgical trauma. Based on the results from the in vivo experiments, the initial impetus 
to separate the generalised term "tumour recurrence" into the more elementary 
mechanisms of tumour cell adhesion and tumour growth was made. 
To study tumour cell adhesion, an in vitro model was designed. The peritoneum was 
recalled by culturing a monolayer of mesothelial cells on a matrix coating. Tumour cell 
adhesion could be studied after pre-incubating the mesothelial monolayer with different 
cytokines and growth factors, known to be produced after surgical peritoneal trauma, 
without the interference of unknown in vivo factors. 
Tumour growth was assessed in an autocrine and paracrine setting. For growth factors 
to establish any effect on proliferation, cells must express receptors on the cell surface. 
If not, no interaction is achieved. Studies at this 'autocrine' level do not represent the in 
vivo situation entirely. Paracrine related mechanisms may affect tumour recurrence as 
well. To achieve paracrine interaction, mesothelial cells and tumour cells were co-
cultured without making contact. Factors produced by both cell types could thus pass 
freely in the culture medium, allowing cross-talking between these cells. 
Surgical peritoneal trauma and tumour recurrence 
The observed preference of tumours to recur at surgically traumatised sites' led us to 
investigate if a correlation existed between peritoneal surgical trauma and tumour 
recurrence. 
In the experiments described in chapter 2, indeed a significant correlation between the 
intensity of surgical trauma and tumour recurrence was demonstrated in vivo. Tumour 
recurrence was greatest at sites where the mesothelial cells were abraded. This 
suggests that tumour cells preferentially recur at the sub-mesothelial extra cellular 
matrix (figure 11.1A). However, enhanced tumour recurrence was also seen at not 
directly traumatised peritoneal sites. Apparently tumour cells recur at both the 
mesothelial and sub-mesothelial surfaces. After placing a solid tumour in the extra-
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peritoneal space, the intensity of surgical trauma also correlated with extra-peritoneal 
tumour growth, suggesting that systemic factors produced after surgical trauma play an 
important role in enhanced tumour growth. 
The apparent generalised character of tumour recurrence led to the hypothesis that 
factors produced after peritoneal trauma, may influence loco-regional and distant 
aspects of tumour recurrence. When these factors were captured in a lavage fluid and 
passively transferred to naive recipients, this hypothesis was confirmed. Further 
analysis of the fragments in the captured lavage fluid brought forward the presence of a 
cellular and soluble fraction. When these were individually injected into pristine 
abdominal cavities, without any form of additional surgical trauma, both induced 
significantly more peritoneal tumour recurrence. However, the effect of the soluble 
factors was inferior to that of the cellular fraction. This difference was apparent in the 
amount of peritoneal tumour load. Significantly more and larger tumours were seen 
after injection with the cellular compared to the soluble component. 
The results of these experiments demonstrate that cellular and soluble factors are the 
mediators of surgical trauma. Furthermore, direct peritoneal injury and the extent of it is 
an additional factor influencing local tumour recurrence. 
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Peritoneal tumour recurrence after direct or indirect surgical trauma of the peritoneum. 
A: Direct surgical trauma of the peritoneum; B: Indirect surgical trauma of the peritoneum. 
The mesothelial monolayer as natural barrier for tumour recurrence 
Normally, the mesothelium is a quiescent population that forms the first barrier free 
abdominal cells come across. Any form of peritoneal injury, including inflammation and 
surgical trauma, damages the monolayer of mesothelial cells lining the peritoneum (see 
figure 4.1, chapter 4).";11 During peritoneal inflammation, mesothelial cells round up, 
hereby increasing the intercellular space where patches of sub-mesothelial matrix 
components become denuded,11 Tumour cells have been shown to produce factors 
that stimulate a similar reaction of mesothelial cell rounding after which adhesion to the 
matrix takes place. 12:13 This may be an unspecific reaction that can be elicited by intra-
peritoneal injection of suspensions in general.14 Drying, wetting or rubbing exfoliates 
mesothelial cells, also uncovering the layer underneath. 10;15;16 The in vivo studies 
described in this thesis demonstrated that at sites where the integrity of the mesothelial 
monolayer was lost, enhanced tumour recurrence could be found. This led to the 
conclusion that direct peritoneal injury augments local tumour recurrence. 
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The results described in chapter 8 clearly show a preferential adhesion of tumour cells 
to sub-mesothelial collagen compared to a monolayer mesothelium. Preferential 
adhesive patterns to matrix components have also been shown for human colon 
carcinoma and ovarian carcinoma cel! lines.17- 19 Cell adhesion to matrix components is 
mediated by integrins. The integrin profile of tumour cells may explain preferential 
recurrence at sub-mesothelial matrices and enhanced tumour recurrence at surgically 
traumatised sites in vivo (figure 11.1A). The experiments in chapter 8 demonstrated 
that preferential tumour cell adhesion to collagen coincided with a2~' integrin 
expression. Variability in integrin expression by tumour cells will determine the affinity 
for different extra cellular matrix components. 
The tumour-mesothelial cell interaction studies described in chapter 9 demonstrated 
that quiescent mesothelial cells inhibited the growth of tumour cells. Contrasting, 
actively proliferating mesothelial cells as seen during peritoneal healing20;21, stimulated 
the growth of tumour cells due to the production of factors by these cells during 
proliferation (chapter 10). It seems different paracrine loops are present during 
activated mesothelial responses than during peritoneal equilibrium when mesothelial 
cells are quiescent. In addition to enhanced adhesion to matrix components, cross-talk 
between mesothelial and tumour cells may be an important mechanism for the 
preferential tumour growth at surgically traumatised peritoneal locations (figure 11.2). 
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Figure 11.2 
Mesothelial cell regeneration and peritonea! tumour recurrence. 
Cellular mediators of surgical trauma 
Peritoneal trauma induces an oscillation in abdominal cells. Apart from an augmented 
absolute cell amount, the ratio changes from primarily monocytes to granulocytes 
(PMN). This observation was made during the acute phase after surgery and most 
likely represents the PMN influx in response to chemoattractant factors. PMN generate 
reactive oxygen metabolites and discharge contents of granular organelles to ingest 
foreign particles or micro-organisms. Both oxygen dependent and oxygen independent 
processes participate in the killing of bacteria and also in damage to host tissue.22-24 
PMN also produce inflammatory mediators like IL-1r and TNF-a, however the capacity 
is low in comparison to peritoneal macrophages.23;25 
Enhanced tumour recurrence after intra-peritoneal injection of primarily PMN, as 
accomplished in the experiments described in chapter 4, may therefore be based on 
several characteristics of these cells. First, through cytokine production an upregulation 
of cell adhesion molecules may be induced26;27, hereby facilitating tumour adhesion 
(figure 1 B). In addition, cytokine activated mesothelial cells produce chemoattractants 
such as IL-S, required for PMN recruitment.";29 In this way, the mesothelium and 
inflammatory cells in the abdominal cavity may perpetuate a cytokine loop, resulting in 
extreme activation of the inflammatory process. Secondly, mesothelial damage may be 
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induced in two ways. By the degranulation of organelles, but most likely through the 
production of reactive oxygen species (ROS).24 
Excessive production of ROS and related tissue injury plays a fundamental role in a 
wide variety of disease processes. 24;30 In ischaemia reperfusion injury, ROS mediated 
injury has been recognised for a long time. 31 In a rather unusual way, the experiments 
described in this thesis also turned in the direction of ROS mediated enhanced tumour 
recurrence (figure 11.3). In chapter 5, red blood cell (RBC) related components were 
recognised as hav'lng a tumour impeding function. This effect mainly took place around 
the acute phase of surgery. The experiments in chapter 6 further unravel that anti-
oxidant scavengers, contained by RBG, are responsible for inhibiting tumour 
recurrence. 
Recent studies brought to light that ROS are potent inducers of the nuclear factor (NF) 
kappaB. Upon activation, NF-kappaB induces transcription of a number of genes 
involved in cell adhesion, immune and pro-inflammatory responses and growth.32;33 
Although the exact pathway by which ROS stimulate peritoneal recurrence was not 
unravelled, both peritoneal tissue damage and activation of NF-kappaB may playa 
role. 
With the use of anti-oxidant scavengers, it was demonstrated that ROS stimulate 
tumour recurrence. This may be a pathway of the tumour promoting effect brought 
about by the cellular component of the lavage fluid since PMN are a major source of 
ROS. These experiments, although indirectly, stress the correlation between tissue 
trauma and tumour recurrence. Furthermore, as deduced from the experiments 
described in chapters 4 and 5, the timing of intervention methods is essential and 
should be aimed within the acute phase after surgical trauma. 
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Figure 11.3 
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PMN mediated trauma of the peritoneum. 
Soluble mediators of surgical trauma 
The soluble fraction of the lavage fluid collected after surgical peritoneal trauma 
represents all substances, including growth factors and inflammatory cytokines, that 
are present in the abdominal cavity in the acute phase after surgical trauma. The 
dichotomy of cell adhesion and growth is now relevant to disclose exact mechanisms of 
tumour recurrence. Other than the demonstrated acute phase cytokines (IL-1~, IL-6, 
TNF-o:) and IGF-I, different components of the wound healing process may also be 
expected in the soluble fraction. 
Insulin-like Growth Factar-I (IGF-I) Serum IGF-I is a metabolic representation of 
trauma intensity.34;35 Laparoscopic bowel resection affects circulating levels less than 
conventional surgery. In chapter 4, it is demonstrated that IGF-I in abdominal lavage 
fluid is also an indicator of trauma intensity. Enhanced concentrations IGF-I could be 
the result of efflux from the blood to the peripheral tissues34 or of local production by 
mesothelial celis. 36 
The effect of IGF-I is mainly exerted during tumour growth. From the investigated 
growth factors, it was selected as the only factor that promoted tumour growth, which 
emphasises its vital role in tumour recurrence. The stUdies described in chapters 9 and 
10 demonstrate IGF-I is used as an autocrine factor by tumour cells. During paracrine 
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interactions a synergistic loop appears to exist when IGF-I is added. These data 
demonstrate the tumour enhancing effect and the difference between autocrine and 
paracrine interactions mediated by IGF-I (figure 11.2). 
Similar to the CC531 colon carcinoma cells used in the described studies, most human 
colon cancers express a significant concentration of IGF-I receptor-like binding Sit8S. 37 
Therefore, IGF-I related interactions might not be restrained to the tumour cell line used 
in this thesis. 
Interleukin-1 jJ (IL-1 jJ) One of the first acute phase cytokines to appear after peritoneal 
trauma is IL-1~. Its whimsical appearance and volatility causes many futile attempts at 
demonstrating its presence. 38 The in vitro studies described in chapter 7 demonstrate a 
pivotal role of this cytokine in tumour cell adhesion. Already at low concentrations a 
significant increase in tumour eel! adhesion to a mesothelial monolayer was seen. The 
time dependency suggested a secondary upregulation of cell adhesion molecules. IL-
1~ is known as an appropriate stimulus for NF-kappaB. Besides a direct IL-1~ 
mediated upregulation of adhesion molecules, activation of this nuclear factor may be 
an indirect pathway ultimately leading to enhanced tumour recurrence. 
Although IL-1~ did not directly stimulate tumour and mesothelial cell growth, at 
paracrine level a significant augmentation of mesothelial cell proliferation was seen, 
illustrating that direct proliferative responses and upregulation of paracrine growth 
stimulatory factors are mediated via different pathways. These data place IL-1~ as an 
imporlant factor in different pathways leading to enhanced tumour recurrence (figures 
11.1Band 11.2). 
Other inflammatory cytokines and growth factors In the adhesion studies, TGF-~ 
mildly enhanced tumour cell adhesion. EGF was a potent stimulator of tumour cell 
adhesion that coincided with mesothelial cell proliferation. In the growth studies EGF 
was indeed a potent stimulator of mesothelial cell growth. Apparently, enhanced 
adhesion and cell growth walk hand in hand. 
Summarising, post surgically produced cytokines and growth factors secreted into the 
peritoneal fluid may cause a generalised state of mesothelial activation. Upregulation of 
cell adhesion molecules by these factors would clarify tumour recurrence at not directly 
traumatised peritoneal surfaces (figure 11.1 B), whereas stimulated mesothelial cell 
proliferation would facilitate tumour adhesion to regenerating areas of traumatised 
peritoneum (figure 11.2). 
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Considerations for clinical application 
Any form of peritoneal trauma is likely to enhance peritoneal tumour recurrence. 
Although it is the best treatment option for gastro-intestinal malignancies, surgery may 
not be the best intervention method to prevent recurrence. Adjuvant measures 
embraced with surgical intervention seem a logical step to eliminate post-operative 
loco-regional recurrent disease. 
In this thesis several pathways of tumour recurrence have been brought into 
perspective. Figure 11.4 shows multiple pathways leading to enhanced tumour 
recurrence that are based on the experiments described in this thesis. In vivo, a 
combination of these pathways is likely to take place. 
I Surgical peritoneal trauma I 
Loss of integrity mesothelial monolayer 
1 l l 
Indirect Mesothelial regeneration Direct 
1\ l t- minimal scavengers -==; \. invasive anti-NF-KB surgery 
cytokines I ROS growth factors uncovering of 
sub-mesothelial matrix 
1 1 1 
L---_.:~I--------1 peritonea! tumour recurrence 
Figure 11.4 
Pathways leading to tumour recurrence. Indirect peritoneal trauma: i.e. inflammatory mediators 
like PMN, cytokines and ROS; Growth stimulating factors during mesothelial regeneration: i.e. 
IGF-I and EGF; Direct peritoneal trauma: surgical handling of the peritoneum. 
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Adjuvant measures to prevent peritoneal tumour recurrence may be sought at different 
levels. Diminishing the extent of direct peritoneal tissue trauma may be achieved with 
the use of minimal invasive surgical techniques, like laporoscopy, and the use of less 
traumatic tools (i.e. gauzes). These surgical measures may be combined with the 
application of a protective layer to the resection site and peritoneum, as has been 
suggested with hyaluronic based gels and coatings (figure 11.4). 
Preventing adhesion of per-operatively spilled tumour cells with the use of monoclonal 
antibodies might prove difficult, as the expression profile of adhesion molecules is likely 
to be highly variable between tumours. Integrin mediated adhesion to matrix 
components may be collectively blocked with the use of peptides containing integrin-
binding sequences (i.e. RGD).39;40 These peptides are capable of interfering with 
integrin function in general and have been shown to block experimental metastasis. 
Given the complexity of the cell adhesion apparatus, blocking one single receptor, 
however, cannot prohibit adhesion through another. Therefore, this pathway may prove 
difficult for clinical application. 
Manipulation of the inflammatory reaction may be a more novel approach of 
diminishing tumour recurrence. Interference with inflammatory cytokines and growth 
factors with the use of antibodies may impede normal peritoneal wound healing and 
disturb the balance of the cytokine network inducing unknown side effects. The key role 
of NF-kappaB in regulating expression of a number of pro-inflammatory genes and 
adhesion molecules makes this protein an attractive target for selective therapeutic 
intervention (figure 11.4). Current studies are investigating the possibility of interfering 
with its regulatory system and form a promising new approach in preventing tumour 
recurrence. 33 
ROS mediated tissue injury can be restrained fairly easily with the use of anti-oxidant 
scavengers. In ischaemia-reperfusion injury, scavengers are widely used to protect 
organs from ROS mediated tissue injury. A wide variety of anti-oxidant scavengers, in 
addition to SOD and catalase, are being used in clinical practice (i.e. preservation fluids 
like UW). The use of a lavage fluid, containing these factors, may prove a manageable 
therapeutical measure to prevent recurrence by per-operatively seeded tumour cells 
without impeding peritoneal wound healing (figure 11.4). 
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Chapter XII 
SUMMARY and CONCLUSIONS 
Surgical treatment of gastro-intestinal malignancies is often complicated by loco-
regional recurrence. Patterns of first recurrence show the resection site is preferential, 
and distant metastases combined with loco-regional intra-abdominal recurrence is 
common. 
The studies described in this thesis were aimed at unravelling links between surgical 
peritoneal trauma and peritoneal tumour recurrence. In vivo and in vitro rat models 
were used to study which surgery related factors affected tumour cell adhesion or 
growth and consequently tumour recurrence. Different facets of the peritoneal 
response to surgical trauma were highlighted with the intention to elucidate which 
pathways may be used for specific therapeutical alternatives. 
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IN VIVO EXPERIMENTS 
Surgical peritoneal trauma and tumour recurrence in vivo 
Surgical trauma to the peritoneum causes the formation of fibrous adhesions. A 
correlation appears to exist between the intensity of surgical trauma and the amount of 
adhesion formation. The first experimental studies presented in this thesis investigated 
whether mechanisms leading to post-operative adhesion formation also applied to 
post-operative tumour recurrence. 
The demonstrated results dearly point out that a similar correlation exists between the 
intensity of surgical peritoneal trauma and the amount of local tumour recurrence. 
However, after infliction of severe peritoneal trauma significantly more tumour 
recurrence was also seen at not directly traumatised sites in addition to enhanced 
tumour growth. It seems that the surgery related tumour enhancing effect is not a local 
phenomenon but has a generalised character. 
The inflammatory response to surgical peritoneal trauma appeared to playa pivotal 
role in the process of tumour recurrence. Inflammatory mediators like cells and 
cytokines could be captivated in a lavage fluid and transferred to naive, non-operated 
recipients. Surgery related factors produced in the early hours after surgical peritoneal 
trauma, were potent stimulators of tumour recurrence. The cellular component of the 
post-surgical inflammatory process was the main stimulator of in vivo tumour 
recurrence. Cytokines also enhanced in vivo recurrence, but played an inferior role. No 
differences in cytokine concentration were detected in mildly or severely traumatised 
rats. However, elevated concentrations of IGF-I were detected in the abdomens of 
severely traumatised rats. 
Intra-abdominal blood loss and peritoneal tumour recurrence in vivo 
Operative skills seem to be a relevant factor in tumour prognosis. Excessive per-
operative blood loss followed by transfusion has been associated with increased 
tumour recurrence. The in vivo studies described in this part of the thesis analysed the 
effect of intra-abdominal blood on peritoneal tumour cell adhesion and growth. 
Simultaneous intra-abdominal injection of blood and tumour cells after surgical 
peritoneal trauma resulted in reduced adhesion of per-operatively spilled tumour cells, 
bul did not affect tumour growth. The tumour inhibitive effect by blood only took place 
within 24 hours after surgical trauma and was mediated by intra-RBC substances. 
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The RBC related anti-oxidant scavengers catalase and superoxide dismutase (SOD) 
were among the effectors of tumour inhibition by RBC. Haemoglobin enhanced tumour 
recurrence significantly. The total inhibition of tumour recurrence that was achieved by 
combining catalase and SOD was not additional to their separate effect and consisted 
of 40%. From these results we concluded that neutral ising the oxidative burst after 
surgical peritoneal trauma with the use of anti-oxidant scavengers may prove a 
successful approach for diminishing peritoneal tumour recurrence. 
Based on these in vivo results, the initial impetus to separating the generalised term 
"tumour recurrence" into the more elementary mechanisms tumour cell adhesion and 
tumour growth was made. The following in vitro experiments were aimed at unravelling 
specific pathways of enhanced tumour cell adhesion and growth. 
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IN VITRO EXPERIMENTS 
Mesothelial and tumour cell adhesive interactions in vitro 
An in vitro cell adhesion model was designed to study the adhesive interactions 
between primary cultures of mesothelial cells and tumour cells. The effect of 
inflammatory cytokines and growth factors, produced after surgical trauma, on tumour 
cell adhesion could be investigated without the interference of unknown in vivo factors. 
Using the same model, adhesion to different proteins of the sub-mesothelial matrix 
mimicked tumour cell adhesion to damaged peritoneum. 
Tumour cell adhesion to mesothelium pre-incubated with IL-1~ and EGF resulted in a 
dose dependent stimulation of tumour cell adhesion of at least 60%. TGF-~ pre-
incubation resulted in a minor though significant stimulation of cell adhesion (maximal 
16%). Enhanced tumour cell adhesion after IL-1~ pre-incubation appeared to depend 
on an upregulation of cell adhesion molecules, whereas after EGF pre-incubation an 
increase in the number of mesothelial cells probably played a role. 
When studying tumour cell adhesion to different sub-mesothelial matrix components, a 
preferential adhesion of tumour cells to collagen type I (50% versus <30% adhesion to 
other sub-mesothelial matrix (ECM) components and mesothelial cells) was seen. 
Tumour cells contained mRNA encoding for ICAM-I, a." a., and ~, integrins and 
expressed these adhesion molecules on the cell surface. Unlike a. integrin chains, ~, 
mediated tumour cell adhesion to all ECM proteins. Tumour cell adhesion to 
mesothelium occurred through an integrin and ICAM-I independent mechanism. 
Analysis of cell adhesion molecules expressed by both cell types elucidated the 
presence of several adhesion molecules offering potential interaction between both cell 
types. 
Mesothelial and tumour cell growth in vitro 
The response of mesothelial cells to growth factors highlights the reparative properties 
of this tissue. During wound healing, tumour cells present at the injured site may profit 
from the same mediators to stimulate tumour growth. Indeed, clinical evidence exists 
that surgically traumatised surfaces are predestined sites for successful implantation of 
tumour cells. This part of the thesis investigated which factors playa role in mesothelial 
and tumour cell proliferation and interaction. 
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We demonstrated that growth stimulation of tumour cells in the autocrine setting was 
preferentially mediated through IGF-1. Mesothelial cells appeared more susceptible to 
the growth stimulating effects of different wound healing factors. In our study, 
significant enhancement of mesothelial cell proliferation was seen after stimulation with 
IGF-I, TGF-a, EGF and bFGF. 
During co-culture, interactions at paracrine level between mesothelial and tumour cells 
could be investigated. Under these conditions, the cell types do not make contact 
however, cross-talking takes place by soluble factors in the culture medium produced 
by both cell types. These studies demonstrated that quiescent mesothelial cells, during 
non-proliferating conditions, produced factors that significantly inhibited the growth of 
tumour cells, while, conversely, tumour cells stimulated the growth of mesothelial cells. 
Adding IGF-I to the culture medium potentiated the inhibitory effect of mesothelial cells 
on tumour celis. Actively proliferating mesothelial cells, as seen during peritoneal 
wound healing, stimulated tumour growth significantly. Under these circumstances IGF-
I, added to the medium, showed additional stimulation of tumour growth. 
Of the cytokines, IL-1f slightly inhibited tumour cell and mesothelial cell growth but 
augmented mesothelial cell proliferation during co-culture with tumour cells. This 
suggests that the direct proliferative responses and upreguJation of paracrine growth 
stimulatory factors are mediated via different pathways. 
It seems different paracrine loops are present during activated mesothelial responses 
than during peritoneal equilibrium when mesothelial cells are quiescent. 
Conclusions 
• Surgical abdominal trauma stimulates peritoneal tumour adhesion and growth. 
(chapter 3) 
• Surgical abdominal trauma stimulates tumour growth. (chapter 3) 
• The extent of surgical trauma correlates with tumour adhesion and growth. (chapter 
3) 
• Inflammatory cells (mainly PMN), present in the abdominal cavity after surgical 
trauma, stimulate tumour adhesion and/or growth. (chapter 4) 
• Cytokines and growth factors, present in the abdominal cavity after surgical trauma, 
stimulate tumour adhesion and/or growth. (chapter 4) 
• Simultaneous injection of blood and tumour cells in the peritoneal cavity inhibits 
adhesion of these tumour cells. (chapter 5) 
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• Intra red blood cell anti-oxidants (catalase and SOD) prevent peritoneal tumour 
adhesion and/or growth. (chapter 6) 
• IL-1 P stimulated tumour cell adhesion is associated with an upregulation of cell 
adhesion molecules. (chapter 7) 
• EGF stimulated tumour cell adhesion coincides with mesothelial cell proliferation. 
(chapter 7) 
• Tumour cells adhere preferentially to sub-mesothelial collagen (type I). (chapter 8) 
• Significantly higher concentrations of IGF-I are found in surgically traumatised 
abdomens. (chapter 4) 
• IGF-I stimulates tumour growth. (chapter 10) 
• A monolayer mesothelial cells inhibits tumour cell proliferation. (chapter 9) 
• Actively proliferating mesothelial cells stimulate tumour cell proliferation. (chapter 
10) 
These conclusions may, however, be restricted to the used rat model and colon 
carcinoma cell line (CC531) in the described experiments. General conclusions that 
may be drawn are: 
• Surgical abdominal trauma stimulates peritoneal tumour recurrence through 
stimulating tumour cell adhesion and tumour growth. 
• The inflammatory process after surgical trauma plays a pivotal role in the promotion 
of peritoneal tumour recurrence. 
• Neutralisation of the oxidative burst after surgical trauma prevents tumour 
recurrence. 
• Tumour cell adhesion is stimulated through an upregulation of cell adhesion 
molecules. 
" Mesothelial proliferation stimulates tumour cell growth and adhesion. 
• An intact peritoneum is the best way of preventing peritoneal tumour recurrence. 
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SAMENVATTING VOOR DE LEEK 
Chirurgische behandeling van tumoren uitgaande van het maagdarmkanaal wordt vaak 
gecompliceerd door het terugkomen van kanker in de buik (Ioco-regionale 
tumorrecurrence). Veelal is de plaats waar de oorspronkelijke tumor is verwijderd de 
voorkeurslocatie voar het terugkomen van kanker. Metastasen buiten de bulk 
gecombineerd met recurrence in de buik wordt oak vee I gezien. 
De studies beschreven in dit proefschrift hebben als doel een mogelijke correlatie aan 
te tonen tussen chirurgisch trauma van het peritoneum (buikvlies) en peritoneale 
tumorrecurrenc8. In vivo en in vitro ratmodellen zijn gebruikt om te onderzoeken of 
factoren die in de buik geproduceerd worden na chirurgie, de aanhechting of de groei 
van tumorcellen beYnvloeden en daarmee tumorrecurrenc8. 
Chirurgisch peritoneaal trauma en tumorrecurrence in vivo 
Chirurgische beschadiging, of trauma, van het peritoneum veroorzaakt fibreuze 
adhesies tussen beschadigde oppervlakken in de buik. Eerder onderzoek heeft 
aangetoond dat er een carrelatie bestaat tussen de inten5iteit van het aangerichte 
chirurgisch trauma en de mate van adhesieformatie. De eerste experimentele studies 
beschreven in dit proefschrift onderzoeken naar aanleiding van deze resultaten de 
invloed van vergelijkbare mechanismen, die leiden tot adhesieformatie, op 
postoperatieve tumorrecurrence. 
De resultaten van deze studies laten zien dat een vergelijkbare correlatie tussen 
trauma-intensiteit en tumorrecurrence aanwezig is. Niet aileen werd er meer 
tumorrecurrence aangetroffen op de chirurgisch beschadigde locaties, maar ook op 
niet beschadigd peritoneum. Bovendien bleken reeds aanwezige tumoren, die niet in 
de buik gelokaliseerd waren, harder te groeien. He! lijkt dan oak dat de factoren die 
geproduceerd worden na een chirurgisch trauma niet aileen locaal (in de buik) maar 
oak op afstand een tumor stimulerend effect hebben. 
De ontstekingsreactie na chirurgisch peritoneaal trauma bleek een centrale rol te 
spelen bij tumorrecurrence. Ontstekingsmediatoren, zoals cellen en cytokinen, werden 
gevangen in een spoelvloeistof en overgebracht naar buiken van niet-geopereerde 
ontvangers. Na deze passieve overdracht werd tumorrecurrence oak gestimuleerd in 
de ontvangers. De cellulaire component van de ontstekingsreactie bleek het meest 
195 
krachtige tumorstimulerende effect te hebben, echter de overdracht van cytokinen 
aileen leidde oak tot significant meer tumorrecurrence. 
Intra-abdominaal bloedverlies en peritoneale tumorrecurrence in vivo 
Operatieve vaardigheid lijkt een belangrijke prognostische factor te zijn voor patienten 
met kanker. Overmatig bloedverlies tijdens de operatie gevolgd door bloedtransfusie is 
geassocieerd met een slechtere prognose. De in vivo studies beschreven in dit deel 
van het proefschrift hebben het effect van de aanwezigheid van bloed in de buik op 
peritoneale tumorcel-aanhechting en -groei onderzochL 
Het achterblijven van bloed en tumorcellen in de buik na het aanrichten van chirurgisch 
trauma ging gepaard met minder aanhechting van tumorcellen. Werd het bloed 
toegevoegd nadat tumorcellen reeds aangehecht waren (24 uur later), dan was het 
tumor~remmend effect verdwenen. Anti-oxidantia, aanwezig in rode bloedceHen, bleken 
verantwoordelijk voor het tumor-remmende effect. Het gebruik van anti-oxidantia lijkt 
dan oak een succesvolle benadering te zijn voar het verminderen van peritoneale 
tumrorecurrence. 
De hierna beschreven studies zijn verricht in een weefselkweekmodel (in vitro) waarin 
de elementaire mechanismen van tumorrecurrence, zeals tumorcel-aanhechting en ~ 
groei, onderzocht kunnen worden. 
De aanhechting van tumorcellen op mesotheel 
Aile organen in de buik worden bedekt door het peritoneum dat bestaat uit 
mesotheelcellen van slechts een laag dik met daaronder een matrix van eiwitten. Door 
de mesotheelcellen in vitro te kweken, kon de aanhechting van tumorcellen bestudeerd 
worden zonder dat onbekende 'in vivo' factoren hier invloed op hadden. 
Door de gekweekte mesotheellaag voor te behandelen met cytokinen en groeifactoren 
werd aangetoond dat sommige van deze factoren de aanhechting van tumorcellen op 
het mesotheel stimuleren. Bovendien bleek er een preferentiele aanhechting te 
bestaan van tumorcellen op de eiwitten die zich in de matrix onder de mesotheellaag 
bevinden. Deze aanhechting werd gereguleerd door specifieke aanhechtingsmoleculen 
waarvan de functie volledig geblokkeerd kon worden met de hulp van antilichamen. 
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Mesotheel~ en tumor6 groei in vitro 
De reactie van mesotheelcellen op groeifactoren en cytokinen stipt de unieke 
herstelmogelijkheden van dit weefsel aan. Tijdens wondheling kunnen tumorcellen die 
aanwezig zijn op de plaats van de wond prafiteren van dezelfde mediatoren als de 
mesotheelcellen wat leidt tot gestimuleerde tumorgraei. In dit deel van het praefschrift 
werd onderzocht welke factoren een ral spelen bij mesotheel- en tumor-graei en of zij 
de interactie tussen deze cellen bernvloeden. 
Mesotheelcellen groeiden significant sneller nadat verschillende groeifactoren 
toegevoegd werden aan het kweekmedium. TumorceHen respondeerden aileen na 
toevoegen van een groeifactor aan het kweekmedlum. 
Door mesotheel- en tumor-ceHen samen te kweken zonder dat ze contact maken met 
elkaar, kon onderzocht worden of deze cellen een interactie met elkaar aangaan door 
te communiceren via het kweekmedium. Deze studies toonden aan dat 
mesotheelcelJen van een cellaag dik, zoals in de bulk voorkomt, factoren produceren 
en uitscheiden die de groei van tumorcellen remmen. Werden tumorcellen samen 
gekweekt met groeiende mesotheelcelien, zoals tijdens wondheling, dan werd 
tumorgroei gestimuleerd. Omgekeerd, bleken tumorcellen de groei van 
mesotheelcellen te stimuleren. 
Samenvattend kan gesteld worden dat chirurgisch abdominaal trauma de groei en 
aanhechting van tumorcellen stimuleert en daarmee peritonea Ie tumorrecurrence. 
Beschadigd peritoneum, waarbij de mesotheeilaag is verdwenen, toont een 
voorkeursplaats voor tumorrecurrence. Tijdens het ontstekingsproces en de 
wondheling na chirurgische beschadiging komen factoren vrij in de buik die locaal de 
aanhechting en groei van tumorceHen stimuleren, maar tevens de tumorgroei op 
aftstand bevorderen. 
Algemeen mag geconcludeerd worden dat een intact peritoneum de beste manier is 
om peritoneale tumorrecurrence te voorkomen. 
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LIST OF ABBREVIATIONS 
bFGF 
CAPD 
E-cad 
ECM 
EGF 
GM-CSF 
ICAM 
IFN 
IGF 
IL 
IL-1RA 
NF-KB 
PAl 
PDGF 
PMN 
PG 
ROS 
SOD 
TGF 
TNF 
VCAM 
basic fibroblast growth factor 
continuous ambulatory peritoneal dialysis 
epithelial cadherin 
extra cellular matrix 
epidermal growth factor 
granulocyte monocyte-colony stimulating factor 
inter celiular adhesion molecule 
interferon 
insulin-like growth factor 
interleukin 
interleukin-1 receptor antagonist 
nuclear factor kappa B 
plaminogen activator inhibitor 
platelet derived growth factor 
polymorph nuclear leukocytes 
prostaglandins 
reactive oxygen species 
superoxide dismutase 
transforming growth factor 
tumour necrosis factor 
vascular cell adhesion molecule 
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